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1 INTRODUCTION 
The biopsychosocial model of musculoskeletal pain (MSP) states that the process of 
MSP becoming chronic is initiated or maintained by multiple, interacting biological, 
psychological and social factors (e.g., Waddell, 2004). These factors reach from 
altered sensory processing to fear-motivated operant learning, social reinforcement of 
pain behavior and coping resources. This complexity of factors and the fact that pain 
is a multidimensional phenomenon in itself complicate diagnostic evaluation of clinical 
and work-related pain syndromes in occupational health settings. The goal of this 
thesis was to phenotype this complexity in chronic MSP syndromes. 
Basically, two aspects were considered: The chronicity construct was reanalyzed in 
terms of differential characteristics underlying the assumed one-dimensional 
composition. Subsequently, necessary and sufficient primary sensory and clinical pain 
markers for chronic MSP were identified. The diagnostic and classification problems of 
chronic MSP presented in the following section were the driving factors to start this 
PhD project.  
1.1 Phenomenology and chronicity mechanisms of musculoskeletal pain 
The phenomenology of MSP changes over time due to the interacting biological, 
psychological and social factors. Eliciting mechanisms closely related to the potential 
tissue damage have to be separated from sustaining mechanisms that become 
relevant as the pain symptomatology persists. Following pain terms were considered 
relevant to characterize chronic MSP. 
1.1.1 Pain terms: Acute vs. chronic pain; pain vs. nociception 
Basically, acute pain has to be distinguished from chronic pain. Acute pain is provoked 
by a local injury and has an alarming function to prevent further potential nociceptive 
input thereby helping to accelerate the healing process (Loeser & Melzack, 1999). 
Chronic pain is regarded as a disease disproportional or different to the possible initial 
tissue damage and defined by pain lasting longer than the natural time of healing 
(Bonica, 1990; Loeser & Melzack, 1999).  
Another important differentiation relates to the pain perception itself: Pain as 
phenomenon has to be differentiated from nociception: Whereas pain is defined as    
“an unpleasant sensory and emotional experience associated with actual or potential 
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tissue damage, or described in terms of such damage” (p. 210, Merskey & Bogduk, 
1994; terms and definitions originally introduced in Merskey et al., 1979), nociception 
is described with “the neural processes of encoding and processing noxious stimuli” 
(p. 473, Loeser & Treede, 2008). Consequently, nociception does not necessarily 
correspond to pain and vice versa, e.g., under local anesthesia peripheral nociception 
occurs without pain.  
1.1.2 Eliciting vs. sustaining mechanisms of chronic musculoskeletal pain 
Depending on the proximity to nociception different mechanisms are associated with 
the process of acute pain becoming chronic. Eliciting mechanisms in MSP are primarily 
related to the pain physiology (proximal level) and are largely neurobiological in nature, 
whereas sustaining mechanisms act mostly independent of the former (at the 
intermediate and distal level) and prevent the alleviation of the pain symptomatology 
(cf. Figure 1: process model of core eliciting and sustaining mechanisms in MSP 
becoming chronic). Selective mechanisms on the three levels contribute to the clinical 
endpoint criteria of chronic MSP syndromes, such as Fibromyalgia Syndrome (FMS) 
or chronic unspecific back pain (cUBP) with varying extent of functional disability (cf. 
Figure 1, right marked in red). 
  
Introduction 
3 
 
Criterion
Pain syndrome
Functional 
disability
Proximal Intermediate Distal 
Sensory 
processing
Operant 
learning 
Psycho-
physiological 
response
Affective pain 
response
Somatic 
comorbidity 
effects
Psychic 
comorbidity 
effects
Fear-of-pain 
conditioning 
Endocrine 
regulation
Social 
consequences
Clinical pain 
perception
Cognitive 
processing
 
 
 
Figure 1: Process model of core eliciting and sustaining mechanisms in MSP becoming 
chronic derived from the available data of the dissertation project (Figure adapted from Hölzl, 
Deuschle, & Benrath, 2000). 
Proximal level: peripheral (enhanced pain sensitivity) and presumably spinal/central 
nociception (wind-up/sensitization) as well as clinical pain; intermediate level: operant 
conditioning of pain escape and avoidance, but also fear of pain (cf. Leeuw et al., 2007; 
Vlaeyen & Linton, 2000), affective (e.g., unpleasantness of the pain experience) and 
psychobiological responses (cortisol level, heart rate); distal level: cognitive processing (e.g., 
catastrophizing), somatic symptom burden and psychic comorbidity. Social consequences are 
supposed to have an effect on all levels in the process of pain becoming chronic. Clinical 
endpoint criteria are the actual pain diagnosis (e.g., FMS in chronic primary pain, ICD-11; 
Treede et al., 2015) but also the functional disability classified by the International 
Classification of Functioning, Disability and Health with differential ICF Core Sets (Bickenbach, 
2014). The ICF Core Sets comprise two core parts: The first part includes functioning and 
disability, whereas the second part contains contextual factors. There are pre-defined sets for 
chronic widespread pain and low back pain available. 
 
The dissertation project was provided with data of sensory processes and clinical pain 
perception at the proximal level. Sensory processes were related to the modulation 
and modification of the nociceptive input as well as the development of pain 
hypersensitivity by neuroplastic changes in the central nervous system, e.g., impaired 
descending inhibitory control (Flor, 2014; Woolf & Salter, 2000). Clinical pain 
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perception encompassed various data on the clinical pain symptomatology, such as 
the pain intensity, pain location or the temporal pattern of occurrence. 
The sustaining mechanisms at the intermediate level are seen as transition stage for 
pain becoming chronic. Research has revealed a number of such supposed transition 
mechanisms among the most prominent the operant learning such as the fear-of-pain 
conditioning (Leeuw et al., 2007; Vlaeyen & Linton, 2000). In this paradigm the pain is 
misinterpreted as fearful threat of potential harm for the individual well-being, resulting 
in negative reinforcement of safety seeking behaviors. These avoidance behaviors 
lead to inactivity and consequently reduced muscle activity and disordered 
coordination of movements prone to result in disability and more pain in a vicious circle. 
Another more direct transition mechanism is the aversive Pavlovian conditioning by 
pain stimuli itself. In this paradigm selected movements provoke pain resulting in 
enhanced muscular response or tension that is, in turn, more likely to be interpreted 
as aversive and, hence, avoided in the future (Schneider, Palomba, & Flor, 2004). 
Other transition mechanisms at the intermediate level are related to neuroendocrine 
responses for which the pathophysiology in developing chronic MSP is not entirely 
understood, yet. Research showed that glucocorticoids such as cortisol levels as 
marker for a Hypothalamic-Pituitary-Adrenocortical Axis dysregulation were higher in 
high risk patients for pain becoming chronic (e.g., Garofalo, Robinson, & Gatchel, 
2006). The same applies to psychophysiological responses such as increased 
cardiovascular activity or muscle tension as a reply to (persisting) pain stimuli (Kyle & 
McNeil, 2014).  
The distal level includes pain enhancing and modulating mechanisms, e.g., cognitive 
processing such as passive coping styles and catastrophic appraisals (Higgins, Bailey, 
LaChapelle, Harman, & Hadjistavropoulos, 2015). In addition, the overall somatic 
symptom complaints and psychic comorbidity such as depression was either 
associated with a higher risk to develop chronic pain (Pincus, Burton, Vogel, & Field, 
2002) or, at least, to vary within the same diagnosis of FMS possibly resulting from 
different underlying subgroups (Gracely, Ceko, & Bushnell, 2012; Thieme, Turk, & Flor, 
2004). Especially depressive symptomatology might enhance pain by intervening 
mechanisms such as helplessness, self-blaming, social withdrawal and physical 
inactivity.  
Social consequences are supposed to have an effect on all proximal, intermediate and 
distal level mechanisms. The most crucial social consequence might be the way 
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significant others respond to the pain symptomatology thereby positively or negatively 
reinforcing pain behaviors, which refers to operant learning mechanisms at the 
intermediate level in this model (Fordyce, 1976).  
The model presented here does not claim to be comprehensive, i.e., neither 
interdependencies of associated mechanisms are taken into account nor abnormal 
functional connectivity and structural changes in cortical areas, genetic or epigenetic 
risk factors are implemented (Flor, 2017). 
1.1.3 Characteristics of musculoskeletal pain: Phenomenology 
The differential consideration of mechanisms acting in different stages in the process 
of pain becoming chronic is partially based on the pioneering multidimensional 
conceptual model of pain (Melzack & Casey, 1968). This model differentiates between 
the sensory-discriminative, affective-motivational and cognitive-evaluative dimension 
and served as framework for the parametrization of marker domains given the 
available study data (cf. Table 1). The sensory-discriminative dimension 
encompassed, with respect to the available study data, peripheral nociceptor 
hypersensitivity, peripheral and central sensitization, endogenous pain modulation as 
well as clinical pain perception (cf. Figure 1; sensory and perceptual mechanisms at 
the proximal level). These mechanisms in pain becoming chronic were represented by 
quantitative markers for enhanced pain sensitivity, wind-up, impaired descending 
inhibitory control as well as clinical pain characteristics (cf. Table 1: experimental pain 
and clinical pain as markers for the sensory-discriminative domain). The affective-
motivational dimension is primarily associated with central structures of the limbic 
system in the central nervous system. It encompasses emotional processes such as 
the affective pain response and the neuronal preparation of avoidance or approaching 
actions. These mechanisms were covered by markers for the affective quality and fear 
of pain (cf. Figure 1; affective pain response and fear of pain at the intermediate level). 
The cognitive-evaluative dimension is supposed to interact as superordinate unit with 
the sensory-discriminative and affective-motivational dimensions and was suggested 
to modulate the pain experience by meta-cognitions (Melzack & Casey, 1968). This 
domain was covered by pain cognitions and coping (cf. Figure 1; cognitive processing 
at the distal level), but also by operant learning as implied by the response of significant 
others (cf. Fordyce, 1976). Besides these three dimensions, comorbidity and 
psychosocial aspects constituted further relevant domains supposed to modulate the 
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pain symptomatology and intervene in the process of pain becoming chronic (cf. Figure 
1; distal and intermediate level). 
Table 1. Domains and characteristics of chronic musculoskeletal pain  
Domain Characteristic 
Sensory-discriminative               
(- perceptive) 
Experimental pain 
- Enhanced sensitivity 
- Wind-up 
- Impaired descending inhibitory control 
Clinical pain 
- Intensity 
- Localization 
- Duration and pattern of occurrence 
- Sensory quality 
Affective-motivational 
Affective pain response 
-  Affective quality 
Fear  
- Fear of pain 
Cognitive-evaluative  
Cognitions and coping 
- Fear-avoidance beliefs 
- Catastrophizing 
- Coping  
Learning 
- Operant conditioning by social response 
Comorbidity 
Somatic  
- Other pain conditions 
- Non pain conditions 
Psychic 
- Mental health 
- Psychiatric disorders 
- Disposition for anxiety (trait anxiety) 
Psychosocial aspects 
Stress load 
- Perceived stress 
Activity level 
- Household, social and leisure  
Domains with respective marker characteristics covered by the available data in the 
dissertation project. The sensory-discriminative, motivational-affective and cognitive-
evaluative component are based on the multidimensional conceptual model of pain (Melzack 
& Casey, 1968), whereas the effects of comorbidity and psychosocial aspects stem from 
various experimental and observational studies as described in the text.  
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Somatic and psychic comorbidity is considered to add to the overall symptom burden 
and the severity of the pain disorder. There is strong evidence for poor physical and 
mental health increasing the risk to develop chronic MSP (O'Neill et al., 2018). The 
relatively high coincidence of chronic MSP with somatic and psychic comorbidity has 
motivated a line of research searching for common etiological factors (Gracely et al., 
2012) and, moreover, the inclusion of aspects of gastrointestinal complains or 
depression as diagnostic criteria for pain disorders (e.g., Häuser, Schmutzer, Brähler, 
& Glaesmer, 2009; Wolfe et al., 2016). The last domain covered by data within the 
dissertation project comprised psychosocial aspects. This domain assembled 
characteristics of perceived stress (cf. Figure 1; primarily related to endocrine and 
psychophysical responses at the intermediate level) and activities associated with 
social consequences. Research has revealed that the subjective stress load affects 
MSP in different contradictory ways: whereas in early acute pain stages stress induced 
analgesia is likely, in chronic pain stress affects the homeostasis and, thus, 
exacerbating the pain symptomatology (Tesarz et al., 2015; Vachon-Presseau, 2018). 
With regard to the last characteristic related to the domain of psychosocial aspects 
moderate physical activities and household chores like gardening were shown to be 
related to lower levels of back pain and, thus, might serve as protective factor 
(Heneweer, Staes, Aufdemkampe, van Rijn, & Vanhees, 2011). 
1.1.4 Research settings: Employees vs. clinic pain patients 
To cover the range from proximal, intermediate to distal mechanisms and especially 
the transition stage from acute pain to chronic pain, research on risk populations for 
pain becoming chronic is promising. While there is a fair amount of research on 
patients with chronic MSP, research in occupational settings, where physical labor is 
performed on a daily basis, is a mean to institutionalize sub-chronic pain.  
Physical load, e.g., in form of exposure to lifting or forceful movements, and work 
dissatisfaction has been shown to be associated with MSP disorders since decades 
(Bernard, 1997; Costa & Vieira, 2010) primarily identifying blue color workers as critical 
group. Static work load, in particular, was shown as major risk factor for MSP disorders, 
possibly due to disproportionate intramuscular pressure that selectively increases in 
low threshold motor units (Cinderella hypothesis: cf. Hägg, 1991, 2003). This selective 
overload is supposed to be associated with metabolic abnormalities in the muscle fiber 
accompanied with tension and, as consequence, MSP (Hägg, 2000). Obviously, 
ergonomic design has improved in occupational settings such as work at assembly 
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lines, driving service or office work and, hence, evidence for a relation of MSP and 
physical load varies across studies leveraging the effects of poor psychosocial work 
conditions on MSP (Lundberg, 2015). Especially low control of work, less social 
support, missing development opportunities and, in particular, job dissatisfaction were 
shown to be associated with back pain (Linton, 2001; Lundberg, 2015; Macfarlane et 
al., 2009). 
Moreover, investigating MSP in occupational settings in comparison to patients in pain 
clinics offers the possibility to gain further insights in cognitive processes, related 
associative learning and the affective pain responses. According to the avoidance-
endurance model of pain (Hasenbring, Chehadi, Titze, & Kreddig, 2014; Hasenbring & 
Verbunt, 2010), MSP potentially evokes two distinct kinds of pain responses: fear-
avoidance responses are characterized by a decrease in physical activity due to fear-
avoidance beliefs, while endurance responses refer to a suppression and distraction 
from the pain leading to an overuse and, consequently, injury. The endurance aspect 
might be especially relevant when addressing MSP in employees. It is likely that for 
this particular setting, the work serves as a distraction from pain, which makes them 
endure the pain and refrain from seeking medical advice. Contrarily, fear-avoidance 
beliefs might be more prevalent in patients already having chronic MSP, which are 
likely to be in sick leave and, consequently, are prone to physical de-conditioning and 
disuse syndrome. 
1.2 Diagnostic and classification problems  
The multidimensionality of the pain characteristics as well as the complexity of 
influencing factors in the process of pain becoming chronic have led to problems in 
diagnostics of pain syndromes, in particular, chronic pain syndromes. It was shown 
that chronic pain is a complex phenomenon caused by more than just somatic agents. 
Hence, a sound diagnostic cannot solely base on a detailed physical examination to 
derive somatic causes and disregard the complexity of influencing differential proximal, 
intermediate and distal mechanisms.  
1.2.1 Diagnostic of medically unexplained pain 
Clinical classification systems, i.e., the International Statistical Classification of 
Diseases and Related Health Problems (ICD-10; World Health Organization, 1992) 
and the Diagnostic and Statistical Manual of Mental Disorders (DSM- IV; American 
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Psychiatric Association, 1994) either classify pain as somatoform or somatic pain and, 
hence, inhere a cartesian dualism philosophy (Flor & Turk, 2011a). Whenever an 
explaining physical cause of the pain symptom is missing and there is a psychological 
involvement, the pain is categorized as somatoform, equivalent to psychic in nature. 
Consequently, the pain can be either result from pain in the body or from the mind. 
This exclusion diagnostic suffers from a logical problem: Falsification is not verification 
in turn. When a medical condition causing the pain symptoms cannot be identified, this 
does not automatically mean that, on the other hand, a psychological condition can be 
verified. There might also exist a somatic cause that cannot yet be measured with the 
available scientific techniques.  
Adjustments were implemented in both classification manuals by the coding of “chronic 
pain disorder with somatic and psychological factors” in the German adaption of the 
ICD-10 (F45.41; Deutsches Institut für Medizinische Dokumentation und Information, 
2009; Nilges & Rief, 2010) and “pain disorder associated with both psychological 
factors and a general medical condition” in the DSM-IV-TR (307.89; American 
Psychiatric Association, 2000), respectively, in which psychological and a general 
medical condition are described as interacting. Whereas the medical condition explains 
the onset, psychological factors determine the severity, the exacerbation and the 
maintenance of the pain symptomatology.  
The latest revision of the DSM-V (American Psychiatric Association, 2013) completely 
abandoned the exclusion practice and does not distinguish between medically 
explained and medically unexplained somatic symptoms anymore (Rief & Martin, 
2014). Now, one somatic symptom leading to a substantial emotional symptom burden 
and subjective stress load qualifies for fulfilling the criteria of the disease category 
“somatic symptom and related disorders” which replaces the former somatoform 
disorders. All patients previously diagnosed with a somatization disorder, 
hypochondria or conversion disorder are now subsumed under this new category. By 
comparison, the Task Force for the Classification of Chronic Pain within the ICD-11 
has made substantial efforts to substantiate pain diagnostic by more etiology-based 
categories (Treede et al., 2015). However, due to the inconclusive etiology of the two 
most prominent chronic MSP disorders in the category “chronic primary pain”, i.e., 
nonspecific back pain and chronic widespread pain, current revisions of both 
classification systems remain far away from a diagnostic basing on positive inclusion 
criteria for chronic unspecific MSP. The need to classify these unspecific MSP 
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syndromes becomes even more relevant taking into consideration their relatively high 
prevalence rate (e.g., lifetime prevalence for unspecific low back pain: 85 %, 
Airaksinen et al., 2006; point prevalence for chronic unspecific back pain: 18 %, 
Gerhardt, Hartmann, Blumenstiel, Tesarz, & Eich, 2014; chronic widespread pain: 
10 % Andrews, Steultjens, & Riskowski, 2018). Moreover, the differentiation between 
these two unspecific MSP syndromes is less clear than one might expect. 
1.2.2 Widespread vs. regional pain 
It has been shown that the individual assignment of regions in pain to respective body 
quadrants varies across studies resulting in considerable different base rates of 
widespread pain and concurrent fibromyalgia syndrome, FMS (Butler, Landmark, 
Glette, Borchgrevink, & Woodhouse, 2016). Widespread pain is defined as pain in four 
body quadrants plus axial skeletal pain and if there are also at least 11 out of 18 tender 
points sensitive to manual palpation the patient qualifies for a diagnosis of FMS 
according to the American College of Rheumatology (ACR) 1990 criteria (Wolfe et al., 
1990). On the contrary, localized pain refers to a circumscribed region in pain, such as 
the lumbar spine region in low back pain (Bogduk, 2009). However, both definitions 
remain less explicit than implied and patients with widespread pain also report 
superordinate regionally distinguishable pain sites (Gerhardt et al., 2014; Natvig, 
Bruusgaard, & Eriksen, 2001). Several efforts have been made to improve the 
quantification of the pain extent, e.g., with markings in body mannequins as suggested 
in the “Manchester” criteria (Hunt, Silman, Benjamin, McBeth, & Macfarlane, 1999) or 
the Michigan Body Map (Brummett et al., 2016), but also by categorical assessments, 
e.g., in the Regional Pain Scale (Wolfe, 2003). The latter set the foundation for the 
development of the Widespread Pain Index (WPI), a checklist of pain loci, as relevant 
part of the revised ACR 2010/2011 criteria for FMS (Wolfe et al., 2010; Wolfe et al., 
2011).  
Since there is evidence for an increase of pain loci in chronic unspecific back pain 
(cUBP) and the gradual development of concurrent widespread pain (Forseth, Husby, 
Gran, & Forre, 1999; Lapossy, Maleitzke, Hrycaj, Mennet, & Müller, 1995), it is not yet 
clear, if both diseases stem from the same pathogenetic mechanisms. The research 
on a differentiation of widespread from regional MSP has much contributed to the 
understanding of the spatial extent, which is possibly better described on a quantitative 
dimension. 
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1.2.3 Pain induced secondary change vs. psychological comorbidity 
Moreover, incidence rates of somatic and psychic comorbidity are higher in patients 
with widespread pain in comparison to patients with regional pain (Viniol et al., 2013). 
However the comorbidity with major depression is relatively high in both MSP 
syndromes (Bletzer, Gantz, Voigt, Neubauer, & Schiltenwolf, 2017; Roch, Follmer, & 
Hampel, 2017). Symptoms of a major depression, such as depressive mood, 
cognitions of helplessness and the decrease in activity level might be a secondary 
change in affect resulting from the pain symptomatology. The high coincidence led to 
the inclusion of depression in the ACR 2010/2011 revised criteria for FMS (Wolfe et 
al., 2010; Wolfe et al., 2011). In this revision a replacement of the tender point count 
by a composite score of self-reported pain locations (WPI) and a symptom severity 
scale (SSS) of characteristic additional symptoms, in particular, fatigue and 
depression, is suggested. This shift from sensory-perceptive pain characteristics to 
clinical and psychological aspects is grounded in application problems of the ACR 
tender point sensory testing (Cott et al., 1992; Fitzcharles & Boulos, 2003; Wolfe et al., 
2016) and the above described high coincidence with psychic comorbidity. However, 
empirical evidence for the inclusion of secondary domains other than the primary 
sensory-clinical pain as cardinal criteria for FMS is limited, but urgently needed. 
Otherwise, including secondary criteria such as a comorbid depression would have the 
potential to increase heterogeneity in this diagnostic group and to hinder the 
identification of core mechanisms active in chronic MSP.  
1.3 Chronicity concepts 
In excess of the clinical pain diagnostics by sensory and clinical pain criteria, the 
assessment of chronic MSP was supposed to consider, in particular, the construct of 
chronicity itself. The quantification of chronicity is supposed to help in the differentiation 
of mechanisms in the process of pain becoming chronic and, as consequence, to ease 
the assignment of optimal treatment and rehabilitation decisions in otherwise 
heterogeneous patient populations. However, also in chronicity assessment the 
multidimensionality of pain characteristics and the complexity of the chronicity process 
itself presents difficulties for both comprehensive and practically viable diagnostic 
characterization of chronic MSP syndromes. Common questionnaires and grading 
instruments deal with the conflict of aims by isolating a general construct of ‘chronicity’ 
from other characteristics of chronic pain. However, it is questionable whether the 
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chronic characteristics of all chronic pain syndromes can be represented in one global 
index of ‘chronicity’ given the multidimensionality of the pain experience and the 
multifactorial causation of different syndromes (e.g., for neuropathic pain vs. MSP). 
1.3.1 Multidimensionality of chronicity 
There is a long tradition in conceptualizing chronic pain. Among the most significant 
are the research on overt pain behavior emphasizing operant aspects (Fordyce, 1976)  
and the research on the empirical clustering of chronic pain out of the West Haven-
Yale Multidimensional Pain Inventory’s cognitive, affective and behavioral information 
(Kerns, Turk, & Rudy, 1985; Turk & Rudy, 1987b, 1988) highlighting the psychosocial 
factors in chronic pain. Several indices evaluate chronicity of MSP across clinical 
syndromes, etiology, psychosocial factors and comorbidity. Among the most common 
are the IASP Taxonomy of chronic pain (IASP Taxonomy Working Group, 2017), the 
Chronic Pain Grade Questionnaire (CPG; Korff, Ormel, Keefe, & Dworkin, 1992) and, 
in the German-speaking part, the Mainz Pain Staging System (MPSS; Pfingsten, 
Schöps, Wille, Terp, & Hildebrandt, 2000). These widely used chronicity indices 
implicate a homogeneous one-dimensional scale of chronicity in pain.  
These and other indices vary in focus of conceptualization of the construct of chronicity. 
At the simplest, pain is defined as chronic when lasting longer than the natural time of 
healing (Bonica, 1990; IASP Taxonomy Working Group, 2017; Loeser & Melzack, 
1999). In clinical practice, this time varies starting at a minimum of three or six months. 
Guidelines for systematic research reviews also recommend 12 weeks duration as 
minimal time period to define chronic pain (Furlan et al., 2015). The importance of the 
aspect of duration in chronic pain is further substantiated by research on the 
development of pain hypersensitivity, because neuroplastic changes in the central 
nervous system (pain memories) were depending on the duration of the nociceptive 
input, its modulation and modification (Woolf & Salter, 2000).  
By comparison, the IASP Taxonomy of chronic pain applies a multiaxial representation 
(five axes) comprising several important dimensions of chronic pain (IASP Taxonomy 
Working Group, 2017). Besides duration, the fourth axis assesses the aspect of 
severity in a compound code. It is built of three intensity and three duration classes 
arranged in series to suggest an ordinal scale. However, the compound interpretation 
of these codes is questionable, as the relation of the intensity and duration categories 
to each other and to external chronicity markers are not yet known. Research of 
biometric criteria of the five axes of the taxonomy is limited to interrater reliability 
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analysis of the first and fifth axis in a consecutive sample of chronic pain patients (Turk 
& Rudy, 1987a).  
In contrast to the IASP Taxonomy of chronic pain, the Chronic Pain Grade 
Questionnaire (CPG; Korff et al., 1992) emphasizes disability as essential component 
of chronicity. The CPG combines pain severity with disability in a compound code, too. 
In the final 4-step ordinal scale the higher grades do no longer depend on pain severity, 
as a result of a certain interpretation of the data analysis. The authors could show 
severity not contributing to higher levels of disability in a Guttman scale analysis. The 
Guttman scale analysis assumes one-dimensionality, consequently, only items fitting 
to a single dimension stayed in the final conceptualization of chronicity. However, this 
emphasis on the consequences of pain symptomatology neglects the primary aspect 
of suffering from enduring pain related to its actual severity and duration. Before the 
final release of the CPG, the items were tested in a group of pain patients with five 
different pain states selected from a sample of health maintenance organization 
enrollers; 42 - 51 % of variance in the samples could be explained with disability, 
average intensity and duration (Korff, Dworkin, & Le Resche, 1990). The other half of 
variance was not reported and, thus, remained unexplained. The authors just 
mentioned that persistence, activity limiting days as well as the self-evaluation of 
chronic or recurring pain was of minor relevance. In the later Guttman scale analysis 
of patients with back pain, headache and temporomandibular joint disorder items of 
duration and well as persistence did not follow one-dimensionality, hence were 
dropped in the final CPG scale construction (Korff et al., 1992). The German version 
of the CPG, validated in primary care back pain patients yielded a two-factor solution 
with the disability score (53.56 % explained variance) and the characteristic pain 
intensity (19.13 % explained variance) (Klasen, Hallner, Schaub, Willburger, & 
Hasenbring, 2004). Both factors comprise three items each, disability days as skewed 
variable was excluded for this factor analyses. 
Another chronicity measure, popular in the German speaking area, is the Mainz Pain 
Staging System (MPSS;  Pfingsten et al., 2000). In this multiaxial index, therapy-
related aspects set up the focus in the construction of the chronicity construct. Besides 
the first axis measuring temporal aspects and the second axis assessing spatial 
aspects of pain, the third axis measures drug taking behavior and the fourth axis 
utilization of the health care system. The scores of each axis are measured on an 
ordinal level. Finally, a compound sum score ranging from 4 to 12 points is derived out 
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of these four dimensions (axes) resulting in three stages of pain chronicity. The higher 
the chronicity stage, the more persistent the pain symptomatology and the more 
complicating factors are presumed requiring intense interventions (Gerbershagen & 
Waisbrod, 1986). Obviously, the instrument measures complex heterogeneous factors 
of different etiology. Validation studies base on external criteria, such as psychological 
comorbidity, other interference scores or simply the treatment success (e.g., Sakinc, 
1998; Schmitt, 1990; Wurmthaler et al., 1996).  
Besides the basic pain characteristics, interference understood as functional limitation 
as well as disability as legal term seem be necessary to consider in a conceptualization 
of chronicity as implied by the International Classification of Functioning, Disability and 
Health ICF-Core sets (Bickenbach, 2014). The ICF-Core sets are a categorial system 
that assess disability with regard to two core parts: functioning and disability as well as 
contextual factors. The first axis functioning and disability is divided into three parts 
body functions (1), body structures (2) and activities and participation (3). The second 
axis of contextual factors consists of two parts comprising environmental factors and 
personal factors, respectively. The sets are pre-defined for specific disorders. The sub-
category body structures, for example, is differently composed for chronic widespread 
pain vs. low back pain: whereas the pre-defined set for the former entails the 
component “musculoskeletal structures related to movement”, the set for low back pain 
includes “spinal cord and related structures”, “structure of pelvic region”, “structure of 
lower extremity” and “structure of trunk”.  
In sum, the conceptualization and understanding of chronicity varies considerably 
across research groups. Hence, a thorough empirical analysis of distinguishable 
components was considered as necessary and overdue. 
1.3.2 Specificity vs. generality of chronicity 
A further problem driving this chronicity research concerned the question of the 
generality of chronicity measures: It was not known whether global indices of 
‘chronicity’ such as the IASP Taxonomy’s Axis IV, the CPG or the MPSS scorings are 
equally applicable to different pain syndromes, e.g., for MSP syndromes and 
neuropathic pain alike, nor whether they are at all suitable to clinical samples with 
severe to very severe and incapacitating MSP as well, e.g., employees at work or 
clinical pain patients. Evidence was limited and inconclusive, either suggesting weak 
relations between the CPG and MPSS and both indices not relating to duration (Klasen 
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et al., 2004) or, on the other hand, high correlations between the MPSS and duration 
(Michalski & Hinz, 2006).   
1.3.3 Critique of current chronicity assessment 
Research on how the different conceptualizations of chronicity relate to each other is 
limited. The available chronicity indices rest on the assumption that chronicity if not 
pain per se is a homogeneous unidimensional characteristic. If this is not the case in 
specified patient populations or syndromes, grading ‘chronicity’ in this way will fail to 
capture important determinants of the chronic development. 
1.4 Phenotypes in chronic musculoskeletal pain 
Following the logical order from proximal to distal mechanisms in chronic MSP, a 
phenomenological classification was considered to be primarily based on 
characteristics related to the sensory-discriminative domain (cf. Figure 1 in chapter 
1.1.2 & Table 1 in chapter 1.1.3). However, the role of sensory and clinical pain 
characteristics in the differentiation of chronic MSP syndromes and the relative 
importance of psychosocial factors and somato-psychic comorbidity is subject to 
controversial debate. This becomes particularly relevant against the background of 
recent revisions in the diagnostics of FMS as discussed in the following sections.   
1.4.1 Sensory changes in musculoskeletal pain 
A precise sensory characterization of the pain symptomatology was regarded as 
essential given the empirical findings, that the transition of acute regional into chronic 
widespread MSP is potentially related to the progression of peripheral to central 
sensitization (Graven-Nielsen & Arendt-Nielsen, 2010). Peripheral sensitization is 
defined as persistent nociceptor activity in deep tissues, whereas central sensitization 
refers to an increased response from dorsal horn neurons. Sensitization either 
peripheral or central produces increased pain sensitivity to noxious stimuli 
(hyperalgesia) as common phenomenon in both regional and widespread MSP. The 
spatial spread and increase in sensitization as observed in widespread pain might be 
the result of augmented synaptic activity in central neurons that ground imbalances 
between descending inhibition and facilitation of pain. Another explanation might be, 
according to the authors, the neural reorganization due to persistent muscle 
nociception (Graven-Nielsen & Arendt-Nielsen, 2010). The reorganization could 
produce a subsequent expansion and development of new receptive fields explaining 
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the spreading of pain to originally non-nociceptive loci as observed in referred pain. 
Central sensitization, in particular, is supposed to be associated with chronic 
widespread pain as compared to regional pain (Roussel et al., 2013; Staud, 2002), 
However, the role of peripheral nociception as necessary maintaining mechanism in 
primarily localized chronic pain remains inconclusive. Research applying quantitative 
sensory testing for pain sensitivity, temporal summation and descending control of pain 
is strongly recommended to better understand the transition from acute to chronic MSP 
and to differentiate subsyndromes between regional and widespread MSP (Graven-
Nielsen & Arendt-Nielsen, 2010). The authors also repeated relevant terms and 
definitions of sensory testing, reported in the following paragraph. 
1.4.2 Terms and definitions in pain sensitivity testing 
Pain sensitivity testing refers to a stimulus-dependent technique applying 
psychophysics such as pain threshold testing at different loci with different stimulation 
intensities to detect the individual “just painful” perception (Graven-Nielsen & Arendt-
Nielsen, 2010). Whereas pain sensitivity testing involves primarily peripheral 
nociception, temporal summation is associated with central and peripheral 
sensitization acting together, since both mechanisms are not separable at the 
measurement level with common quantitative sensory testing procedures. Temporal 
summation is defined as the positive or negative increase in pain perception as 
response to several somatosensory stimuli applied at the same site, with the same 
intensity and repeated in relatively short intervals. In contrast to the former, descending 
pain control is an entirely central pain mechanism and refers to the excitability along 
the neuro-spinal cord. A means to assess descending pain control is the application of 
a painful stimulus applied at the same time, but at a different location than a 
conditioned stimulus resulting in a decreased pain perception at the application site of 
the conditioned stimulus (diffuse noxious inhibition control, DNIC paradigm). 
1.4.3 Sensory testing in fibromyalgia  
The relevance of the involvement of sensory processes is in contrast to the recent 
development of FMS diagnostics: The 2010/11 ACR revisions abandoned the sensory 
testing entirely by excluding the manual probing of tender points (Wolfe et al., 2010; 
Wolfe et al., 2011). Given the empirical evidence for the importance of sensory 
characteristics to determine contributing pathophysiological mechanisms as discussed 
previously, it is at least regarded as questionable to exclude tender point testing. With 
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regard to the specific tender point testing, tenderness at tender points was repeatedly 
shown to be associated with sensitive myofascial trigger points (Ge et al., 2009; Ge, 
Wang, Danneskiold-Samsoe, Graven-Nielsen, & Arendt-Nielsen, 2010) suggesting a 
known peripheral etiology driving subsequent central sensitization notwithstanding 
characteristic differences between tender and trigger points in terms of stimulation and 
origin (Mense, 2011). Sensitivity to pressure pain has also been shown to be 
generalized to some degree across the body, hence not limited to tender points, but 
also to control points in FMS (Granges & Littlejohn, 1993; Wolfe, 1998). Furthermore, 
there is evidence that FMS are not only hypersensitive to pressure pain at the 
characteristic tender points, but also to other measurement modalities of evoked pain 
not selectively applied at tender point locations; possibly relating to a differential 
pattern of pain sensitivity selective for FMS diagnosis (Gracely, Grant, & Giesecke, 
2003). Besides pressure pain sensitivity there is also evidence for increased heat pain 
sensitivity in FMS compared to patients with regional pain such as cUPB, presumed to 
be related to impaired descending inhibitory control (Gerhardt et al., 2016; Julien, 
Goffaux, Arsenault, & Marchand, 2005). Scientific findings are inconsistent, either 
identifying a common factor representing pain sensitivity irrespective of the stimulus 
modality (Neddermeyer, Fluhr, & Lotsch, 2008) or a multimodal structure of pain 
sensitivity (Neziri et al., 2011). In summary, the role of the specificity of the modality in 
quantitative sensory testing and their diagnostic significance to identify subgroups 
better differentiating within the spectrum from regional to widespread pain is not yet 
known (Uddin & MacDermid, 2016). 
1.4.4  Relations of sensory and clinical pain characteristics 
Moreover, a linear relation of hypersensitivity to pressure pain with clinical pain 
characteristics such as self-reported pain loci or pain intensity has not yet been shown 
either. Validation studies of the 2010/11 revised criteria for FMS concentrate on 
detecting FMS with sensitivity and specificity analysis, but the actual relation of the 
tender point count or the pressure pain sensitivity with the self-reported regions in pain 
has not been in focus before (Wolfe et al., 2016). Adding up to this, a meta-analysis 
revealed only weak associations of clinical pain intensity with pressure and heat pain 
sensitivity (Hübscher et al., 2013). There is, thus, strong support that sensory and 
clinical pain characteristics are better described on two separate dimensions. 
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1.4.5 Comorbidity and psychosocial factors in fibromyalgia 
Some authors argue that psychic comorbidity constitute a major determinant of FMS 
(Häuser et al., 2009; Wolfe & Michaud, 2009). The number of tender points, in this 
regard, might serve as marker for psychological distress. This assumption is based on 
high correlations of sensitive tender points with markers for poor mental health, such 
as, screening questionnaires for anxiety and depression but also worse sleeping 
quality (Brown et al., 2016)  Obviously, there is a coincidence of psychosocial factors 
and somato-psychic comorbidity especially in FMS. Research revealed widespread 
pain patients with concurrent FMS scoring higher on these factors in contrast to 
patients without concurrent FMS possibly related to a distinct qualitatively different 
group of patients (White, Nielson, Harth, Ostbye, & Speechley, 2002). There might also 
exist subgroups within FMS patients as shown by distinctive psychophysiological 
patterns of stress-related parameters (e.g., blood pressure and skin conductance level) 
associated with differences in psychological coping and prevalence rates of mental 
disorders (Thieme, Turk, Gracely, Maixner, & Flor, 2015). Interestingly, although 
classified with FMS, this study revealed one cluster labeled as “adaptive copers” 
without any psychic comorbidity, challenging the inclusion of psychic characteristics in 
FMS diagnostic. 
Moreover, pertinent research dismantled the frequent association of FMS and 
depressive symptomatology by comparing FMS to controls with major depression 
without FMS (Gracely et al., 2012). Both shared the same pathophysiology but with 
different alterations in involved processes such as the dysregulation of the 
hypothalamic-pituitary-adrenal (HPA) function, which is supposed to be mediated by 
cytokine only in FMS. The authors also point out measurement problems, since many 
items in questionnaires for depression relate to somatic symptoms of hurt confounding 
the associations of the FMS pain disorder with depression. They concluded, that the 
diagnostic value of psychosocial factors is of minor importance relative to primary 
sensory-pain aspects and the somatic symptom burden.   
1.4.6 Critique of the revised diagnostic criteria for fibromyalgia 
Although strong evidence for the importance of nociceptive sensory processes in MSP, 
the new ACR 2010/11 criteria abandoned the manual probing of tender points primarily 
because of application problems by non-rheumatologists in conventional physician 
practice (Wolfe et al., 2016). FMS obviously show characteristics such as sleeping 
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abnormalities or depressive symptoms. However, diagnostics suffer from circular 
reasoning if these characteristics are included as cardinal criteria for FMS without a 
thorough systematic empirical basis. The shift from sensory to clinical pain 
characteristics and psychic comorbidity in the recent ACR 2010/11 criteria has possibly 
created a different pool of patients now classified with FMS. This effects the research 
on proximal mechanisms closely related to the pain pathophysiology because variance 
not related to the primary sensory pain processing potentially intervenes. 
1.5 PhD project realization 
The diagnostic and classification problems of chronic MSP presented above provided 
the basis to start this PhD project. The two original contributions investigated the 
dimensional structure of the chronicity construct (study #1) and isolated sensory-
clinical pain phenotypes in chronic MSP (study #2). The following section describes 
how this research was realized. 
1.5.1 Research aims 
Purpose of study #1 was to analyze the structure and composition of chronicity 
operationalized by established chronicity indices, in particular, Axis IV of the IASP 
Taxonomy of chronic pain, the widely used Chronic Pain Grade (CPG), compared to a 
national system of evaluating pain chronicity, the Mainz Pain Staging System (MPSS). 
The dimensionality of these indices was analyzed, aiming to isolate the construct of 
chronicity from possible additional clinically relevant aspects of pain in becoming 
chronic. The dimensional structure was analyzed within an occupational sample of 
working employees and a sample of chronic pain patients. 
Study #2 aimed to find sensory and clinical pain phenotypes that differentiate within 
the spectrum from chronic widespread pain to regional pain exemplarily for a sample 
of patients with FMS vs. cUBP. The phenotypes were supposed to be evaluated with 
respect to clinical significance relative to chronicity and functionality, psychosocial 
stress load and psychosomatic comorbidity. 
1.5.2 Data basis and work program 
Data of this PhD thesis stem from two different studies: The pain patient sample was 
part of a multicenter study: “Neuroplasticity and Learning in Chronic Pain”  (Projects 
HO 904/11 & FL 156/26) funded by the Deutsche Forschungsgemeinschaft (Clinical 
Research Group 107), whereas the occupational sample was provided by the German 
Introduction 
20 
 
Occupational Health Association, Section Nutrition and Gastronomy Business 
(Berufsgenossenschaft Nahrungsmittel & Gaststätten, BGN). 
Pain patients of the former sample were assigned to subprojects at different institutes, 
that were each investigating pain mechanisms of their own accord. A pharmacological 
central project was established under contribution from all of these subprojects. This 
central project performed a randomized placebo-controlled clinical trial testing the 
efficiency of an extinction training combined with a low dose of dose of the cannabinoid 
receptor agonist Delta-9-Tetrahydrocannabinol. Data come from this central project as 
well as two subprojects (P3 and P4). Subproject P3 investigated learning processes 
involved in the acquisition and extinction of pain and their neuronal correlates (Thieme 
et al., 2006; Yilmaz et al., 2010). Subproject P4 focused on implicit operant learning of 
pain sensitization and the role of psycho-somatic comorbidity as well as stress in pain 
becoming chronic (Becker, Kleinböhl, Klossika, & Hölzl, 2008). 
The occupational sample was acquired within a study on the prevention of work-related 
MSP disorders and concentrated on risk evaluation of employees working in jobs that 
involved a seating or standing activity with a high musculoskeletal load and an 
assumed high a priori risk to develop MSP disorders. The funders allowed access to 
sensitive, in other circumstances confidential, data of active workers within their 
associated companies. An overview of the work program is provided in Table 2. 
Before the two original contributions were written, several pre-studies had to be done 
(some of them prior to the enrollment as PhD in December 2013). Besides proof of 
principle analyses by checking minimal sample sizes in the combined data sets, an 
additional sample of patients with neuropathic and cancer pain from a pilot study on 
multidimensional sequential risk assessment was recruited at the Clinic of Anaesthesia 
and Intensive Care at the University Medical Cent in Mannheim. Moreover, a large 
sample acquired within a multidimensional diagnostic risk assessment of stress and 
somato-psychic comorbidity was prepared to serve as additional study sample 
because of the rich content on endocrine and psychobiological data. These two 
datasets were dropped in the final stage of this dissertation project due to a lack of 
primary pain-related data (especially psychophysical variables) in the a priori applied 
Multidimensional Sequential Risk Assessment for Stress, MSRA-S (Hölzl et al., 2010).  
As further part of the preparatory work, all study data had to be checked for the same 
item content and labeling to allow merging. Moreover, the IASP Taxonomy of chronic 
pain was mapped on all datasets as starting phenotypic approach to classify MSP 
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(IASP Taxonomy Working Group, 2017). The data, hence, had to be recoded to fit the 
categories suggested in five axes (Axis I: pain region, Axis II: system, Axis III: temporal 
characteristics of pain, i.e., the pattern of occurrence; Axis IV: intensity and the time 
since onset of pain; Axis V: etiology of pain).  
Subsequently, all parameters in the datasets had to be checked for their potential 
applicability within the multidimensional model of selective marker domains in chronic 
MSP (cf. Table 1 in chapter 1.1.3). Incongruences due to different parametrization of 
core domains in different datasets had to be corrected by analytic and theoretical data 
comparisons. The final parameters were then thoroughly selected according to the 
research aims defined in both articles. 
 
Table 2. Work program with timeline of the PhD thesis  
Year 2012 2013 2014 2015 2016 2017 2018 2019 
Pre-studies 
Conceptualization, 
data collection, 
sample selection, data 
preparation 
        
Research paper #1 
Deconstructing 
chronicity of 
musculoskeletal pain: 
intensity-duration 
relations, minimal 
dimensions and 
clusters of chronicity  
        
Research paper #2 
Reclassifying patients 
with widespread and 
regional MSP by 
sensory and clinical 
phenotypes; principal 
components and 
latent class analyses  
        
Write PhD thesis  
General introduction 
and discussion 
        
PhD thesis subprojects with respective timeline. There were two research papers written 
(research paper #1 published in 2018 in the Scandinavian Journal of Pain, research paper #2 
under review by co-authors for submission to PAIN). 
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Research paper #1, reanalyzed the construct of chronicity for discriminable dimensions 
and generality across different samples with MSP. Subsequently, research                
paper #2 identified sensory-clinical pain phenotypes according to a proximal to distal 
search strategy of necessary and sufficient dimensions of chronic MSP (cf. Figure 1 in 
chapter 1.1.2). After sensory-clinical pain phenotypes were isolated, relevant markers 
for somato-psychic comorbidity and psychosocial aspects at domains at the 
intermediate and distal level were compared for differences on these sensory-clinical 
pain phenotypes.    
1.5.3 Research questions and hypothesis 
In study #1 we asked what are the core components of chronicity and is it justified to 
apply one global index in different groups with MSP? We expected variation in content 
and structure of chronicity across pain syndromes, durations, severity ranges and 
diagnostic groups. 
In study #2 we questioned the recent diagnostic shift in FMS diagnostics by re-
examining the role of altered pain sensitivity and primary clinical pain characteristics in 
a selected sample of widespread and regional pain (FMS and cUBP patients, 
respectively). The dimensional structure of pain sensitivity and clinical pain was 
assessed and sensory-clinical phenotypes were derived. Moreover, the generalization 
of sensory pressure hypersensitivity to heat pain was checked by asking for discernible 
phenotypes as modalities change. Finally, we were interested in the role of comorbid 
psycho-somatic pathology and stress and asked if there are any differences between 
the sensory-clinical pain phenotypes. We expected a better differentiation of the prior 
diagnostic groups by sensory-clinical pain phenotypes, discernible clusters of 
enhanced heat pain sensitivity and differences in comorbid psycho-somatic pathology 
and stress. 
1.5.4 General methods 
The following studies applied an empirical phenotypic approach throughout as an 
example for a dimensional assessment of MSP with quantitative data provided from 
responses in questionnaires and psychophysics. Based on a framework of the 
multidimensional model of chronic pain well-established marker domains and 
respective characteristics were selected and parameterized (cf. Figure 1 in chapter 
1.1.2 and Table 1 in chapter 1.1.3). The search followed the theoretical cascade of 
domains involved in MSP becoming chronic. The marker domains were selected 
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starting from proximal to distal mechanisms in the process of pain becoming chronic. 
After a thorough descriptive characterization of marker parameters in the respective 
domain, linear (factor analyses) and probabilistic (latent class analyses) structure 
finding methods were applied to elaborate on the dimensional structure of MSP 
syndromes.                                                                                                                                                                                                                                                      
Original contributions 
24 
 
2 ORIGINAL CONTRIBUTIONS 
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2.1 Deconstructing chronicity of musculoskeletal pain: Intensity-duration relations, 
minimal dimensions and clusters of chronicity1 
 
 
1 Finnern, M.M., Kleinbohl, D., Flor, H., Benrath, J., Hölzl, R. (2018). Deconstructing 
chronicity of musculoskeletal pain: intensity-duration relations, minimal dimensions 
and clusters of chronicity. Scandinavian Journal of Pain,18(3), 363-377. doi: 
10.1515/sjpain-2018-0021 
The online version of this article offers supplementary material: 
https://doi.org/10.1515/sjpain-2018-0021. 
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Abstract 
Background and aims: Evaluating the degree to which pain has become chronic 
beyond mere duration poses several problems. The IASP Pain Taxonomy Axis IV 
employs intensity and duration combined to 9 ordered categories. The Chronic Pain 
Grade links intensity and disability, but only the latter contributes to higher grades. The 
Mainz Pain Staging System includes temporal and spatial aspects, medication and 
health care utilization. Their interrelations, scale properties and construct validity are 
not always known or debatable. The study challenges the generality and homogeneity 
of the chronicity construct of musculoskeletal pain aiming at necessary and sufficient 
sub-constructs identified by separable marker clusters. We show chronicity to vary in 
content and structure with severity and duration and between different populations. 
This raises the question of validity conditions of general chronicity indices and requires 
further work on adequate chronicity measures. 
Method: Diagnostic entrance data of 185 patients with chronic regional vs. widespread 
musculoskeletal pain (unspecific back pain, fibromyalgia) from regional pain clinics and 
170 active employees in a nationwide prevention program were included in a 
retrospective cross-sectional analysis of the combined marker sets of the three 
chronicity indices above. The samples of patients and employees provided intensity, 
duration and disability degrees over the whole range of the assumed chronicity. 
Intensity-duration relations were quantified by correlations and frequency distributions 
of successive duration classes. The dimensional structure of pain and chronicity 
variables was assessed by factor and cluster analyses.  
Results: Pain intensity distributions showed inhomogeneous courses from short to long 
durations - lowest intensities predominating at longer durations in patients and at 
shorter in employees. Moreover, pain intensity and duration related nonlinearly to 
Chronic Pain Grade and Mainz Pain Stage and differently in patients compared to 
employees, and these indices correlated only moderately to each other. Factor and 
cluster analyses revealed different dimensions and clusters of chronicity markers for 
patients and employees. In the former, three dimensions with four clusters were 
identified with clinical characteristics (intensity, temporal and spatial aspects) 
separated from direct consequences (disability/interference with activities, medication 
usage) and chronic development (duration, healthcare utilization). In employees, only 
two dimensions with three clusters were obtained and clinical pain characteristics 
clustered with direct consequences both separated from chronic development. Similar 
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differences were shown between unspecific back pain and fibromyalgia but were less 
well defined.  
Conclusions: There appears to be no coherent ‘chronicity’ entity over the entire range 
of severity and duration for all pain populations with different clinical pictures and social 
contexts. Statements about chronicity must be differentiated with respect to those 
aspects relative to patient career.  
Implications: General indices do not capture the complex and changing composition of 
chronicity. There is evidence for at least three weakly coupled core domains of 
chronicity, i.e., the primary clinical characteristics, the direct consequences of current 
interference with activities, and aspects of the patient history. Hence, multivariate 
assessment is recommended. The particular syndrome, the diagnostic context and the 
population under investigation should likewise be considered. 
 
Keywords: Chronicity; Chronic Pain Grade; Mainz Pain Staging System; IASP 
Taxonomy of Chronic Pain; Musculoskeletal Pain; Validity  
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1. Introduction 
The multidimensionality of pain and the complexity of chronicity factors have led to 
varied approaches to quantify the general degree to which pain has become chronic 
beyond the normal healing time, across different populations and syndromes. The 
latest consensus for ICD-11 has fixed this time at three months [1]. However, further 
aspects of chronic pain, for example, the time course of intensity, quality and location, 
are important. In addition, cognitive, affective and behavioral characteristics have been 
related to chronicity [2]. Not all of these aspects may be necessary core variables for 
a general construct of chronicity and more comprehensive measures have been 
proposed. For instance, Axis IV of the IASP Taxonomy of chronic pain [3] employs a 
combination of 3-point intensity and duration scales yielding a composite scale of nine 
ordinal chronicity categories leaving biometric properties undefined. The internationally 
used Chronic Pain Grade (CPG; [4]) combines intensity with disability, but only the 
latter contributes to higher grades due to the item response theory-based scale 
construction. The multiaxial Mainz Pain Staging System (MPSS; [5, 6]) used in German 
speaking countries includes temporal and spatial aspects, medication and health care 
utilization. The relations between different indices and subscales vary, scale metrics 
are often unclear, and validation studies are based on external criteria like comorbid 
psychopathology, treatment success or return to work [5]. This raises the question of 
necessary and sufficient components, the internal structure of the chronicity construct 
and the stability over time, across different severities, populations and syndromes 
(internal and construct validity). 
We report pertinent results including only the primary properties of duration and 
intensity at different times and the subscales of extant chronicity indices (CPG, MPSS) 
in the retrospective analysis of a large data-set from patients of pain clinics and a non-
patient group of employees with musculoskeletal pain (MSP). Combining these groups 
ensured coverage of the full range of pain severity, duration, and impairment. We 
hypothesized:  
(1) Pain intensities develop over time in non-linear ways differing between patients and 
employees: Monotonic (uniform) increases prevail in employees with lower intensity 
and shorter duration, whereas this relation gets lost in patients with a longer pain 
history, levelling off at higher severity. 
(2) Intensity increases monotonically with duration in relatively localized (regional) 
pain, in particular, in chronic unspecific back pain (cUBP). In contrast, widespread pain, 
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in particular, fibromyalgia (FMS), shows variable symptom development, from 
continuous spreading and higher severity to no change at all. 
(3) Combined structural analyses of the chronicity markers (Axis IV of IASP Taxonomy 
with the subscales of CPG and MPSS) do not reveal one common but multiple factors 
of chronicity. These differ between patients and employees and between syndromes. 
In patients, clinical picture, severity, and patient career are most important, while 
severity and disability constitute the main components in employees. 
Analyzing the internal structures of the core marker set of extant indices, we aimed to 
obtain a minimal set of scales to quantify the necessary chronicity aspects specific to 
the model populations and syndromes while excluding secondary cofactors and 
consequences. 
2. Material and methods  
2.1. Study sample 
The present cross-sectional analysis is based on the initial assessment data of (1) 
patients participating in a collaborative multicenter project on plasticity and learning in 
pain becoming chronic and (2) employees taking part in a nationwide prevention 
program for work-related stress and musculoskeletal disorders in the nutritional and 
gastronomy businesses. Both studies were approved by the Local Ethics Committee. 
Patient data were partially acquired in connection with a clinical trial of combined 
behavioral and cannabinoid treatment for chronic pain (ClinicalTrials.gov Identifier: 
NCT00176163). Patients were eligible for the study if they reported musculoskeletal 
pain (MSP) for at least three months, and employees were included also when they 
reported pain for shorter durations. Healthy controls were not considered as the 
research questions required only comparisons within MSP pain populations. General 
exclusion criteria collected on first contact and confirmed in the initial medical 
screening were psychotic disorders and substance abuse, disorders of the central 
nervous system (epilepsy, craniocerebral injury, stroke, Parkinson’s disease, multiple 
sclerosis), infectious diseases (HIV, hepatitis), autoimmune diseases (untreated 
thyroid disease), and/or the current use of neuroleptics, benzodiazepines or mood-
stabilizers. Pregnant and nursing women and persons with insufficient German 
language competence (written and spoken) were also excluded. 
Neither patients nor employees were selected for representativeness but 
systematically recruited according to the quasi-experimental study designs in the 
Original contributions 
30 
 
original intervention and prevention projects. Thus, frequencies in subcategories varied 
widely due to different base rates and acquisition quota of pain clinics and occupational 
health centers. However, age, sex and other variables pertinent to the present 
research questions were matched where possible. Main analyses focused on within-
group associations of chronic pain markers more or less neutral against selection 
effects. Further details on recruiting, exclusions and dropouts (CONSORT flow 
diagram), sociodemographic and diagnostic data are provided in supplementary 
material (Table S1 and Fig. S4).  
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2.1.1. Patients of regional pain clinics 
For the present study, initial assessment data of all N = 261 patients eligible for the 
multicenter study suffering from clinically relevant chronic unspecific back pain (cUBP) 
or widespread muscle pain were considered. Of the 261 data sets 60 were incomplete 
or inconsistent leaving 201 patients qualifying. Further 16 patients met additional 
exclusion criteria so that 185 patients (107 cUBP, 78 FMS) entered the final analysis 
(CONSORT flow chart in the supplementary material). Additional exclusion criteria 
were relevant drug taking or change in medication within 3 months prior to data 
collection; cardiovascular disease or hypertension not treatable with drugs, and renal 
insufficiency requiring dialysis assessed by doctor’s checklist (supplementary material, 
Fig. S5). Entry assessment for mental disorders was done with the Structured Clinical 
Interview for DSM IV Axis I Disorders (SKID-I; [7]). Patients with major depression or 
anxiety disorders remained in the sample because affective comorbidity was a 
research question of the source projects. Comorbidity relations of chronicity as such 
were not subject of the present analysis and will be reported elsewhere.  
cUBP criteria required that pain in upper or lower back was the primary problem and 
was not related to acute trauma, inflammatory or neurologic disease; radicular and 
neuropathic signs were also excluded on final medical investigation (Fig. S5: Doctor’s 
checklist in supplementary material). Chronic widespread pain criteria corresponded 
to earlier ACR fibromyalgia (FMS) criteria based solely on muscle pain (11 of 18 tender 
points; [8]). This left 107 patients with cUBP and 78 with FMS diagnoses. Of the latter 
63 matched also the FMS criteria suggested in 2010/2011 [9]. 
2.1.2. Employees at risk for musculoskeletal pain 
Data of employees currently at work were acquired according to an adapted protocol 
of the patient study. The cooperating occupational health service centers collected the 
data, guaranteeing full anonymity of individualized data against employers as well as 
study partners. Employees were eligible for participating when in jobs requiring a 
seating or standing activity with high musculoskeletal load and established risk and 
prevalence of work-related musculoskeletal pain (detailed information on field of work 
and work schedule in supplementary material, Table S1). Initially, nine companies in 
the program were interested and allowed contacting employees. One-hundred-and-
forty employees fulfilling the inclusion criteria German language comprehension, age 
18 – 65 years, actively working and reporting musculoskeletal pain at present, 
Original contributions 
33 
 
continuing or repeatedly during the last years were recruited this way; another 32 
participants were acquired through advertisements in the press and brochures 
displayed in local practitioners’ offices. After exclusion of 2 persons without pain related 
to the musculoskeletal system 170 employees remained in the analysis (Table 1). 
2.2. Diagnostic Instruments 
All assessments were performed using the multidimensional battery of validated 
instruments initially assembled for the patient multicenter study. The complete battery 
included established pain questionnaires as well as scales on coping and functional 
level, quantitative sensory testing, von Korff’s Chronic Pain Grade (CPG; [4]) 
questionnaire as well as checklists of anxiety, depression, life quality and general 
health. A subset of this battery was adapted for the occupational group with identical 
instruments for the core variables of the present study. In the occupational health 
project additional instruments were included in further diagnostic steps to assess 
perceived stress at work, psychosocial and physical work factors as well as biological 
stress markers (MSRA-P; [10]). Only data of the common variable set for both groups 
at study entry are included here as described below. 
2.2.1. Pain assessment 
Assessment of pain and related variables comprised the West Haven-Yale 
Multidimensional Pain Inventory (German version, MPI-D; [11]), the German Pain 
Questionnaire (Deutscher Schmerzfragebogen, DSF; [12, 13]) and the questionnaire 
for the Mainz Pain Staging System (MPSS; [14, 15]). The latter was only applied in the 
employee sample; for pain patients, MPSS variables were recoded from corresponding 
items of the DSF. 
2.2.2. Chronicity measures 
Chronicity was first coded according to Axis IV of the IASP Taxonomy of chronic pain 
[3, 16] using current pain intensity derived from the MPI-D [11]; item #1: present pain 
intensity) and the duration parameter of the DSF ([13]; item #25: time since onset). 
Secondly, von Korff’s Chronic Pain Grade questionnaire (CPG, German version; [17]) 
and the Mainz Pain Staging System (MPSS; [5]) were included as global chronicity 
indices and analyzed at item and subscale level. Only the results of the latter are 
reported here for brevity. 
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The CPG consists of item response theory based subscales [18-20] comprising three 
items on pain intensity (present, average, worst), three items on disability (interference 
with daily, recreational, social and family and work-related activities) using 11-point 
Likert scales to derive a disability score. An additional question concerns the number 
of days the person was not able to perform at work or carry out other relevant activities 
due to pain.  
The MPSS is a multiaxial system for staging pain chronicity used in the German 
speaking area. Three stages of pain chronicity are derived from a compound sum score 
ranging from 4 to 12 points out of four “axes” of 3-point items. Axis I evaluates 
“temporal characteristics” of pain (occurrence pattern, episode duration, changes in 
intensity). Axis II codes “spatial aspects” of pain (number of painful areas). Axis III 
evaluates “medication use” (drug intake, previous withdrawal treatments). Axis IV 
concerns current and previous “utilization of the health care system/patient career” 
(number of physician changes, pain-related hospitalizations, pain-related operations, 
pain-related stays in a spa, rehabilitation center or pain center). Scores of 4 – 6 points 
on these items correspond to pain chronicity stage I, 7 – 8 points code as stage II, and 
9 – 12 as stage III. The higher the “pain stage”, the more persistent the pain 
symptomatology and the more intense therapeutic intervention is needed for 
complicating factors [21]. 
2.2.3. Control variables 
Control variables were pain medication and psychological comorbidity assessed with 
the DSF [13], the Center for Epidemiological Studies Depression (German version: 
ADS; [22]) and the State-Trait Anxiety Inventory (German version: STAI-T; [23]).  
2.3. Data analyses 
Data were analyzed with the program packages IBM SPSS Statistics (version 23; 
Armonk, NY, USA) and R (version 3.2.0; The R Foundation for Statistical Computing, 
Vienna, Austria). Main analyses covered the internal relations between chronicity 
attributes within the two groups of participants, separately as well as combined to 
control for Simpson effect-like dependencies [24]. A multimethod strategy was applied, 
which comprised correlational, contingency and frequency analysis, dimensional 
analyses with exploratory and confirmatory factor analyses as well as maximum 
likelihood estimation of latent class models of marker clustering.  
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2.3.1. Correlation and frequency analyses 
Relations of intensities to duration, CPG grades and MPSS stages were calculated as 
nonparametric correlations (Spearman’s Rho, Kendall’s Tau) or contingency 
coefficients (Pearson’s contingency coefficient Ccorr, adjusted for number of categories 
[25]). Specific intensity characteristics at different durations and chronicity levels were 
further explored by analyses of frequency distributions across single duration classes 
and chronicity grades. Differences of pain intensity-duration characteristics and global 
chronicity indices were assessed by non-parametric planned post-hoc tests. Effects of 
control variables were checked by correlation and median-split analyses. Significance 
levels were Bonferroni-Holm corrected for multiple testing, familywise and separately 
for each chronicity index and dataset of patients and employees. The significance level 
was set at p < 0.05 throughout; exact probabilities are reported where appropriate. 
2.3.2. Dimensional analyses at scale and item level 
The dimensional structure of the IASP Taxonomy Axis IV coding, CPG and MPSS was 
explored by principal component analysis (PCA) and principal axis factoring (PAF) with 
varimax rotation and pairwise exclusion of cases with missing data for both samples 
separately and combined. The Kaiser and scree criteria were applied to determine the 
number of components to be extracted. Confirmatory factor analyses (CFA) were 
conducted with the lavaan package in R [26] to evaluate the dimensions derived from 
exploratory factor analyses by descriptive fit indices [27]. 
2.3.3. Latent class analyses 
To substantiate the dimensional relations found and to identify specific variable 
groupings possibly obscured in conventional factor analyses, hierarchical latent class 
analysis (LCA, R program pvclust; [28–30]) was employed as second structure finding 
method. LCA generates variable groupings by a maximum likelihood model. It is apt to 
support and inform the results of classic dimensional analysis from a different 
perspective operating on the same data set. In addition, pvclust provides tests of 
robustness of cluster solutions. Probability values were calculated for each cluster with 
non-parametric bootstrap probability (BP) and approximately unbiased (AU) p-values 
in % ranging from 0 (not robust) to 100 (highly robust). To reduce a type 2 error, AU 
and BP values were uncorrected for multiple testing and used only for descriptive 
assessment of cluster dendrograms, not for inferential difference testing. Correlations 
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between observed IASP Axis IV, CPG and MPSS marker values entered the cluster 
analysis with the average linkage method. Data were permuted 1,000 times to assess 
the stability of cluster solutions.  
3. Results  
3.1. Sample characteristics: pain intensity, duration and chronicity 
As expected, due to different recruiting paths and source populations, patients and 
employees with musculoskeletal pain differed significantly in all chronicity markers 
included (Table 2): On average, patients reported pain intensities in the medium range 
and long-term durations; only two indicated no pain at present. In contrast, pain 
intensities were generally low in employees, none reported the strongest intensity and 
54 (31.8%) had no pain at present. Again, long durations > 5 years dominated although 
less frequent than in the patients. 
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On average, global chronicity grades were also higher in patients than employees 
(medians: CPG = III vs. I; MPSS = III vs. I) for the same reasons; no patient was 
classified with CPG 0 or MPSS stage I. Average chronicity was higher for FMS as in 
cUBP (medians: CPG III vs. II; MPSS: III for both; modal values: CPG IV vs. III, MPSS: 
III vs. II). Interestingly, patients’ chronicity indices showed second modes at CPG I and 
MPSS stage II indicating a mixed composition of low and high chronicity. In employees’ 
chronicity indices declined consistently in frequency at higher grades. The apparent 
qualitative differences in distribution are further explored in the following sections. 
3.2. Intensity-duration relations 
3.2.1. Correlations of intensity and duration 
As expected, pain intensities were only weakly although significantly associated with 
duration for the combined sample of patients and employees (Spearman’s ρ = 0.24; 
Kendall’s τ = 0.20; coefficient of association, corrected for number of categories, Ccorr 
= 0.39; p < 0.01, adjusted).  
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However, the low overall correlation is misleading because correlations differed 
qualitatively and in sign between the subgroups (Table 3). In patients, pain intensity 
correlated weakly negatively with duration (ρ = - 0.156; τ = - 0.136; N = 170; p < 0.05, 
adjusted) for both cUBP and FMS patients. In contrast, pain intensity correlated weakly 
positively although insignificantly with duration in employees with MSP (ρ = + 0.135; 
p = 0.079; τ = + 0.109; p = 0.069 adjusted; N = 170; Ccorr = n. s.).  
3.2.2. Frequency distribution analyses 
The inconsistent intensity-duration correlations found are likely due to nonlinear and 
group-dependent relations in accordance with hypothesis 1. This was confirmed by 
significant differences in cumulative intensity distributions between particular duration 
classes in the total sample, i.e., between shorter and longer durations (p < 0.01;             
2-sample K-S, U-test,). Further, intensity distributions across duration classes differed 
between patients and employees in specific ways (Fig. 1): In patients, lower, not higher 
intensities prevailed at longer durations above five years, whereas in employees, lower 
intensities dominated in shorter durations (p < 0.001 and 0.05; 2-sample K-S, U-test; 
Figs. 1 C and D).  
The two-dimensional temperature-plots of intensity-duration distributions corrected for 
base rates are apt to further clarify these specific relations in patients and employees 
(Figs. 1 E, F): In patients, contrary to hypothesis 1, pain intensities decreased with 
increasing duration only up to 5 years and leveled out above (Fig. 1 E). The picture 
differed completely in employees (Fig. 1 F): Pain intensities first increased with duration 
at shorter durations (according to hypothesis 1) but decreased again at longer 
durations (see also in supplementary material, Figs. S6 and S7). 
Finally, contradicting hypothesis 2 and according to the correlational analysis above, 
there were neither significant syndrome-specific intensity-duration characteristics 
between cUBP and FMS patients nor significant differences in absolute intensities or 
durations. However, the negative result may be due to low power, particularly, in males 
and FMS subgroups. 
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    , 
     
     
Figure 1: Different of intensity-duration characteristics in clinic patients and employees. First 
and second rows: Histograms (A, B) and cumulative relative frequency distributions (C, D) of 
pain intensities per duration class in patients and employees (N = 170, each). Duration classes 
d ]i … j]: i < d ≤ j months; no durations ≤ 6 months in patients. Differences: (1) Intensity 
histograms of patients (A) and employees (B) at all durations (p < 0.001; K-S and U-tests, 
corrected). (2) Cumulative relative intensity frequencies at long durations > 60 mths shifted to 
lower intensities in patients (C, violet; p < 0.05), which tend to dominate at short durations ≤ 6 
mths. in employees (D, blue; p < 0.08). Third row: Temperature plots of the relative intensity 
frequencies per duration class with marginal distributions controlled: colour-coded differences 
between observed (fobs) and expected (fexp) frequencies; fexp = fi. * f.d / Ntotal; fi. = N of intensity 
i; f.d = N of duration d. (E) patients; (F) employees. Intensity-duration contours generated with 
statistical package R, function filled.contour. Note. (1) In patients, difference frequencies 
concentrated in the red-to-orange area starting from low to medium intensities at very long and 
long durations and decreasing to high and very high intensities at medium to short durations 
at the lower right. This indicates a general tendency of lower pain intensities at shorter times 
since onset consistent with the negative overall-correlation (Table 3 and text). (2) In 
employees, the difference plane shows a different picture concordant with the zero overall-
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correlation of intensity and duration. In addition to the low intensity main group with short 
durations (red, bottom left), subgroups with different intensity-duration relations appeared: one 
with pain intensity increasing with longer durations, another with decreasing intensity after one 
year since onset and a third subgroup again worse at durations longer than 2 years (bifurcation 
at pain intensity 2). 
 
3.3. Dimensions and clusters of chronicity markers 
To investigate whether these variable relations between intensity and duration of pain 
in patients and employees are connected to the changing composition of chronicity 
indices, dimensional and cluster analyses including the marker sets of CPG and MPSS 
were calculated. In an initial step, overall correlations of intensity and duration with the 
source indices were considered. 
3.3.1. Correlations of pain intensity and duration with CPG and MPSS 
Pain intensity correlated moderately positively with both chronicity indices (Table 3). 
These associations were much lower when patients and employees were considered 
separately, and held also at the syndrome level for both cUBP and FMS patients. Table 
3 illustrates that, contrary to expectation, duration correlated negatively with CPG and 
zero with the MPSS in patients, while CPG correlated zero and the MPSS correlated 
positively in employees.  Similar inconsistent and weak correlations of pain duration 
with chronicity indices were repeated for the patient sample at the syndrome level, 
separately for cUBP and FMS patients. Corresponding intensity and duration 
frequency characteristics underlined these different relations to the chronicity indices 
in patients and employees. For instance, in patients, lower intensities were more 
frequent at grade III than at II and the intensity frequencies of grade II did not 
significantly differ from that of grade IV (supplementary material, Figs. S8 - S10). In 
employees, in contrast, intensity characteristics progressed with increasing CPG.  
Complex relations of the chronicity indices held also for duration: In patients, contra-
intuitively, longer durations were more frequent at the lowest CPG and shorter at the 
highest. In employees, however, duration characteristics across CPG grades 
resembled the expected sequence of longer durations with increasing grades more 
closely. The intensity and duration distributions for the MPSS showed a more 
systematic sequence from lower to higher intensities and from shorter to longer 
durations with progressive MPSS stages. 
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The different relation of CPG and MPSS to the primary pain properties intensity and 
duration shown above raised the question of their relation to each other. Accordingly, 
correlations differed largely between subgroups and were not significant in patients 
(Table 3). Frequency distribution analyses specified this (supplementary material, Figs. 
S11 and S12).  
3.3.2. Exploratory factor analyses of the combined chronicity markers 
When data of patients and employees were combined, exploratory factor analyses of 
pain intensity, duration and CPG/MPSS subscale values produced two principal 
components and principle axis factors accounting for 58.5% of the total variance (Table 
4 C). The dominant first component (46.3%) was characterized by disability (CPG 
disability score and disability days), pain intensity (CPG intensity scale and MPI-D), 
MPSS scales temporal characteristics and medication use. The second component 
(12.3%) related closely to chronic development itself indicated by duration and MPSS 
scales health care utilization/patient career and spatial aspects (number of painful 
areas). The remaining 41.5% of the variance were distributed over seven non-
significant components. 
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The two-factors structure was replicated in the separate analysis for the employee 
sample (Table 4 B); a general common chronicity factor was not detected. However, 
when the patient data were analyzed separately, three rather than two significant 
principal factors explaining 62.3% of the variance were necessary (Table 4 A). Again, 
the dominant first component (32.3%) was best characterized by disability, pain 
intensity and medication use, but not by temporal characteristics of the pain symptoms. 
Moreover, pain intensity (CPG, MPI-D) loaded most on the second component (15.5%) 
together with temporal characteristics and spatial aspects (number of painful areas) 
independently of disability. The third component (14.5%) resembled the chronic 
development marked by duration (time since onset) and health care utilization/patient 
career similar to factor 2 in the pooled sample except for the spatial aspects (number 
of painful areas), which loaded mainly on the second component in the clinical sample.  
The stability of these principal dimensions at the syndrome level was checked by 
separate analyses for cUBP and FMS patients excluding the MPSS scale spatial 
aspects because of maximal values (≥ 3) in the latter (supplementary material, Table 
S2). The FMS data yielded three significant components explaining 69.2% of the 
variance mapping well onto the 3-factors structure for all patients. In contrast, the 
corresponding factor analysis for the cUBP group revealed four significant components 
accounting for 80.8% of the variance. Three of them were concordant with the previous 
analyses. An important exception consisted in disability scales forming a separate 
factor (extracted second) on their own.   
The 3- and 2-factor models suggested by the exploratory factor analyses for patients 
and employees were tested by confirmatory factor analyses (CFA) using the three 
diagnostic markers with the highest PCA and/or PAF loadings (shaded cells in Table 
4). The 3-factor model for patients was confirmed for non-orthogonal (correlated) 
factors with acceptable fit indices (corrected chi-square, χ2/df < 3). The 2-factor model 
for employees showed excellent fit (corrected chi-square, χ2/df < 2; RMSEA = 0.00; 
CFI = 1.00; supplementary material, Table S3).  
In summary, no common factor of chronicity was found and dimensional structures of 
MSP chronicity patterns differed between patients and employees. The composition of 
the third factor in patients and the second factor in employees suggests that the 
dimensional structure of the related chronicity was varying with duration. Syndrome-
specificity within the patient sample was only partially supported by the 4- vs. 3-factor 
solutions for cUBP and FMS patient data, respectively. 
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Qualitative inspection of mutual variable distances in factorial space suggested three 
conspicuous and clinically meaningful tentative clusters of chronicity markers (Figs. 
2A, B; supplementary material, Fig. S13), which differed in important aspects between 
patients and employees. In patients, disability and intensity markers from the CPG and 
IASP Axis IV, on the one hand, and spatial and temporal characteristics from the 
MPSS, on the other hand, formed three separate groups of closely related variables. 
Duration (time since onset) and the MPSS variables medication use and health care 
utilization/patient career remained relatively isolated. In employees, in contrast, 
markers of the chronic development (duration, healthcare utilization/patient career) 
formed a cluster with spatial aspects (number of painful areas) while temporal 
characteristics grouped with medication usage. Interestingly, in the still active 
employees pain intensity clustered with the disability markers from the CPG (Fig. 2B, 
at the right).  
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Figure 2: Dimensions of pain and chronicity markers in clinic patients and employees.  
(A) Patients: Three principal components in relation to main markers and associated variables, 
symbols as in Table 4: PC 1, Direct Consequences, marked by “disability days” and “disability 
score (interference)” of the CPG; PC 2, Clinical Characteristics, marked by “pain intensity” and 
“temporal” and “spatial aspects” (number of painful areas) of the MPSS; PC 3, Chronic 
Development, marked by “duration (time since onset)” of the DSF and “health care utilization” 
from the MPSS. Descriptively, four clusters (elliptic frames) of variables may be identified by 
their distances in the 3D vector space including associated variables with moderate loadings 
on more than one principal component, labelled tentatively as (1) “intensity cluster”, (2) 
“temporo-spatial pattern cluster”, (3) “disability cluster” and (4) “chronic development”.              
(B) Employees: Two principal components in relation to main markers and associated 
variables, symbols as in Table 4: PC 1, Direct Consequences & Clinical Characteristics, 
marked equally strong by pain intensity and disability variables of the CPG and MPI-D; PC 2, 
Chronic Development, marked by “duration (time since onset)” of the DSF and “health care 
utilization/patient career” from the MPSS as in patients. Three descriptively defined clusters of 
variables differing from those in patients: (1) intensity and disability variables now closely 
related except for “disability days” of the CPG, all mainly loading on PC 1; (2) “temporal pattern 
and medication usage”, also near PC 1; (3) a cluster “chronic development” including duration 
and health care utilization related to the MPSS variable “spatial aspects” (number of painful 
areas). 
Original contributions 
53 
 
3.3.3. Hierarchical Latent Class Analysis of Chronic Pain Markers  
The clinically meaningful clustering of variables apparent in the distance mapping of 
principal pain markers in two- and three-dimensional factor space was cross-examined 
by hierarchical latent class analyses (LCA) for patients and employees, separately and 
combined. In the LCA two super-clusters of variables could be distinguished in both 
patients and employees analyzed separately (Fig. 3) according to the 95%-AU 
criterion. 
Cluster 1 comprised scales related directly to the chronic development as such 
(duration/time since onset, healthcare utilization/patient career), while Cluster 2 
contained clinical characteristics (intensity, temporal and spatial aspects) and direct 
consequences of the pain (disability score and disability days) together with medication 
usage (Figs. 3A, B). Intensity and the direct consequences (disability) were strongly 
interconnected within a coherent sub-cluster itself connected only weakly with 
medication use. Temporal characteristics and spatial aspects formed a second less 
coherent sub-cluster (AU criterion > 80%). This cluster structure was replicated in 
single analyses for cUBP and FMS patients and for employees analyzed alone, 
although the cluster pattern for the latter was somewhat less differentiated and spatial 
aspects did not cluster (supplementary material, Fig. S14). 
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Figure 3: Clusters of chronic pain markers of clinic patients and employees at the subscale 
level. Dendrograms of variable clusters according to latent class analyses of all pain markers 
of present pain intensity, duration (time since onset) and chronicity scales (CPG, MPSS); 
multiscale bootstrap resampling technique [33]. Red and green numbers AU/BP (arbitrary 
unbiased/bootstrap probability) values of significant clusters (AU ≥ 95% significant). Symbols 
as in Table 4 and Fig. 2; numbers in parentheses refer to tentative descriptive clusters in   Fig. 
2. (A) Patients: Two super-clusters representing (1) Chronic Development (left dendron) 
separated from (2) Pain Intensity, Clinical Characteristics and Direct Consequences which 
related more closely to each other (right dendra): The MPSS marker “healthcare 
utilization/patient career” (MPS-HC) clustered with “duration (time-since-onset)” (left dendron; 
AU/BP = 99/84) as in the PCA (Fig. 2). Within the second dendron at the right sub-clusters of 
Pain Intensity and of Disability were detected (AU/BP = 98/71). “Temporal characteristic” 
(MPS-TC) and “spatial aspects” (MPS-SA) were separated from all other variables of 
supercluster (2) (AU/BP = 84/40). (B) Employees: Two super-clusters of variables appeared 
also in the data of employees similar to those in patients, but less clearly defined and some 
variables grouping differently: (1) As in patients, “duration (time since onset)” and “healthcare 
utilization/patient career” clustered strongly together, but “spatial aspects” (MPS-SA, left-most) 
complicated the picture. (2) The second dendron (right) represents a super-cluster of pain 
severity with Clinical Characteristics similar to that in patients as well as with Direct 
Consequences. The general cluster structure is less well defined, mainly because of instable 
groupings of MPSS variables, but disability and intensity variables remained closely related as 
in the factor analyses. 
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4. Discussion  
The reported studies applied a multimethod approach to reappraise the generality of 
the pain chronicity construct in musculoskeletal pain by characterizing the composition 
and internal structure of frequently used chronicity indices (IASP Axis IV, CPG, MPSS). 
Two exemplary samples from model populations of patients and a nationwide sample 
of employees at risk for chronic MSP and currently in pain from two multicenter studies 
were compared in a cross-sectional retrospective study. The combined entrance data 
of established instruments for the assessment of chronic pain were analyzed by 
frequency distribution, correlational, factor and cluster analyses. Three hypotheses 
were tested assuming intensity-, duration-, population- and syndrome-dependent 
internal relations between chronicity characteristics with variable composition and 
dimensional structures. 
Hypothesis 1: Non-linear, population-specific relations between intensity and 
duration  
Intensity-duration correlations differed qualitatively and had opposite signs in patients 
(negative) as compared to the employees (positive). Patients reported lower pain 
intensities after longer rather than shorter pain duration, while employees recorded the 
lowest intensities at durations below six months. Non-monotonic shifts of intensity 
distributions over successive duration categories suggest that the process of pain 
becoming chronic is not uniform at all times and that it depends on individual 
circumstances. The inverse relation of pain severity to duration in patients could not 
have been due to more effective medication with longer treatment because the current 
medication was limited by the strict inclusion criteria and controlled by medication 
records. Instead, we assume that non-medical factors like long-term adaptation to 
prevailing pain, anchoring effects on scale responses, and/or change in coping caused 
this state of affairs. In contrast, a monotonic intensity-duration relation prevails in 
employees at lower intensity and shorter pain durations but this relation disappears at 
longer pain durations in a subgroup. 
Hypothesis 2: Monotonic relations of pain intensity-duration are more 
pronounced in chronic unspecific back pain compared to widespread pain. 
Contrary to hypothesis 2, syndrome-specific intensity-duration relations were not found 
in patients. This may be partially due to generally low overall intensity-duration 
correlations and/or low power because of low and unbalanced frequencies in several 
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intensity and/or duration categories. However, the general trend of lower pain 
intensities with longer durations in patients was stronger in FMS than in cUBP 
(negative correlations, shift to lower intensities). This suggests a difference in the 
intensity-duration relation in widespread pain compared to regional pain possibly due 
to more pronounced long-term adaptation. However, the variability in symptom pattern 
and development and, in particular, of comorbidities of the FMS group may have 
obliterated the differences. Furthermore, there is evidence for an increase in pain loci 
in cUBP and gradual development of concurrent widespread pain over time [32, 33], 
but this would require a longitudinal analysis to clarify. As there is evidence for different 
underlying mechanisms in both syndromes [33], it remains to be seen whether specific 
intensity trajectories can be differentiated between MSP subsyndromes. 
The complex picture of pain intensity developing unevenly with duration had not been 
in focus previously and mostly global correlations with variable duration categories 
have been considered. In part, this may explain the inconsistent intensity differences 
found between different times since onset (e.g., [34]) and weak or absent relations of 
intensity as well as duration to global chronicity indices (CPG, MPSS: [4, 5, 35-37]).  
Our results add to these findings demonstrating that the correlation of intensity and 
duration with each other and with chronicity indices depend on the group considered 
and possibly also on the MSP syndrome. The results indicate a dynamic interrelation 
between severity and duration changing from early to later stages and over the life 
span. This dynamic interaction may not be completely captured by the chronicity 
indices we examined. In the case of the CPG, this may be due to its scale construction 
based on IRT, which selects items to form a weakly monotonous (homogeneous) scale 
[4]. In consequence, pain intensity is not scoring above grade II. However, we showed 
that the prevailing pain intensity may still have a significant impact on the patient’s 
degree of suffering during the further chronic development although manifest disability 
may grow over time decoupled from severity [38]. The chronicity aspect of suffering, 
although clinically important, may be overlooked by using one-dimensional chronicity 
indices emphasizing disability. We assume that the extent of suffering expressed in 
the pain intensity report remains a relevant dimension of pain becoming chronic also 
in later stages, for treatment decisions and success or relapse through reconditioning 
[39]. This was further specified by the factor and cluster analyses. 
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Hypothesis 3: There is no common factor of chronicity but multiple dimensions 
differing between populations and syndromes. 
The convergent results of the structure finding approach with factor and cluster 
analyses demonstrate that chronicity is indeed not a homogeneous construct, but 
composed of the clinically relevant components of pain, that is, severity, clinical picture 
and history apart from disability, which are not easily condensed in one single scalar 
score. Furthermore, the composition is not invariant across subgroups with MSP and 
may differ between localized and widespread pain. This further limits the scope of 
global pain chronicity indices despite indirect validation by reports of significant 
correlations with other health domains such as, general health and well-being (e.g., 
SF- 36; [40]).  
Our data suggest that a minimum of three independent marker sets is necessary to 
grasp the chronicity spectrum of chronic MSP in different subpopulations. This includes 
(1) primary clinical characteristics, at least, intensity and spatial and temporal 
extension; (2) direct consequences of current interference with daily functioning; (3) 
characteristics of the chronic development such as duration, health care utilization and 
patient career including medication and treatment history. However, it remains unclear 
where instrumental aspects, like pending compensation and/or early retirement would 
fit in, because sufficient data were not available. Based on previous studies [41] we 
expect that these variables would either cluster with the third major component or form 
a separate cluster of characteristics.  
Thus, it is not surprising that different indices reconstruct chronicity differently and we 
find generally weak and population-specific intercorrelations between the CPG and 
MPSS. This is in accordance with previous research emphasizing qualitative 
differences between various chronicity indices [42]. We expect that other indices not 
considered here such as those derived from the Örebro Musculoskeletal Pain 
Questionnaire [43] or the Heidelberg Short Questionnaire [44] might show similar 
deviations. 
Limitations 
The generalizability of our results is limited because of the special samples and their 
recruitment. They were not drawn randomly from the underlying population, but 
selected by the consent to collaborate of the outpatient clinic or center and the patient 
or participant. The sample of employees was restricted to the nutritional industries and 
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gastronomy businesses. However, this should not compromise the core results nor the 
soundness of the conclusions since these were exemplary cases. 
A more serious limitation concerns the necessarily different base distributions of 
intensity and duration in patients and employees, but it was central for the study to 
obtain datasets covering the full range of severity, duration and impairment. This was 
partially compensated by sufficient overlap in intensities but less so in durations. These 
limitations preclude representativeness for the general MSP population and the 
syndromes selected, but this was not an aim of this study. The primary aim of the study 
to differentiate intrinsic structural properties of extant indices and their population-
specific composition should not have been impaired by these limitations. 
5. Conclusions 
The study shows that Chronicity of musculoskeletal pain is no coherent general 
construct, inherently multifactorial and composed of independent components varying 
in weight with severity and duration, in different groups and, possibly, in different pain 
syndromes. 
6. Implications 
Our results have implications for research and clinical applications as they underline 
that there is no unique way of assessing chronicity, over the entire range of severity 
and durations of the pain disorder for all pain populations. The conceptualizations of 
“chronicity“ implied by current indices underestimate the complexity of the 
development of chronic pain. Chronicity evaluation should be designed specific to the 
population, the diagnostic context, clinical or occupational, and the particular syndrome 
of musculoskeletal pain, in particular, of regional vs. widespread pain. We recommend 
3- to 4-dimensional (multivariate) instead of global scalar indices in assessing the 
chronicity of musculoskeletal pain. They should comprise the core components of 
chronic pain that have emerged as essential aspects from our and previous analyses 
of extant indices, i.e., the primary clinical characteristics with severity, spatial and 
temporal extension, the direct consequences of current interference with daily 
activities, as well as aspects of the chronic development, in particular, duration, health 
care utilization and patient career including medication and treatment history. Further 
analyses of time- and population-specific compositions of chronicity are needed, which 
include characteristics of pain processing, for example, altered pain sensitivity and 
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topography at later stages. The result of our cross-section analysis of three chronicity-
coding schemes is suggestive, but requires further support with longitudinal data from 
a cross-validation sample including other pain syndromes with distinctly different 
clinical pictures and high chronicity potential such as neuropathic pain. 
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2.2 Reclassifying patients with widespread and regional musculoskeletal pain by 
sensory and clinical phenotypes: Principal components and latent class analyses 
of multimethod data from pain clinic patients with prior FMS and cUBP diagnoses2
 
2 Finnern, M.M., Kleinböhl, D., Flor, H., Benrath, J., Hölzl, R. (2019). Reclassifying 
patients with widespread and regional musculoskeletal pain by clinical and sensory 
phenotypes: Principal components and latent class analyses of multimethod data from 
pain clinic patients with prior FMS and cUBP diagnoses. MS under review by co-
authors for submission to PAIN.  
 
The supplemental material will be published in electronic form on the website of the 
journal and is available from the author on request. 
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Abstract 
Background: Differentiating chronic unspecific widespread and regional 
musculoskeletal pain syndromes has been plagued by controversial discussions of 
pathognomonic clinical criteria and sensory phenotypes related to mechanisms of 
chronic pain. The problem has crystallized recently particularly around the repeated 
revisions of fibromyalgia criteria since the first ACR version of 1990. In the latest 
versions, sensory characteristics such as number of “tender points” have been 
discarded and additional symptoms such as fatigue and depression were added to 
distinguish the syndrome from other widespread pain and chronic unspecific regional 
pain with several pain loci. The present study examined the justification of these 
diagnostic shift, re-examines the diagnostic value of altered pain sensitivity and aims 
to identify circumscribed pain sensory-clinical phenotypes in patients with classical 
fibromyalgia syndrome (FMS) and chronic unspecific back pain (cUBP). We 
hypothesized that intermediate states exist between these exemplary syndromes of 
widespread and regional pain with different combinations of sensory and clinical 
phenotypes. 
Methods: Sensory and clinical characteristics of 185 patients with prior diagnoses of 
FMS and cUBP having participated in a multicenter study on chronic pain mechanisms 
were reanalyzed retrospectively. Combined sensory-clinical phenotypes were derived 
by a stepwise data-reduction through descriptive statistical, correlational, principal 
components and latent class analyses of primary data (PCA, LCA). Patients were 
reclassified according to their sensory-clinical phenotypes of pressure pain sensitivity 
combined with severity and spatial spread of the clinical pain. LCA clusters were cross-
validated by linear discriminant analysis. The resulting clusters were compared with 
respect to further pain characteristics, chronicity, somato-psychic comorbidity and 
psychosocial factors.  
Results: Four clusters of patients with different sensory characteristics and clinical 
markers were identified requiring four pressure pain sensitivity markers (number of 
sensitive ACR tender and control points, test pain intensity and pressure pain 
threshold) and two clinical pain characteristics (pain regions, present pain intensity). 
Two clusters were closely related to the prior diagnoses of classical FMS and cUBP, 
respectively. The other two clusters represented clusters with intermediate pressure 
sensitivity and mixed pain related to FMS and cUBP. Subsequent discriminant analysis 
revealed that three discriminant functions of pressure sensitivity markers sufficed to 
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discriminate between these coherent clusters with a high correct rate. These sensory-
clinical phenotypes differed mainly in functional somatic symptoms and impairment but 
neither in psychopathology nor in psychosocial co-factors. 
Conclusions: An indicator set of four sensory and two clinical essential markers is apt 
to identify subgroups of patients with distinguishable sensory-clinical pain phenotypes. 
Sensory phenotyping should be retained in the diagnostic assessment in addition to 
the clinical pain picture while secondary psychopathology and psychosocial chronicity 
factors do not add to differential diagnosis of widespread pain. 
Keywords: Pain Phenotypes; Widespread Pain; Fibromyalgia; Musculoskeletal Pain; 
Latent Class Analysis. 
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1 Introduction 
1.1  Multiple pain loci, chronic widespread pain (CWP) and fibromyalgia (FMS) 
Differentiating syndromes of chronic unspecific musculoskeletal pain has been subject 
to controversial discussions since decades (Clauw, 2015; Mense & Gerwin, 2010). 
This problem has not been addressed so far by the superordinate category of “chronic 
primary pain” of the IASP classification of chronic pain for ICD-11 (Nicholas et al., 
2019). Distinguishing patients diagnosed with “fibromyalgia syndrome” (FMS) from 
others suffering of “chronic widespread pain” (CWP) and persons with regionally 
confined pain at multiple loci, in particular,  chronic unspecific back pain (cUBP), is still 
subject to debate despite intensified large scale epidemiological research (Gerhardt et 
al., 2016; Hardt, Jacobsen, Goldberg, Nickel, & Buchwald, 2008; Mease, 2005; Viniol 
et al., 2013) 
Recent revisions of the classical ACR criteria of FMS (Wolfe et al., 2010; Wolfe et al., 
2011; Wolfe et al., 2016) have centered on CWP as the obligatory core characteristic 
of FMS and abandoned the sensory criterion of enhanced pressure sensitivity in a 
minimum of 11 of 18 “tender points” (Wolfe et al., 1990). CWP was originally defined 
as persisting pain in all four body quadrants plus the axis and is now operationalized 
by the Widespread Pain Index (WPI) developed out of the Regional Pain Scale (Wolfe, 
2003). For the FMS diagnosis pain in four sites in at least four out of five body regions 
covered by a WPI ≥ 7 or 4 – 6 is required depending on the symptom severity measured 
by the Symptom Severity Score (SSS; Wolfe et al., 2016). Both scores are combined 
in the Fibromyalgia Symptom scale (FS; 0 – 31). A cutoff of FS ≥ 12 was found to 
discriminate patients meeting the ACR 1990 criteria from those with regional 
musculoskeletal pain without recourse to the original sensory indicator of spatially 
distributed pressure hypersensitivity (Häuser et al., 2012). Notably, the SSS addresses 
abdominal pain and additional symptoms of unrefreshing sleep, fatigue, cognitive 
symptoms as well as depression. 
It is debatable whether the resulting purely clinical FMS criteria are apt to define a 
clinically coherent and pathogenetically meaningful diagnostic entity. For instance, 
many cUBP patients show an increase in pain loci and the gradual development of 
concurrent widespread pain (Forseth, Husby, Gran, & Forre, 1999; Lapossy, Maleitzke, 
Hrycaj, Mennet, & Müller, 1995). There appears to be a continuum between “regional” 
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and “widespread pain” rendering categorical distinctions by empirical cutoffs 
problematic, not to speak of comorbid combinations of both. 
Moreover, it may be argued that this development has created a different, incoherent 
nosological FMS entity altogether, with a number of problematic consequences such 
as symptom overlap with psychiatric disorders (Gracely, Ceko, & Bushnell, 2012) and 
secondary shift in gender prevalence (Vincent et al., 2013). The inclusion of comorbid 
depression and depression equivalents like sleep disorders is apt to compound chronic 
unspecific musculoskeletal pain with circumscribed psychiatric disorders and 
stigmatizes patients whose primary problem is the chronic pain disease which should 
be the center of diagnostic evaluation and treatment. The problem of inflation of 
comorbid diagnoses by inhomogeneous diagnostic criteria is well-known from other 
disease classification (American Psychiatric Association, 2013; World Health 
Organization, 1992) and has hindered the development of differential diagnosis on the 
basis of pathogenetic mechanisms (cf. the recent discussion of the IASP category of 
chronic primary pain: Henningsen, Layer, Fink, & Häuser, 2019; Rief et al., 2019). 
In fact, the current controversies on diagnostic criteria (“Are the ACR 2010 diagnostic 
criteria for fibromyalgia better than the 1990 criteria?”; Sarzi-Puttini et al., 2018) 
support the suggestion of subgroups of CWP including FMS with different underlying 
pathogenesis which cannot be discriminated by clinical indicators from each other and 
from patients with chronic musculoskeletal pain in multiple regions and additional 
somatic symptoms. This is corroborated by well documented differences between FMS 
patients with and without functional disorders other than pain, e.g., cardiac or 
gastrointestinal complaints. This cautions against using comorbid disorders of other 
domains to differentiate between CWP syndromes (Becker, Kleinböhl, Baus, & Hölzl, 
2011; Cole, Rothman, Cabral, Zhang, & Farraye, 2006; Georgescu et al., 2018).  
1.2  Diagnostic significance of sensory aspects of CWP and the specificity for 
FMS 
Focusing on non-sensory facets of the pain response such as suffering, coping and 
immediate consequences of the pain to differentiate a core syndrome of FMS avoids 
the comorbidity trap (Thieme, Turk, Gracely, Maixner, & Flor, 2015) but may be of 
limited value in uncovering changes in primary pain perception as an underlying causal 
factor. From a mechanistic view, therefore, abandoning direct sensory assessment 
could lead to overlook genuine peripheral and/or central nociceptive sensitization 
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leading to enhanced deep pain sensitivity in at least part of the FMS patients (cf. 
Mense, 2008; Oaklander, Herzog, Downs, & Klein, 2013). Besides, the early studies 
suggesting specific changes in pressure sensitivity in “tender points” proximal to 
muscle-tendon junctions to be related to peripheral myofascial hypersensitivity have 
not been disproved so far (Simons, 1975, 1976; Smythe & Moldofsky, 1978). Thus, the 
involvement of sensory enhancement in a core group of FMS and the relation of 
regional hypersensitivities to pain loci in CWP in general remain open questions.  
1.2.1 Hyperalgesia to pressure stimulation 
Therefore, dispensing with assessment of pressure hypersensitivity at the ACR “tender 
points” because practitioners may have neglected or assessed them not reliably by the 
manual probing (Cott et al., 1992; Fitzcharles & Boulos, 2003; Wolfe et al., 2016) may 
have been premature. The diagnostic relevance of the spatial distribution of 
hypersensitivity to pressure stimuli in addition to the number of spontaneously painful 
body sites can only be decided on the basis of adequate sensory testing as established 
in the last decades exemplarily for neuropathic pain (Baron et al., 2017) and relating 
the sensory parameters to current clinical diagnostic criteria. Patients at the transition 
between regional and widespread pain not fulfilling FMS criteria could not be classified 
correctly without considering sensory aspects of their pain and the spatial distribution 
of their sensitivity to pressure stimulation. 
The relevance of precise sensory characterization of the pain symptomatology and the 
related pain sensitivity in different body regions is supported by the finding that “tender 
points” are often associated with myofascial trigger points (Ge et al., 2009; Ge, Wang, 
Danneskiold-Samsoe, Graven-Nielsen, & Arendt-Nielsen, 2010) suggesting a related 
peripheral etiology possibly driving subsequent central sensitization in FMS despite 
some differences between tender vs. trigger points in terms of response to stimulation 
and origin (Mense, 2011). Enhanced sensitivity to pressure pain of FMS patients can 
be distributed to some degree across the whole body, is not limited to ACR “tender 
points” and may occur also in control points (Granges & Littlejohn, 1993; Wolfe, 1998). 
It is not clear whether such distributed enhanced pressure sensitivity is limited to FMS 
or whether it may be observed also in patients with chronic pain in multiple regions but 
not fulfilling the FMS criteria (Gerhardt et al., 2016). 
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1.2.2 Modality specificity of hyperalgesia in widespread and regional pain   
There is evidence that FMS patients are hypersensitive not only to pressure, but also 
to other stimulus modalities, e.g., heat, and this was not limited to ACR tender points 
(Gracely, Grant, & Giesecke, 2003). Whether such generalized hyperalgesia would 
differentiate regional and widespread pain is not known (Uddin & MacDermid, 2016). 
Multimodal quantitative sensory testing (QST) has produced inconsistent findings on a 
common (cross-modal) factor of pain sensitivity (Neddermeyer, Fluhr, & Lotsch, 2008) 
in contrast to multiple modality-specific sensitivities (Neziri et al., 2011). However, FMS 
patients have shown increased heat pain sensitivity possibly related to impaired 
descending inhibitory control when compared to regional pain such as chronic 
unspecific back pain (Gerhardt et al., 2016; Horn-Hofmann, Kunz, Madden, Schnabel, 
& Lautenbacher, 2018; Julien, Goffaux, Arsenault, & Marchand, 2005). 
1.3  Psychosocial factors and somato-psychic comorbidity of widespread pain 
The role of psychosocial factors in chronic unspecific musculoskeletal pain has long 
been established, social stress and the response of significant others being important 
(Flor, 2017; Flor, Kerns, & Turk, 1987; Thieme, Gromnica-Ihle, & Flor, 2003; Thieme, 
Spies, Sinha, Turk, & Flor, 2005). Affective comorbidity and associated distress play a 
key role in the determination of functional impairment of CWP/FMS compared to 
patients with regional pain (Häuser, Schmutzer, Brähler, & Glaesmer, 2009). Patients 
with CWP have repeatedly shown to have higher rates of somatic symptoms and 
depression than patients with regional pain (Viniol et al., 2013). Poor mental and 
physical health increases the risk to develop chronic musculoskeletal pain in general 
(O'Neill et al., 2018). In FMS, but also in cUBP depressive symptoms contitute the 
major part of psychic comorbidity, anxiety being less important (Bletzer, Gantz, Voigt, 
Neubauer, & Schiltenwolf, 2017; Roch, Follmer, & Hampel, 2017). It had been shown 
earlier that adding fatigue symptoms, also a marker of major depression, to pain 
symptoms improved the differentiation of clinically defined FMS from rheumatic arthritis 
(White, Harth, Speechley, & Ostbye, 1999). However, it is difficult to disentangle the 
role of these important comorbidity factors from that of basic mechanisms of enhanced 
pain sensitivity after including them into the defining criteria of the “FMS” entity in the 
first place. Relying on a more differentiated clinical picture of CWP alone, however, 
may also not lead to pathogenetically discernable subsyndromes of chronic unspecific 
musculoskeletal pain. For example, including “pain or cramps in lower abdomen” as in 
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the recent revision of the FMS criteria (page 326; Wolfe et al., 2016) creates a high, 
partly spurious, comorbidity with functional gastrointestinal disorders as repeatedly 
reported. Moreover, this hampers the differentiation of MSP from visceral pain 
syndromes and the identification of common pathogenetic factors such as central 
sensitization (Costantini, Affaitati, Wesselmann, Czakanski, & Giamberardino, 2017). 
Mechanism-oriented diagnostic classification would rather require a systematic 
comparative assessment of sensory and clinical characteristics of exemplary 
syndromes of widespread and regional pain and the structural analysis of their 
interrelations with comorbid symptoms and well-known psychosocial determination 
factors. 
1.4  Aims, research questions and hypotheses 
We assume that there is a continuum from regional to widespread pain in chronic 
unspecific musculoskeletal syndromes with respect to numbers of regions in pain and 
degrees of severity and impact. Trying to differentiate the distinct syndrome of 
fibromyalgia from other chronic musculoskeletal pain with multiple pain loci by 
combining these gradually varying indicators with secondary, not directly pain-related 
properties, particularly, psychosocial factors and somatic or psychic comorbidity may 
be insufficient. Ignoring sensory aspects of pain sensitivity and its spatial distribution 
across body regions may, in fact, obscure phenotypical subgroups with different 
underlying pain mechanisms for which different treatments should be appropriate. 
The present study aims to clarify these issues by reclassifying patients from two model 
populations for widespread vs. regional pain with prior diagnoses of FMS or cUBP into 
subgroups with distinguishable pain phenotypes by combining the clinical picture with 
comprehensive sensory characterization and structure finding statistical methods. 
Subsequently, these phenotypes were to be compared to each other and to prior 
diagnoses with respect to clinical significance relative to chronicity and functionality, 
psychosocial stress load and psychosomatic comorbidity. 
Clinical pain was assessed in terms of intensity and spatial spread supplemented by 
sensory testing of pressure and heat pain sensitivity including temporal summation to 
identify modality- and/or region-specific phenotypes in relation to prior diagnosis 
groups. For this purpose, the complete arrays of sensory indicators of 32 sites in 9 
body regions and 10 clinical pain variables were statistically reduced to optimal sets of 
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discriminators by principal components and cluster analysis aiming at sufficient power 
for reclassification. 
We hypothesized: 
(1) FMS and cUBP patients may be further differentiated into subgroups with 
characteristic sensory phenotypes with respect to the intensity and spatial distribution 
of pressure pain sensitivity as measured by manual probing and/or quantitative 
sensory testing.  
(2) The total number of hypersensitive body sites and their spatial spread or regional 
restriction indicates a more or less generalized pressure (mechano-/muscle-
nociceptor) hypersensitivity which is characteristic for pathogenetically different 
subgroups of FMS and cUBP. Specific “tender points”, the previous cardinal indicators 
of FMS, are not qualitatively different from “control points” at other muscle or soft tissue 
body sites and provide no better differentiation than the total number of hypersensitive 
body sites.  
(3) There is a substantial overlap in degree and spread of hypersensitivity to pressure 
stimuli which can be related to a “transition” stage between FMS and cUBP with 
overlapping numbers of pain loci and differentiable by combined sensory and clinical 
phenotyping. 
(4) Combined sensory and clinical phenotypes identified by structure-finding 
classification methods (latent class analyses) differentiate subgroups of widespread 
and regional pain with different pain mechanisms, somatic and psychic comorbidity 
and psychosocial co-factors better than the global diagnostic categories of FMS and 
cUBP. 
(5) Generalization of sensory hypersensitivity to other modalities such as heat pain 
forms a discernible phenotype of enhanced secondary pain processing within the 
diagnostic groups. 
(6) Cross-modal generalization of pressure pain sensitivity to heat pain may 
characterize a subgroup of FMS patients with impaired descending inhibitory control 
marked by the dynamic wind-up response (temporal summation) to tonic stimulation. 
2 Method 
2.1  Participants 
The present study is based on the initial assessment of sensory and clinical pain 
characteristics of patients with musculoskeletal pain participating in a collaborative 
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multicenter project on plasticity and learning in pain becoming chronic. Our group has 
previously reported results of the project with respect to the composition of pain 
severity and duration, interference and chronicity specific to musculoskeletal pain 
(details on sample in: Finnern, Kleinböhl, Flor, Benrath, & Hölzl, 2018). As for the 
previous study, patient data were partially acquired in connection with a clinical trial of 
combined behavioral and cannabinoid treatment for chronic pain (ClinicalTrials.gov 
Identifier: NCT00176163). The reanalysis was approved by the Local Ethics 
Committee. Patients were eligible for the study if they reported musculoskeletal pain 
for at least three months. Exclusion criteria were current psychotic disorders and 
substance abuse, disorders of the central nervous system, infectious and autoimmune 
diseases as well as current use of neuroleptics and benzodiazepines or mood-
stabilizers. Patients with major depression or anxiety disorders remained in the sample 
because affective comorbidity was a research question. Self-reported life-time medical 
diagnoses were recorded for control purpose showing a relative preponderance of past 
somatic diagnoses in FMS patients but apparent differences were not related to their 
pain symptoms (cf. Table S1 in Supplemental). 
According to the inclusion criteria of the previous study, 185 patients with clinically 
relevant pain in at least one body region for longer than six months were included. The 
majority (65.4 %) had pain for longer than 5 years. At entrance, 78 patients had a prior 
diagnosis of fibromyalgia (FMS ACR criteria: 11 out of 18 tender points; Wolfe et al., 
1990); 107 patients fulfilled criteria for chronic unspecific pain (cUBP) which required 
that pain in upper or lower back was the primary problem and was not related to acute 
trauma, inflammatory or neurologic disease, radicular and neuropathic signs absent. 
Table 1 gives an overview of the sociodemographic and chronicity data of patients. 
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Table 1. Sociodemographic, clinical and chronicity data 
(A) Sociodemographic characteristics 
 
FMS:  
N = 78 
cUBP:  
N = 107 
Healthy controls: 
N = 41 
Age [yrs.]    
Mean ± SD 50.8 ± 9.5 48.3 ± 12.2 48.9 ± 8.8 
Range 23 – 68 18 – 68 23 – 69 
Sex N (%) 
Female 73 (93.6) 69 (64.5) 30 (73.2) 
Male 5 (6.4) 38 (35.5) 11 (26.8) 
Education N (%) 
up to college level 62 (79.5) 77 (72.0 26 (63.4) 
University 11 (14.1) 19 (17.8) 13 (31.7) 
Missing 5 (6.4) 11 (10.3) 2 (4.9) 
Work N (%) 
Working  26 (33.3) 46 (43.0) 25 (61.0) 
Not working 47 (60.3) 51 (47.7) 6 (4.9) 
Missing 5 (6.4) 10 (9.3) 10 (24.4) 
Notes. Absolute numbers, % in brackets; varying N due to missings 
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(B) Chronicity data 
 
FMS:  
N = 78 
cUBP:  
N = 107 
Duration ]mths] a  N (%) 
]0-6] 0 (0.0) 0 (0.0) 
]6-12] 2 (2.6) 7 (6.5) 
]12-24] 4 (5.1) 8 (7.5) 
]24-60] 14 (18.0) 15 (14.0) 
> 60 53 (68.0) 68 (63.6) 
Missings 5 (6.4) 9 (8.4) 
Mean ± SD 50 ± 25 48 ± 32 
Median ± ½ IQD 60 ± 18 60 ± 18 
Chronic Pain Grade b N (%) 
Grade I 13 (16.7) 32 (29.9) 
Grade II 6 (7.7) 7 (6.5) 
Grade III 14 (18.0) 19 (17.8) 
Grade IV 23 (29.5) 16 (15.0) 
Missings 22 (28.2) 33 (30.8) 
Mean ± SD 2.8 ± 1.2 2.3 ± 1.2 
Median ± ½ IQD 3.0 ± 1.0 2.0 ± 1.0 
a Duration categories in left-open/right-closed intervals ]…] (excluding first, including second 
limit). 
b Chronic Pain Grade (CPG; Korff, Ormel, Keefe, & Dworkin, 1992). 
Differences between FMS and cUBP (U-test & K-S test): duration n. s.; CPG n. s. 
 
Sex ratio differed between FMS and cUBP according to the base rates in the clinical 
population consecutively recruited by the regional pain clinics participating in the 
collaborative research focus program. However, the frequency of prior diagnoses of 
FMS and cUBP were balanced in females to control sex bias. Other variables pertinent 
to the present research questions such as education and work situation were also 
matched. In particular, duration and Chronic Pain Grades (CPG; Korff et al., 1992) did 
not differ significantly between FMS and cUPB patients in the clinical population (cf. 
Finnern et al., 2018). Structural main analyses focused on within-group associations 
of sensory and clinical pain indicators and are neutral against selection effects. Data 
of N = 41 healthy controls (gender and age matched) with no clinically relevant pain 
assessed in the clinical trial served as reference for the sensory data of patients. 
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Further details on recruiting, exclusions and dropouts, sociodemographic and 
diagnostic data were reported in the previous study. 
2.2  Clinical pain assessment 
Clinical pain was assessed with a comprehensive battery of validated questionnaires. 
It consisted of the German version of the Westhaven-Yale Multiphasic Pain Inventory 
(MPI-D; Flor, Rudy, Birbaumer, Streit, & Schugens, 1990), the German Pain 
Questionnaire (Deutscher Schmerzfragebogen, DSF; Nagel, Gerbershagen, Lindena, 
& Pfingsten, 2002), the Pain Perception Scale (Schmerzempfindungsskala, SES; 
Geissner, 1996), the Fibromyalgia Impact Questionnaire (FIQ; German version: 
Offenbächer, Waltz, & Schöps, 2000; original version: Burckhardt, Clark, & Bennett, 
1991) and the Hannover Functional Ability Questionnaire (FFbH-R; Kohlmann & 
Raspe, 1996). In addition, pain-related cognitions and coping with pain were assessed 
by the German version of the Pain-Related Self-Statements Scale (FSS; Flor, Behle, 
& Birbaumer, 1993) and fear-avoidance-beliefs with the Fear-Avoidance-Beliefs 
Questionnaire (FABQ; subscales “work as cause”, “return to work prognosis”, “physical 
activity”; Pfingsten et al., 1997). 
Pain loci were extracted from the DSF with respect to current pain sites (item #20) and 
major pain (item #21). Reported pain localizations were aggregated into 9 regions 
according to Axis I of the IASP Taxonomy of chronic pain (IASP Taxonomy Working 
Group, 2017) and into 19 regions for the Widespread Pain Index (WPI, regions as 
stated in the Fibromyalgia Survey Questionnaire, FSQ; Häuser et al., 2012), the survey 
version of the FS scale (Wolfe et al., 2016; cf. Table S2 for the concordance of 
locularity and regionality definitions in Supplemental). A further question applied 
concerned “pain all over my body” for non-localized pain.  
2.3  Sensory testing 
2.3.1 Pressure pain sensitivity 
2.3.1.1 Manual tender point probe 
Sensitivity to pressure stimuli was assessed semi-quantitatively by a standardized 
manual probe at 18 “tender points” and 14 control sites adapted from Wolfe et al. 
(1990) and Okifuji, Turk, Sinclair, Starz and Marcus (1997) applied by trained 
physicians adhering to about 1 kp/cm2/s up to 4 kp/cm2 maximum pressure (Figure 
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S3 in Supplemental). Subjective pain intensity at endpoint was rated by a numerically 
anchored visual analogue scale from no to worst pain (VAS, 0 – 10). In order to 
represent the complete sensitivity range all over the body, the lean criterion of VAS ≥ 1 
was applied to define a sensitive point. 
In addition, the spatial distribution of pressure sensitivity was evaluated per body 
region by aggregated measures. For this purpose, the 32 single ratings of pressure 
pain intensity (VAS, 0-10) in the manual probe were averaged for 5 body regions 
adapted from the Heidelberg pain drawing mask (head-cervical, thoracic, lumbar, 
upper and lower limb region; Gerhardt, Hartmann, Blumenstiel, Tesarz, & Eich, 2014; 
cf. Table S6 correspondence for Heidelberg pain drawing mask).  
2.3.1.2 Quantitative algometer test 
Pressure sensitivity was quantitatively assessed by an algometer (Algometer; Wagner, 
Inc.) with 8 mm diameter stimulation area. Phasic pressure pain thresholds (“just 
painful”) were obtained bilaterally with the method of limits at the tender point in the 
center of the trapezius and the control point on the thenar eminence (0.5 kp/s ramps; 
mean of 3 trials). In addition, pain intensity ratings (VAS 0 – 10) for each completed 
series were recorded as a subjective scale anchor. 
2.3.2 Heat pain sensitivity 
A rectangular Peltier thermode with a contact surface of 1.6 × 3.6 cm was used for the 
assessment of heat pain sensitivity (PATH Tester MPI 100; Galfe, Lautenbacher, Hölzl, 
& Strian, 1990, accuracy 0.05 °C; 0.7 °C/s heating and 2.0 °C/s cooling rate). All test 
procedures were controlled by computer and subject’s responses were acquired 
automatically by a keyboard for yes/no, up/down and a trackball for rating responses, 
respectively. Instructions, control signals and graphic rating scales were presented on 
a computer screen in front of the subject (for details of apparatus and procedures: cf. 
Kleinböhl et al., 1999; Kleinböhl, Trojan, Konrad, & Hölzl, 2006). 
2.3.2.1 Heat pain thresholds 
Phasic heat pain thresholds were obtained from the center of the trapezius (dominant 
side) and the thenar eminence (non-dominant hand) with continuous versions of the 
method of limits and the method of adjustment (means of 5 trials). The tonic heat pain 
threshold was defined as the “just painful” temperature adjusted by the subject after 
30 s constant heat stimuli above and below the self-adjusted threshold. 
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2.3.2.2 Supra-threshold heat pain sensitivity 
Absolute magnitude estimates (AME) of the perceived heat pain were recorded at the 
end of the tonic stimulation on a numerically and verbally anchored visual analogue 
scale ranging from 0 (warm sensation) to 100 (very strong pain) with the pain threshold 
set at 40 (just painful). The linear regression of AMEs on stimulus temperature was 
used as estimate of the psychophysical function (Steven’s coefficient) for heat pain. 
2.3.2.3 Short-term sensitization to heat: Temporal summation  
Short-term sensitization to heat was measured with the previously established dual 
sensitization method (Kleinböhl et al., 1999) based on temporal summation. The 
method provides both a behavioral re-adjustment measure (ΔT) as well as a subjective 
estimate (ΔE) of perceived temperature change over 30 s of tonic heat as a function 
of the initial temperature (temperature gradient). Nine initial temperatures, 3 below and 
6 above the previously self-adjusted pain threshold, were applied in steps of 0.33°C in 
a pseudo-randomized order. At the end of the tonic stimulation period subjects were 
to rate the perceived temperature change (ΔE) and the perceived heat pain intensity 
(absolute magnitude estimation, AME) on numerically anchored visual analogue 
scales and, finally, to re-adjust the thermode to the (assumed) initial temperature (ΔT). 
2.4  Assessment of comorbidity and psychosocial co-factors 
2.4.1 Somatic symptoms and well-being  
In addition to the general medical entrance diagnostics and anamnestic data, somatic 
well-being and subjective body complaints were specified by established and validated 
questionnaires. The general somatic symptom burden was evaluated by the SF-12, 
physical component (short-form of the SF-36, Health-Related Quality of Life 
Questionnaire; Bullinger & Kirchberger, 1998) and the global symptom score of the 
Giessen Symptom Questionnaire (GBB-24; Brähler, Hinz, & Scheer, 1995). Specific 
symptoms were quantified by the GBB subscales for exhaustion, gastric symptoms, 
heart complaints and limb pain (German “Gliederschmerzen”, equivalent to 
musculoskeletal pain). The presence of specific functional gastrointestinal disorders 
was checked by the questionnaire for functional gastrointestinal disorders (FGID; 
Drossman et al., 1992; Herschbach, 1996). Sleep quality was evaluated by the 
Pittsburg Sleeping Quality Index (PSQI; Buysse, Reynolds, Monk, Berman, & Kupfer, 
1989). 
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2.4.2 Psychopathology 
General mental health was assessed by the mental health component of the SF-12; 
depressive and anxiety symptom burden was quantified by the Center for 
Epidemiological Studies Depression Scale (German version: ADS; Hautzinger & 
Bailer, 1993) and the Trait Anxiety Scale of the State-Trait Anxiety Inventory (German 
version: STAI-T; Laux, Glanzmann, Schaffner, & Spielberger, 1981), respectively. An 
ADS score ≥ 24 indicates a risk for major depression and allows for a tentative 
diagnosis while the STAI-T score indicates only a general anxious disposition. 
Untransformed sum scores were used in all calculations instead of population-
dependent percentile ranks or T-values. 
2.4.3 Psychosocial co-factors 
The Short Stress Questionnaire (German “Kurzer Fragebogen zur Erfassung von 
Belastungen, KFB; Flor, 1991, a short stress scale adapted from the Daily-Hassles-
Scale; Kanner, Coyne, Schaefer, & Lazarus, 1981) for chronic pain, was applied to 
determine self-reported stress burden on four subscales (partnership, daily problems, 
social contacts, trouble at work) and the sum-score as indicator of overall strain. 
2.5  Data analyses 
The sequential multimethod strategy consisted of initial descriptive statistical, 
correlational and contingency analysis followed by structure-finding methods. Data 
were analyzed with the program packages IBM SPSS Statistics (version 25; Armonk, 
NY, USA), R (version 3.4.1; The R Foundation for Statistical Computing, Vienna, 
Austria) and LatentGOLD® (version 5.1.0.17248; Statistical Innovations Inc., Belmont, 
MA, USA).  
Main analyses comprised principal component (SPSS program), hierarchical cluster 
analyses (R program pvclust; Shimodaira, 2002; Suzuki & Shimodaira, 2006, 2015) 
and latent class analyses (LatentGOLD®, program LC cluster) to identify sensory 
phenotypes with respect to pressure pain sensitivity separately and combined with 
heat pain sensitivity and short-term sensitization. Heat pain served as non-
mechanoceptive control for the modality-specificity of phenotypes. 
Preparatory correlation analyses served as basis for identifying common variable 
groupings. Principal components analyses were calculated to uncover dimensions and 
spatial relations of pressure sensitivity indicators of the semi-quantitative manual probe 
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and the quantitative algometer test to derive an optimal set of indicators for the latent 
class analysis (LCA) defining coherent sensory phenotypes of the target modality. A 
similar analysis was run for the heat pain sensitivity and sensitization parameters and 
for both sensory modalities combined. These initial exploratory steps implied repeated, 
statistically dependent analyses on the same dataset. Thus, the extracted principle 
components and clusters of sensory indicators served merely for a descriptive 
selection of the reduced set of best sensory markers to be combined with clinical pain 
characteristics while minimizing sample attrition in the database.  
The selected indicator set was included in the final step of sensory-clinical phenotyping 
by robust LCA at the individual level and reclassifying the patients with prior FMS or 
cUBP diagnoses (LatentGOLD®, program LC cluster). The identified transdiagnostic 
sensory-clinical profile clusters were cross-validated by a stepwise linear discriminant 
function analysis applying Wilks' lambda for variable selection. 
Finally, the identified sensory-clinical phenotypes were compared to prior FMS and 
cUBP groups with respect to clinical pain characteristics, comorbidity and psychosocial 
co-factors not included in the previous LCAs. Parametric t-tests and nonparametric U-
tests for ordinal data were used for comparisons between clusters throughout, K-S 2-
samples tests were calculated for control when appropriate. Cross-classifications of 
prior diagnoses and clusters were evaluated by contingency analysis using the 
corrected contingency coefficient (Ccorr). In view of current controversies about the 
validity of conventional significance levels (cf. Amrhein, Greenland, & McShane, 2019) 
exact probabilities are reported up to p = 0.001 where possible; else, classical 
significance was set at p < 0.05 with p-values corrected familywise. 
3 Results 
In the following the main results of the 3-step analysis of sensory and clinical 
phenotypes of patients with prior FMS and cUBP diagnoses serving as exemplary 
samples of widespread and (more or less) regional pain with no known organic origin 
are described. First, the clinical picture, in particular, spatial extension of pain sites and 
regions, current pain intensity, quality and severity of the prior diagnosis groups were 
re-evaluated according to the comprehensive entrance assessment. Second, the 
extraction of a minimal set of sensory classifiers from the initial indicators of enhanced 
pain sensitivity in the database by PCA and LCA was delineated (cf. the Supplemental 
for details). Third, combining the minimal classifier with selected clinical pain 
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characteristics four distinguishable sensory-clinical phenotypes were identified 
differing in spatial patterns of pressure sensitivity and clinical pain, forming two extreme 
subgroups with high and low pressure pain sensitivity associated with widespread and 
regionally confined pain, respectively, and two intermediary clusters. Finally, patients 
with prior FMS and cUBP diagnoses were reclassified into these sensory-clinical 
phenotypes revealing partially overlapping subgroups at the transition between cUBP 
to FMS. These were related to the clinical pain picture, psychic and somatic 
comorbidity and psychosocial co-factors specifying their role in differential diagnosis of 
widespread and regional musculoskeletal pain syndromes. 
3.1  Re-evaluation of clinical pain 
3.1.1 Spatial extension and regions in pain 
Table 2. Re-evaluation of spatial extent and severity of current pain  
Pain Characteristic 
Prior Diagnosis at study entrance 
FMS ACR 1990 a: N = 78 cUBP: N = 107 
“Widespread pain” b  
4 quadrants + axis 71 (91.0) 28 (26.2) 
< 5 regions 2 (2.6) 70 (65.4) 
FS scale c   
FMS criterion ≥ 12 63 (80.8) 23 (21.5) 
FMS criterion < 12 15 (19.2) 84 (78.5) 
Mean ± SD 16.3 ± 6.3 8.2 ± 4.5 *** 
Median ± ½ IQD 17.0 ± 4.5 8.0 ± 3.0 *** 
Range 0 – 20 0 – 20 
Widespread Pain Index, WPI d  
Mean ± SD 11.8 ± 3.8 5.5 ± 2.9 *** 
Median ± ½ IQD 12 ± 3.0 5 ± 1.5 *** 
Range 4 – 19 0 – 15 
No. present pain sites e   
0 0 (0.0) 1 (0.9) 
1 0 (0.0) 2 (1.9) 
2 0 (0.0) 7 (6.5) 
3 1 (1.3) 10 (9.3) 
   
Original contributions 
 
 83 
[Table 2, continued:]  
Pain Characteristic 
Prior Diagnosis at study entrance 
FMS ACR 1990 a: N = 78 cUBP: N = 107 
4 2 (2.6) 29 (27.1) 
5 12 (15.4) 22 (20.6) 
6 15 (19.2) 12 (11.2) 
7 21 (26.9) 9 (8.4) 
8 12 (15.4) 5 (4.7) 
9 10 (12.8) 1 (0.9) 
Mean ± SD 6.8 ± 1.4 4.7 ± 1.7 *** 
Median ± ½ IQD 7 ± 1 4.5 ± 1 *** 
No. major pain sites f  
1 19 (24.4) e 35 (32.7) 
2 12 (15.4) 33 (30.8) 
3 14 (17.9) 17 (15.9) 
4 9 (11.5) 7 (6.5) 
5 8 (10.3) 0 (0.0) 
6 4 (5.1) 4 (3.7) 
7 0 (0.0) 0 (0.0) 
8 1 (1.3) 1 (0.9) 
9 0 (0.0) 0 (0.0) 
Mean ± SD 2.79 ± 1.72 2.19 ± 1.36 * 
Median ± ½ IQD 3.0 ± 1.5 2.0 ± 1 * 
Pain all over my body g 15 (19.2) 1 (0.9) 
Present pain intensity h   
Mean ± SD 3.3 ± 1.3 2.9 ± 1.3 
Median ± ½ IQD 3 ± 0.5 3 ± 1.0 
Range 0 – 6 0 – 6 
Pain severity i   
Mean ± SD 3.7 ± 1.1 3.4 ± 1.1 * 
Median ± ½ IQD 3.7 ± 0.9 3.3 ± 1.2 * 
Range 1.3 – 6.0 1.0 – 6.0 
Missings 8 12 
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[Table 2, continued:]   
Pain Characteristic 
Prior Diagnosis at Study Entrance 
FMS ACR 1990 a: N = 78 cUBP: N = 107 
Pain quality j    
Sensory scale SS10    
Mean ± SD  21.7 ± 7.0 17.7 ± 6.5 ** 
Median ± ½ IQD 20.0 ± 4.9 16.0 ± 3.5 ** 
Range 10.0 – 39.0 10.0 – 40.0 
Affective scale AS14   
Mean ± SD 34.3 ± 9.9 30.7 ± 9.3 * 
Median ± ½ IQD 33.0 ± 8.0 29.0 ± 7.3 * 
Range 18.0 – 56.0 14.0 – 53.9 
a ACR criteria: 11 out of 18 tender points (Wolfe et al., 1990). 
b “Widespread pain” according to Wolfe, 1990 (ACR criteria for fibromyalgia): present pain in 
4 body quadrants plus axis; N cases (%). 
c Fibromyalgia Symptom Scale, FS scale ≥ 12 (Wolfe et al., 2016); N cases (%). 
d Widespread Pain Index, (WPI, range 0 - 19) according to the Fibromyalgia Survey 
Questionnaire (FSQ, Häuser et al., 2012), the survey version of the FS scale (Wolfe et al., 
2016). 
e All present pain sites reported by patients corresponding to Axis I, IASP Taxonomy of chronic 
pain (IASP Taxonomy Working Group, 2018); N cases (%); responses to item #20 in DSF 
(Nagel et al., 2002), cf. Table S2 in Supplemental for correspondence of pain regions. 
 f Responses to item #21 in DSF (Nagel et al., 2002), which includes max. 3 separate sites for 
back pain; N cases (%). 
g Responses to item #21: “pain all over my body”, in DSF (Nagel et al., 2002); N cases (%). 
h Intensity ratings of present pain, MPI-D item #1 (Flor et al., 1990). 
i Pain severity: MPI-D, section I, scale 1 score (Flor et al., 1990). 
j Raw sum scores of the affective and sensory subscales (AS: 14 and SS: 10 items, 
respectively) of the German Pain Perception Scale (Schmerzempfindungs-Skala, SES, 
Geissner, 1996); for comparisons between subscales values were corrected for different item 
numbers; 17 missing patient values imputed according to test manual. 
Differences between FMS and cUBP (U-test, K-S test and t-test where applicable): FS scale: 
*** p < 0.001; WPI: *** p < 0.001; present pain sites: *** p < 0.001; major pain sites: * p < 0.05; 
present pain intensity: n. s.; pain severity: * p < 0.05; sensory scale: ** p < 0.01; affective scale: 
* p < 0.05. 
 
Seventy-one FMS patients of 78 with complete data sets reported pain in four body 
quadrants and along the axis consistent with the ACR 1990 criteria of “widespread 
pain”, but 28 (26.2 %) patients previously diagnosed with chronic unspecific back pain 
reported also pain in all body quadrants in addition to their primary pain area at the 
back (Table 2). The FS criterion ≥ 12 was fulfilled by comparable quota (63 FMS, 23 
cUBP patients). The WPI values of the FS scale of FMS patients was twice as high 
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than for cUBP patients (U-test; p < 0.001). However, the WPI of the latter ranged up to 
15 and the distributions of both groups overlapped substantially (Figure 1). 
 
Figure 1: Absolute frequencies of self-reported pain loci according to the Widespread Pain 
Index, WPI (Wolfe et al., 2010; Wolfe et al., 2011). By definition, patients with prior FMS 
diagnoses indicated more pain loci than cUBP but many reported only 10 or less pain loci at 
re-assessment. WPI distributions of FMS and cUBP patients overlapped between 4 and 15 
indicating a subgroup of patients in a transition stage neither fulfilling entirely FMS criteria nor 
having only regionally restrained pain as in cUBP proper.  
 
The number of body sites currently in pain named by patients when presented with the 
nine IASP Taxonomy regions corroborate and specify this finding (Table 2): The FMS 
patients indicated generally more IASP regions “currently in pain” than cUBP patients 
and the distribution was dominated by higher numbers (5 – 9) while the number of pain 
regions of UBP patients were symmetrically distributed around 4 and 5. Similar 
overlaps of the spatial extent of pain symptoms were reported when patients were 
asked for the region of their “major pain” (DSF item #21): 48 FMS patients indicated 
“major pain” in more than one IASP region (median = 3; max = 8) while 19 FMS patients 
localized their “major pain” in only one region, 11 reporting “pain all over my body” in 
addition. Four FMS patients were not able to indicate a distinct major pain region and 
felt pain all over their body. For comparison, 62 cUBP patients reported also more than 
one major pain region and 54 one to five additional, not back-related major pain 
regions. One cUBP patient also indicated “pain all over my body”. In summary, the 
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spatial extent and pattern of pain sites and/or regions showed distinct differences 
between the FMS and the cUBP group but a high variability and substantial overlap 
between the prior diagnoses prevailed.  
3.1.2 Pain severity 
In contrast, the severity of pain symptoms did not differ consistently between prior FMS 
and cUBP groups: The intensity ratings of present intensity (MPI-D, item #1) of the 
major pain were marginally higher in FMS patients (U-test, p = 0.060, n. s.; Table 2) 
covering the whole range from 0 – 6 with the same median at 3.0 in both groups. Global 
pain severity summarizing present and recent pain with subjective suffering (MPI-D 
Scale 1, section I) was only moderately higher by FMS than cUBP patients (t-test, p = 
0.033; Table 2). 
3.1.3 Pain quality: sensory and affective descriptors 
Sensory and affective qualities of the major pain measured by the SES scored 
significantly higher in FMS compared to cUBP patients (t-tests; affective descriptors: 
p = 0.017; sensory: p < 0.001). FMS patients differed from cUBP most pronouncedly 
in sensory rather than affective pain descriptors (standardized differences: 0.59 SD vs. 
0.38 SD; Figure S4 in Supplemental). Moreover, the differences between sensory and 
affective evaluations were equivalent in both groups indicating that FMS patients did 
not emphasize the affective stronger than the sensory aspect of their pain. 
3.2  Sensory phenotyping: Experimental measures of pain sensitivity 
The measures of enhanced sensitivity to provoked pressure pain available in the 
database showed important but complex relations to each other and to the heat pain 
control modality. Therefore, extensive descriptive and structural analyses including 
PCA and LCA were needed in order to extract a parsimonious marker set for coherent 
sensory phenotypes to be finally combined with clinical pain characteristics and related 
to chronicity factors. A detailed description of the procedure is available in the 
Supplemental. Here we report only the main results of (1) the descriptive analysis of 
the spatial distribution of pressure sensitivity to standardized manual and algometer 
stimulation of ACR “tender” and control points in FMS and cUBP patients and (2) the 
final sensory profiles used in phenotyping. 
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3.2.1 Spatial distribution of pressure pain sensitivity 
The standardized manual probe of pressure sensitivity at 32 body sites confirmed the 
pronounced enhancement of sensitivity to pressure stimulation in FMS patients 
established by previous research, both in terms of number of hypersensitive body sites 
as well as provoked pain intensities compared to cUBP patients (U-tests, p < 0.001; 
Table 3); with one exception healthy controls had neither sensitive tender nor control 
points in the manual probe. 
Table 3. Spatial distribution of pressure sensitivity in 18 ACR “tender” and 14 
control points 
(A)  Number and pain intensity of standardized manual stimulation 
 
FMS:  
N = 78 
cUBP:  
N = 107 
No. sensitive tender points a, b   
Mean ± SD 15.0 ± 2.8 5.0 ± 4.6 
Median ± ½ IQD 15.5 ± 3.0 4.0 ± 4.0 *** 
Range 7.0 – 18.0 0.0 – 18.0  
Missings 2 5 
No. sensitive control points a,b    
Mean ± SD 4.4 ± 4.0 1.1 ± 2.0 
Median ± ½ IQD 3.0 ± 3.3 0.0 ± 1.0 *** 
Range 0.0 – 14.0 0.0 – 10.0 
Missings 1 6 
No. all sensitive points a,b   
Mean ± SD 19.2 ± 6.1 6.1 ± 6.6 
Median ± ½ IQD 19.0 ± 4.8 4.0 ± 4.3 *** 
Range 0.0 - 32.0 0.0 – 26.0 
Missings 1 5 
Intensity tender points b,c   
Mean ± SD 5.755 ± 1.684 4.2 ± 1.8 
Median +- ½ IQD 5.7 ± 1.3 4.0 ± 1.2 *** 
Range 2.6 – 10.0 1.0 – 10.0 
Missings 2 5 
Intensity control points b,c   
Mean ± SD 4.9 ± 1.9 3.8 ± 1.9 
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[Table 3 A, continued:] 
 
FMS:  
N = 78 
cUBP:  
N = 107 
Median ± ½ IQD 4.8 ± 1.3 3.0 ± 1.1 ** 
Range 1.5 – 9.0 1.0 – 10.0 
Missings 15 74 
Intensity tender and control points b,c  
Mean ± SD 5.5 ± 1.6 4.10 ± 1.7 *** 
Median ± ½ IQD 5.6 ± 1.2 3.7 ± 1.2 *** 
Range 2.7 – 9.6 1.0 – 10.0 
Missings 2 26 
VAS pain intensity average of head-cervical region d 
Mean ± SD 5.1 ± 1.9 4.1 ± 1.8 
Median ± ½ IQD 5.0 ± 1.5 4.0 ± 1.4 **  
Range 1.8 – 9.4 1.0 – 10.0 
Missings 4 53 
VAS pain intensity average of thoracic region d 
Mean ± SD 5.6 ± 1.8 4.1 ± 1.8  
Median ± ½ IQD 5.6 ± 1.4 4.0 ± 1.4 *** 
Range 1.3 – 10.0 1.0 – 8.1 
Missings 2 44 
VAS pain intensity average of lumbar region d 
Mean ± SD 5.8 ± 2.3 4.1 ± 1.8 
Median ± ½ IQD 5.9 ± 2.0 4.0 ± 1.0 *** 
Range 1.0 – 10.0 1.0 – 10.0 
Missings 2 69 
VAS pain intensity average of upper limb region d 
Mean ± SD 5.5 ± 2.0 4.1 ± 2.1 
Median ± ½ IQD 5.5 ± 1.5 4.0 ± 1.3 *** 
Range 1.9 – 10.0 1.0 – 10.0 
Missings 10 73 
VAS pain intensity average of lower limb region d 
Mean ± SD 5.6 ± 1.9 4.0 ± 2.3  
Median ± ½ IQD 5.8 ± 1.6 3.3 ± 2.0 *** 
Range 2.0 – 9.5 1.0 – 8.5 
Missings 4 62 
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a Number of tender and control points on both sides with VAS ratings ≥ 1 (max. 18 tender and 
14 control points) corrected for individual maximum number of test sites. Differences between 
left and right n. s. (t-test, Wilcoxon). 
b One healthy control with sensitive ACR tender points > 0 (TP at left and right knee/ lower limb 
region); no healthy control indicated sensitive control points. Average pain intensity for control 
points not calculated for healthy controls. 
c Means of intensity ratings > 0; zero values predominating at the thenar control point in both 
FMS and cUBP, but not at the trapezius “tender point” in FMS (cf. histograms in Figure S5 in 
Supplemental).  
d Average pressure pain intensity ratings (VAS, 0-10) of the manual probes in the five body 
regions of the Heidelberg pain drawing mask (Gerhardt et al., 2014), zero-values excluded. 
Average pain intensity for pain regions (head-cervical, thoracic, lumbar, upper limbs) in healthy 
controls and comparisons with patients not calculated. 
Notes. ½ IQD, ½ inter-quartile distance = 0.5 × [Q(75) – Q(25)]. 
*** p < 0.001; ** Difference FMS vs. cUPB, Intensity control points: p = 0.003; and VAS pain 
intensity average of head-cervical region p = 0.005 (U-test). 
 
(B)  Pressure pain thresholds and intensity in algometer test 
 FMS: 
N = 78 
cUBP: 
N = 107 
Healthy 
controls:  
N = 41 
Pressure threshold: Trapezius with algometer a  
Mean ± SD 2.45 ± 1.46 4.18 ± 1.71 *** 3.55 ± 0.97 *** 
Median ± ½ IQD 2.05 ± 1.33 4.00 ± 0.83  3.50 ± 0.47 
Range 0.10 – 7.00 0.75 – 9.90 1.55 – 7.25 
Missings 0 4 1 
Pressure threshold: Thenar with algometer a  
Mean ± SD 2.85 ± 1.26 3.71 ± 0.99 *** 3.30 ± 1.00 * 
Median ± ½ IQD 3.30 ± 1.11 4.00 ± 0.40 3.35 ± 0.79 
Range 0.10 – 5.00 0.95 – 6.75 1.30 – 5.50 
Missings 0 4 1 
Pain intensity VAS rating trapezius b   
Mean ± SD 5.99 ± 2.12 3.92 ± 2.81 *** 4.26 ± 2.83 ** 
Median ± ½ IQD 6.00 ± 1.75 4.00 ± 2.63 5.00 ± 2.50 
Range 1.00 – 10.00 0.00 – 9.00 0.00 – 8.00 
Missings 1 6 3 
Pain intensity VAS rating thenar b  
Mean ± SD 3.14 ± 3.00 2.84 ± 2.93 4.26 ± 2.74 
Median ± ½ IQD 3.00 ± 2.75 2.50 ± 2.75 4.00 ± 2.5 
Range 0.00 – 9.00 0.00 – 9.00 0.00 – 8.00 
Missings 1 5 2 
Original contributions 
 
 90 
a Phasic pressure pain thresholds were obtained using ramps of 0.5 kp/s. After initial trials the 
threshold (“just painful”) was recorded three times at each site. Differences between left and 
right n. s. (t-test, Wilcoxon). 
b Mean pain intensity ratings (VAS 0 – 10) for completed series after the phasic pressure pain 
threshold testing. Differences between left and right n. s. (t-test, Wilcoxon). 
Notes. ½ IQD, ½ inter-quartile distance = 0.5 × [Q(75) – Q(25)]. 
*** p < 0.001; ** Difference FMS vs. HC: p = 0.001, cUBP vs. HC: p = 0.518; * Difference FMS 
vs. HC: p = 0.037, cUBP vs. HC: p = 0.031 (t-test). 
 
As shown in Table 3, however, the pressure hypersensitivity was not limited to the 18 
“tender points” specified by the ACR 1990 protocol but applied also to control points if 
fewer and less pronounced. The number of hypersensitive ACR tender points of FMS 
patients ranged from 7 to 18 (median = 15.5) three patients not fulfilling the criterion 
of ≥ 11 tender points at second testing. Moreover, 16 cUBP patients (15 %) showed 
also 11 or more hypersensitive ACR tender points indicating substantial overlap 
between prior FMS and cUBP diagnoses on second testing. Moreover, 63 (81 %) FMS 
and 33 (31 %) cUBP patients reported also one or more hypersensitive control sites 
numbers ranging respectively from 0 to 14 and from 0 to 10. The total number of 
hypersensitive body sites, irrespective of ACR tender or control position, differed also 
significantly between FMS and cUBP (median = 19 vs. 4) but ranges overlapped 
considerably (0 – 32 vs. 0 – 26). At the same time, pain intensity ratings of the manual 
stimulation were consistently higher at ACR tender points than at control points in both 
groups (U-test; FMS: p < 0.001; cUBP: p = 0.003). This and the higher numbers of 
sensitive tender points suggest enhanced pressure sensitivity at classical “tender 
points” to be specific to FMS. The question is further explored in the next section by 
considering the variation of pain ratings as a function of numbers of hypersensitive 
body sites, overall and separately for tender and control points (Figure 2).  
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Figure 2: Average pain intensities of standardized manual probing as a function of number of 
pressure-sensitive body sites; pain intensity: NRS 0 – 10; sensitive site: NRS > 0 (just clearly 
painful or more); number of sensitive sites corrected for missings. (A) All sensitive points; (B) 
sensitive ACR “tender points”; (C) sensitive control points. Box-plots: group median ± P25/P75; 
circles = individual values; whiskers: range windsorized at 1.5 × IQR ± P75/P25. 
Average pain intensity ratings of painful thumb probes (classic “tender” and control point 
locations taken together) were significantly higher in FMS than in cUBP patients and increased 
with the number of sensitive sites in FMS, but not in cUBP patients (right vs. left half of 
diagrams (A – C). In FMS, evoked pain intensity correlated with the actual number of sensitive 
tender points (B: ρ = 0.347, p < 0.065), but not with the number of sensitive control points (C: 
ρ = 0.048, n. s.); no correlation in cUBP. 
 
Figure 2 A demonstrates that test pain intensity increases systematically with numbers 
of sensitive points in both FMS and cUBP; there is a more or less continuous transition 
from the regional to the widespread pain syndrome with a large overlap between the 
two syndromes. Closer inspection shows that the relation is mainly due to the FMS 
group confirmed by group-specific correlations (FMS: ρ = 0.363, p = 0.001; cUBP: 
ρ = 0.116, p = 0.302, n. s.; respective correlation-regression analysis in Table S7 and 
Figure S8 in Supplemental). Moreover, the high number × intensity correlation in FMS 
was limited to the 18 ACR tender points (Figure 2 B) whereas pressure pain intensity 
did not increase systematically with the number of sensitive control points (Figure 2 C). 
This increase could also be found in cUPB patients with more than 7 classical ACR 
tender points (right half of Figure 2 B). Thus, local pressure sensitivity appears to be 
associated with the spatial extent of sensitive areas across the whole body. This was 
Original contributions 
 
 93 
particularly pronounced when ACR tender points were considered for which the 
relation held also in those cUBP patients in the transition to widespread 
hypersensitivity above 7 sensitive ACR tender points. 
This supports the notion of a sensory difference between classical tender and control 
points as suggested by earlier research. Note, however, the ceiling effect due to scale 
clipping at the maximum of 18 tender points tested in FMS causing the accumulation 
of observations at the rightmost category 18 in Figure 2 B. Accordingly, provoked pain 
intensity correlated maximally with the number of sensitive ACR points when only 
subjects with 16 or less sensitive ACR points were taken into account; the partial 
correlation above cannot be evaluated reliably. Therefore, the FMS subgroup with 17 
or more sensitive test points (max = 32) and the corresponding frequency distributions 
of provoked pain intensity deserve further consideration as they may represent a 
different population. Accordingly, the highest pain intensities were found in FMS 
patients with 25 - 28 sensitive points out of 32 tested, the lowest intensities in patients 
with 13-16 sensitive points. The intensity distributions of patients with 17 - 20, 21 – 24 
and 29 - 32 sensitive points exhibited the most systematic shift from lower to higher 
intensities with increasing numbers irrespective of “tender” or “control” sites 
(cumulative frequency distributions of intensities in Figure S9 in Supplemental). 
Note also, that these specific patterns of spatially spread pressure sensitivity were lost 
when the site-specific manual probes were aggregated for macro-anatomic functional 
body regions, e.g., the five body regions of the Heidelberg pain drawing mask. cUPB 
patients indicated generally lower pain intensities than FMS patients (multiple U-tests, 
p < 0.001, corrected; Table 3) but the aggregated intensity ratings lay in the medium 
range for both patient groups irrespective of region, tender or control points. 
Cross-examination of the results of the semi-quantitative manual assessment by 
comparisons with selected quantitative algometer tests at respective marker loci on 
the trapezius muscle (“tender point”) and the thenar eminence (extra-spinal control 
point) reproduced the sensitivity differences between FMS and cUBP patients. 
Algometer pressure pain thresholds were significantly lower at both sites in FMS than 
in cUBP (multiple t-tests, p < 0.001). The corresponding pain intensity ratings of FMS 
patients were higher only at the trapezius tender point marker (trapezius: p < 0.001; 
thenar: p = 0.512, n. s.; Table 3 B). cUBP data were generally less consistent and, for 
instance, differed from healthy controls (HC) by higher thresholds, particularly on the 
trapezius, and lower provoked pain intensity. Moreover, the correlations between these 
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algometer measures of near- and supra-threshold pressure sensitivity differed 
between the selected “tender point” on the trapezius and the control site in both groups 
(cf. Table S10 in Supplemental). Therefore, the algometer pain threshold and intensity 
were included from both test sites in the final measurement model for sensory 
phenotyping of patients. 
3.2.2 Regional clusters of pressure sensitivity 
For this purpose, the initial set of 32 pain intensity ratings from bilateral manual 
pressure stimulation at 18 tender (TP) and 14 control points (CP) was first reduced by 
PCA revealing bilateral and regional redundancies. Nine significant components were 
sufficient to describe the spatial distribution of the test pain in both FMS and cUBP 
(Kaiser criterion; 79.5 % and 80.4 % variance) with 5 dominant components 
(loadings ≥ 0.50) collecting most of the variance (64.1 % and 60.7 %). These 
components represented systematic relations to the functional body regions on head, 
neck, shoulder, trunk and extremities as defined in Table 3. The ninth component was 
selective for the extremities (tender and control points on arms, legs and foot; PCA in 
Table S11 in Supplemental). Notably, tender and control points loaded on separate 
components only in FMS while the cUBP intensity ratings showed 3 composite TP-CP 
components. In general, loading patterns reflected the functional difference between 
TP and CP in FMS patients apparent in the sensory differences described in the 
previous section. Moreover, CP loadings were distributed all over the body without left-
right asymmetries. The first dominant component (28 %) consisted only of TPs from 
the head, neck, shoulder and upper back in both FMS and cUBP with minor gluteal 
loading in the latter. The second, third and fourth components, in contrast, differed in 
composition between FMS and cUBP with separation of tender and control points in 
the former and TP-CP combined in the latter. The fifth dominant component was mainly 
thoracal in both groups extending to the cervix in FMS. The other components 6 to 9 
explained neglectable further 3 – 4 % of the variance from different sites on the 
extremities. 
The group-specific dimensional structure of pressure pain sensitivity was principally 
reproduced in additional PCAs including the pressure pain thresholds and intensity 
ratings from the quantitative algometer test at the exemplary ACR tender and control 
points (cf. Table S12 in Supplemental). In FMS, in particular, the algometer pain 
intensities at the trapezius tender point and the thenar control point loaded on the 
corresponding tender and control point components of the manual test as well as TP 
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and CP were separated on different components. This well-defined structure 
represents the functional differences between tender and control points in FMS. This 
was different in the cUBP group where algometer and manual measures created 
different, method-specific components irrespective of their functional relation to 
“tender” vs. “control points”. 
The distinct functional and regional dimensional structures of pain intensities provoked 
in the manual pressure probe and the quantitative algometer test allowed the reduction 
of the final parameter sets to define economic sensory phenotypes by appropriate 
cluster analyses at the parameter level. The first set covered the pain intensities of the 
manual test at all tender and control points related to body regions; the second set 
combined the algometer pain thresholds and supra-threshold intensities at the 
trapezius “tender” and the thenar control point with the corresponding manual probe 
measures. The described dimensional differences in FMS and cUBP argued for 
separate cluster analyses. Their results are shown in the body maps and 
corresponding cluster dendrograms of Figure 3, A – D. 
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Figure 3: Results of cluster analysis of individual pain intensity ratings at “tender” and “control 
point” sites; hierarchical latent class with multiscale bootstrap resampling (Suzuki & 
Shimodaira, 2015). (A, B): regional clusters of pain sensitivity to manual pressure probing on 
body map; sites of the same regional clusters on front and back marked by identical colors.    
(C, D): cluster dendrogram of sensitive body sites; nodes corresponding to regional clusters. 
Red and green numbers AU/BP (arbitrary unbiased/bootstrap probability) values of significant 
clusters (AU ≥ 95% significant). TP = ACR tender point, CP = control point, l = left, r = right; 
“height” scale on the left: distance from the center of gravity of the particular cluster, i.e., the 
dissimilarity relative to the other members of the cluster. 
ACR tender points were clearly separated from control points in the dendrogram for FMS 
patients (C), but not in cUBP (D). In FMS patients, tender points on the upper back and cervical 
region formed a coherent region of pressure pain sensitivity (violet marks in A; left dendra in 
C) so did the tender points on the arms and legs including the gluteal and hip (orange and olive 
marks, medial dendra) and were clearly separated from the control points on the hands and 
feet (blue marks, right dendra). The control points on the clavicle and the forearm formed a 
cluster of their own (green marks, separate sub-dendron middle-left). In cUBP, in contrast, 
pressure pain sensitivity was clustered mainly according to macro-anatomical regions and 
distributed across ACR tender and control points (e.g., green marks on hands and epicondyle, 
olive marks on clavicle and second rib, in B). 
 
In FMS, latent class analysis separated pain intensities of the manual probes at tender 
and control points in functionally and regionally distinct clusters; in cUBP regional 
clusters were retained also but with tender and control sites in the same clusters. The 
separation of the regional and functional groupings of pressure pain sensitivities were 
reproduced by the LCA of the combined algometer and manual test at the exemplary 
tender and control points on the trapezius and the thenar in both groups (dendrograms 
in Figure S13 in Supplemental). 
In FMS patients, in particular, the cluster of tender points on the back, shoulder, neck 
and occiput formed a coherent region (pink and purple sites in Figure 3 A) as did the 
tender points on the extremities (olive, orange) and one on the upper back 
(supraspinatus, dark orange). These regions of classical tender points separated from 
the corresponding pressure-sensitive control points (cf. cluster dendrogram in Figure 
3 C). Notably, pressure pain sensitivity at control points were arranged in separate 
regional groups, too, on hands and feet (dark blue), on the clavicle and the forearm 
(green) and the forehead (turquoise) with the only exception of the CP on the biceps 
femoris (dark orange). Tender and control points at left and right body sides were 
consistently linked at the lowest dendrogram level in both FMS and cUBP patients. 
The LCA of pressure sensitivities of cUBP patients resulted in a different but also well-
structured cluster solution reflecting predominantly anatomical vicinity regardless of 
the “tender” or “control point” status of the stimulation site (Figure 3 B, D). In particular, 
tender and control points on the head, upper back and front and the hip were classified 
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together (olive, orange, red, purple) as were the test sites on the upper and lower 
extremities (blue and green). 
The consistent spatial and functional organization of pressure sensitivities was 
confirmed by the separate combined LCAs using only the algometer and manual test 
indicators from the selected exemplary trapezius “tender” and the thenar “control” 
points at both sides of the body (dendrograms in Figure S13 in Supplemental). Again, 
tender and control point measures were separated into different sub-clusters in FMS 
for both algometer and manual tests while in cUBP patients the sub-clusters were 
classified according to the assessment method, one by the algometer measures, the 
other by the manual pressure measures irrespective of tender or control point status. 
This confirms the structural differences to FMS found in the preparatory PCA and 
argues for the inclusion of both algometer and manual probe measures in the final 
indicator set for the LCA profiling at the personal level.  
3.2.3 Sensitivity to non-mechanoceptive pain: heat-pain  
The comparison with heat pain sensitivity at the selected trapezius “tender” and thenar 
control sites showed that the enhanced pressure sensitivity of FMS patients was not 
paralleled by the non-mechanoceptive cutaneous pain modality. The characteristic 
spatial and/or functional differences of pressure pain sensitivity between the exemplary 
tender and control points were not reproduced and varied widely over different 
measures of near- and supra-threshold heat pain sensitivity. Phasic heat pain 
thresholds did not differ between FMS and cUBP at both sites (averages: 44.7 ± 3.0 °C 
vs. 46.1 ± 2.6 °C) while tonic heat pain thresholds at the thenar of FMS patients tended 
to be lower than in cUBP (43.3 ± 1.7 °C vs. 44.6 ± 1.6 °C; p < 0.05, uncorrected). 
Accordingly, phasic as well as tonic heat pain thresholds at the thenar of healthy 
controls were higher than in FMS patients (e.g., PTlim:  46.2 ± 2.3 vs. 43.4 ± 2.9 °C; 
p < 0.001). Supra-threshold sensitivity to heat pain in terms of pain intensity as a 
function of stimulus temperature did not differ between groups (cf. summary of sensory 
assessments for heat pain in Table S14 in Supplemental). 
These differential patterns of heat pain indicators across body sites and prior 
diagnostic groups were incorporated in the measurement model for the non-
mechanoceptive modality. It consists of a minimal set of heat pain sensitivity 
parameters derived from the intercorrelations between specific measures of the 
extended initial assessment set (summary of correlation and principal component 
analysis of heat pain indicators in Table S15 & S16 in Supplemental). In particular, 
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phasic self-adjusted (PTadj) and tonic heat pain thresholds (PTton) at the same site were 
highly correlated in both FMS (, thenar: 0.923; trapezius: 0.956; p < 0.001) and cUBP 
patients (, thenar: 0.915; trapezius: 0.863; p < 0.001). Threshold correlations between 
stimulation sites, however, were low or insignificant in FMS patients and only moderate 
in cUBP. This reproduces the intercorrelations of algometer thresholds in FMS vs. 
cUBP described earlier. Heat pain thresholds correlated weakly with supra-threshold 
pain intensities in FMS patients (0.217 - 0.653; p < 0.05) and moderately in cUBP 
(0.414 - 0.517; p < 0.01). Stimulation method mattered being highest between 
thresholds with similar stimulation and response mode, that is, for PTadj × PTton. 
Therefore, only one phasic threshold and one tonic threshold per site and supra-
threshold pain intensity were included in the final set of heat pain sensitivity markers 
for the identification of pressure and heat pain phenotypes below. In addition, the 
behavioral measure (ΔT) of temporal summation after 30 s of tonic heat was retained 
as an indicator of short-term sensitization or “wind-up” in which FMS differed from 
healthy controls (t-test: p = 0.032) although not from cUBP. We assumed that the 
sensory heterogeneity of the prior diagnosis groups could have obscured relevant 
differences in sensitization propensities between subgroups with widespread and/or 
regional pain however apt to show different sensory profiles at final reclassification. 
The suggested measurement model for heat pain sensitivity for the cross-modal 
comparison was verified stepwise by principal components analysis and latent class 
analysis. The former comprised several successive exploratory PCAs with partial heat 
pain vectors to maximize entry numbers for specific combinations. First, only heat pain 
thresholds at the two selected tender and control sites on the trapezius and thenar, 
were entered; second, supra-threshold intensity and, third, temporal summation were 
added (cf. PCA overview in Table S16 in Supplemental). The first threshold PCA 
yielded two distinct components for both FMS and cUBP explaining respectively 
88.5 % and 81.3 % variance with different compositions: In FMS, the two components 
represented the “tender” (trapezius) and “control points” (thenar) with high loadings of 
phasic and tonic thresholds from left and right body sides. In cUBP, in contrast, the two 
principal components were not related to the functional difference between the 
trapezius and thenar but to method differences between phasic and tonic thresholds. 
This corresponds to the correlations above and reflects analogous group-specific 
relations in pressure sensitivity (section 3.2.1.). The second exploratory PCA with 
supra-threshold heat pain intensity at corresponding stimulation sites separated near-
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threshold from supra-threshold sensitivity on two different components explaining 
76.2 % and 79.3 % variance in FMS and cUBP, respectively. This underscores the 
difference between heat pain thresholds and supra-threshold sensitivity and the 
necessity to include both in sensory profiling. The third exploratory PCA including 
temporal summation yielded a separate third sensitization component in FMS patients 
(72.3 % variance). In cUBP thresholds formed also a separate component while 
temporal summation loaded together with supra-threshold intensity on the second of 
two components (62.8 % variance). These exploratory PCAs showed that (1) heat pain 
thresholds, (2) supra-threshold sensitivity and (3) temporal summation are 
independent aspects of thermo-nociceptive processing and at least one marker of each 
heat pain dimension would be necessary in a comprehensive sensory profile. Further, 
the non-mechanoceptive pain modality at “tender points” appeared to differ also from 
that in control points and should be represented in the sensory profile. 
This was confirmed in the subsequent LCA of the full heat pain vector which resulted 
in simple 2-cluster structures reproducing the PCA components with important 
specifications (dendrograms in Figure S17 in Supplemental): In both FMS and cUBP 
patients, phasic heat pain thresholds, PTlim, were well separated from tonic thresholds, 
PTton (AU/BP: FMS = 100/99; cUBP = 100/94). The LCAs with supra-threshold intensity 
and temporal summation confirmed the PCA in classifying thresholds, intensity ratings 
and temporal summation in different clusters. As behavioral and subjective measures 
of the latter (ΔT, ΔE) were equivalent, only ΔT was included as sensitization marker in 
the final thermo-nociceptive indicator set used for the cross-modal group comparison 
of pressure pain sensitivity with the non-mechanoceptive sensory modality. 
3.2.4 Transmodal hyperalgesia  
To identify transmodal factors and sensory classes of generally enhanced pain 
sensitivity common to pressure and heat pain sensitivity (hypothesis #6) relevant for 
comprehensive sensory phenotyping combined LCAs were run on a further minimal 
indicator set of both. Again, preparatory correlation and principal component analyses 
were necessary to minimize the entered indicator vectors to retain maximal eligible 
cases for sufficient power of the combined cluster analyses. 
3.2.4.1 Correlations between pressure and heat pain sensitivity 
Pressure and heat pain sensitivity indicators (thresholds, supra-threshold intensity) 
correlated weakly to moderately with each other in FMS and mostly insignificantly in 
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cUBP patients (overview in Table S18 in Supplemental). Sporadic correlations 
distributed across measures and body regions in both groups and were higher within 
homologous than across different body regions (FMS: algometer pain × phasic heat 
pain thresholds: ρ = 0.452, p < 0.05; cUBP: n. s.). Remarkably, the number of sensitive 
ACR “tender” and control points of FMS patients correlated also with the heat pain 
thresholds at the trapezius “tender” ( =  0.430, p > 0.01) and the thenar control point 
( 0567, p < 0.05). In FMS, temporal summation to heat correlated also moderately 
with the algometer pressure pain threshold and intensity on both the trapezius and the 
thenar suggesting that temporal heat summation reflected a generalized tendency to 
sensitize in this group with widespread pain. However, sample size was much reduced 
for this parameter combination (26) and enough cUBP data were not available for 
comparison. The measure was retained nevertheless in the combination of pressure 
and heat pain indicators for the following PCA and LCA of FMS data. 
3.2.4.2 Transmodal dimensions of pain sensitivity 
Common trans-modal dimensions of pressure and heat pain sensitivity were extracted 
by exploratory PCAs of site-specific and regional averages of pressure pain sensitivity 
combined, first, with heat pain thresholds at corresponding sites and, second, with 
supra-threshold heat pain intensity and temporal summation added (overview in Table 
S19 & S20 in Supplemental). 
The transmodal PCA of pressure and heat pain sensitivity of FMS patients (excluding 
summation) resulted in three principal components explaining 65 % of the variance: 
The first component (27.0 % variance) represented a combination of the spatial spread 
of pressure sensitivity (number of sensitive tender and control points) with heat pain 
thresholds at the thenar reference; the second component (22.1 %) combined the 
algometer measures of pressure sensitivity (thresholds, supra-threshold intensity) with 
the heat pain thresholds at the trapezius tender point. The independent third 
component (15.9 %) contained only pressure pain sensitivity at the trapezius “tender 
point”. Using regional averages of pressure and heat pain sensitivity resulted in 
corresponding components. The separate PCA including the behavioral temporal 
summation measure (ΔT) and the absolute intensity at the end of 30 s tonic heat of 
FMS patients yielded five components (74% variance) with a separate component for 
the sensitization indicator ΔT (mean and temperature gradient; 12.4 %, cf. Table S21 
in Supplemental). The other factors reproduced the basic FMS structure described 
above with more or less similar cross-modal and modality-specific loadings. 
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The transmodal PCA of cUBP data (restricted to phasic heat pain thresholds) produced 
four components (80 % variance) repeating the method-specific loading pattern of the 
separate PCAs of pressure and heat pain sensitivity which differed characteristically 
from that of FMS. The first three components were composed exclusively of pressure 
pain indicators from the manual probe (first component, 29.5 %: number of sensitive 
tender and control points; pain intensity at the trapezius) and the algometer test 
(second component, 20.2 %: supra-threshold pain intensity at the trapezius and the 
thenar; third component: algometer pressure pain thresholds). Heat pain thresholds 
loaded on a separate fourth thermo-nociceptive component. 
3.2.4.3 Transmodal clusters of pain sensitivity 
The principal components of the combined set of pressure and heat pain sensitivity 
measures were used to select optimal indicator sets for two separate LCAs to identify 
cross-modal sensory phenotypes with maximum case numbers despite increased 
sample attrition after including heat pain measures. The first LCA included pressure 
and heat pain thresholds and supra-threshold intensities from corresponding sites at 
the right trapezius “tender” and the left thenar control point. The second LCA used 
average pain intensities of sites in the functional anatomy regions of the Heidelberg 
pain drawing mask (head-cervical, thoracic, lumbar, upper and lower limb region) 
instead of individual test sites to account for regional associations. Two main clusters 
of pressure and heat pain sensitivity measures at the trapezius and thenar were found 
with some composition differences between FMS and cUBP. The second LCA with 
regional averages reproduced the general two-cluster structure corresponding to 
anatomical regions (cf. Figure S22 in Supplemental). 
In FMS patients, the main cluster 1 was pressure pain-specific composed of the semi-
quantitative manual probe and the quantitative algometer test in method-specific sub-
clusters. The manual probe sub-cluster comprised the number of hypersensitive body 
sites together with the pain intensity of the probe at the trapezius “tender” and the 
thenar control point. Tender and control point measures were well separated at the 
third and fourth level. The pain ratings of the quantitative algometer test at the trapezius 
tender point and the thenar control point classified appropriately in the algometer sub-
cluster. Main cluster 2 collected the pain thresholds in both modalities at the selected 
tender and control sites on the trapezius and thenar with algometer pressure and 
thermode heat pain thresholds in modality-specific sub-clusters at the second dendron 
level. The trapezius tender point site at the back separated from the control site at the 
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thenar at the third dendron level in both modalities. Phasic and tonic heat pain 
thresholds on the left and right body side grouped together at the lowest level 
apparently measuring the same sensitivity aspect. 
In cUBP, the main cluster 1 was pressure-specific as in FMS patients including the 
numbers of hypersensitive tender and control points with the pain intensity ratings of 
both the manual and the algometer test at the trapezius tender as well as the thenar 
control point (cf. Figure S22 b, left in Supplemental). Main cluster 2 contained all 
threshold measures of both modalities as in FMS; however, the site-specific and 
function-related grouping of heat pain thresholds at the trapezius tender point versus 
the thenar control point was not retained and substituted by method-specific sub-
clusters within the heat pain modality (phasic vs. tonic heat pain thresholds). The 
second, region-related LCA revealed another striking deviation in classifying the pain 
intensity of the manual probes in the lumbar region with the heat pain thresholds. This 
deserves consideration with respect to the high prevalence of lower back pain in our 
sample of cUBP patients (63.6 %). 
Additional exploratory site- and region-related cross-modal cluster analyses of 
pressure and heat pain indicators were run with supra-threshold sensitivity to tonic heat 
and temporal summation of heat as indicator of cross-modal short-term sensitization 
for which complete data were available only for FMS patients (cf. Figure S22 e,f in 
Supplemental). Here the previous modality specificity of pressure and heat pain 
measures was lost and the heat pain thresholds and supra-threshold heat pain 
intensity clustered together with number of sensitive tender and control points. 
Remarkably, temporal heat pain summation was linked to the algometer pressure 
threshold. This would argue for a common source of general pain sensitivity and the 
inclusion as classificator for the sensory phenotyping at the patient level.  
3.3  Sensory and clinical phenotypes in patients with prior diagnoses of       
fibromyalgia and chronic unspecific back pain 
The statistical and structural analysis of semi-quantitative and quantitative sensory 
characteristics defined the necessary and sufficient indicator set for the sensory 
phenotyping in relation to clinical pain characteristics of the FMS and cUBP patients. 
Accordingly, the optimal set of sensory parameters should include one representative 
of (1) the spatial distribution of hypersensitivity to percutaneous pressure; (2) 
quantitative sensory test measures of pressure pain sensitivity; and (3) quantitative 
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sensory test measures of cutaneous heat pain sensitivity from representative body 
areas. 
However, combining the heat pain sensitivity with hypersensitivity to pressure 
stimulation and essential aspects of clinical pain resulted in small case numbers in the 
available database and low power. Further, preparatory correlational analysis showed 
that heat pain parameters correlated only scarcely with clinical pain in both FMS and 
cUBP patients (cf. overview in Table S23 in Supplemental). In contrast, pressure pain 
sensitivity correlated at least moderately with clinical pain, in particular, the number of 
sensitive “tender points” with the WPI (number of regions in pain; FMS:  = 0.287; 
p = 0.003, < 0.01, corrected; cUBP: n. s.). In addition, these correlations appear to be 
underestimated because both the WPI and the numbers of sensitive test points are 
scale-limited variables subject to ceiling effects in FMS and floor effects in cUBP 
(cf. lower and upper scale limits in Figures 1, 2 and Figure S24 in Supplemental). 
Therefore, the final sensory profiling by LCA at the patient level concentrated on the 
necessary indicators of pressure sensitivity (categories 1 and 2) and sufficient clinical 
pain markers (WPI and current pain intensity). Heat pain sensitivity was compared only 
ex post between the sensory-clinical phenotypes identified by the LCA in relation to 
prior FMS and cUBP diagnoses (section 3.3.3.).   
3.3.1 Profiles of pressure pain sensitivity and clinical widespread pain 
Initial exploratory LCA runs with the combined set of pressure pain sensitivity and 
clinical pain characteristics derived above showed that no more than six classifiers 
should be entered to produce stable profile clusters given the number of FMS and 
cUBP patients with complete data sets remaining in the analysis (69 and 90). The best 
six classifiers (BIC and CAIC indices) included present pain intensity and number of 
pain regions as clinical characteristics with selected pressure sensitivity indicators from 
the manual probe and the algometer test, i.e., number of sensitive “tender” and “control 
points”, test pain intensity and the algometer pressure pain threshold at the right 
trapezius “tender point”. In the following, only this final LCA on the total sample of 159 
patients with reliable and interpretable cluster solutions is reported (Figure 4; further 
information on LCAs methods, fit criteria, etc., in Table S25 and Table S26 in 
Supplemental). 
The LC model with four clusters of patients with prior diagnoses of either FMS or cUBP 
fitted best (BIC, CAIC) with very similar profiles irrespective of whether the number of 
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pain sites was based on current or major pain or the WPI. Sensory-clinical profiles 
differentiated best when the WPI was used for the spread of pain regions as clinical 
marker (Figure 4). These characteristic sensory phenotypes were reproduced with 
female data only to control for the uneven gender distributions in the FMS and cUBP 
groups (cf. Table S27; Figure S28 in Supplemental). 
 
Figure 4: Discriminator profiles of four phenotypes of pain and pressure sensitivity of patients 
with prior FMS and cUBP diagnoses. Polar chart of sensory-clinical profiles of the four main 
clusters of FMS and cUBP patients identified by the LCA with the best fit (BIC/CAIC indices) 
for the reduced indicator set. Polar axes: range-standardized means of indicators (0 – 1; cf. 
Vermunt & Magidson, 2015). MPI Intensity = present pain intensity (MPI-D, scale 1, item #1); 
WPI = Widespread Pain Index; Sens TPs = number of sensitive ACR “tender points”; Sens 
CPs = number of sensitive control points; PPT qst trap-r = pressure pain threshold at the right 
trapezius in quantitative algometer test; PPI man trap-r = pressure pain intensity at the right 
trapezius in semi-quantitative manual probe. 
Highly pressure-sensitive clusters 1 and 2 (dark red and pink) overlap considerably. They are 
primarily characterized by widespread pain (high WPI), many pressure-sensitive ACR “tender 
points” and a relatively high number of sensitive control points as well as distinct pain of the 
manual probe at the trapezius tender point. Cluster 1 was distinguished additionally by the very 
low pressure pain threshold in the algometer test. The low pressure-sensitive clusters 3 and 4 
(light and dark blue) exhibited a low WPI and few sensitive “tender” and control points. Pain 
intensity of the manual probe at the right trapezius was also low. 
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All four clusters were characterized by medium intensity of current pain divided into 
two cluster pairs with high vs. moderate WPI and high vs. low pain intensity in the 
manual sensitivity test (cluster 1 & 2 vs. cluster 3 & 4 in Figure 4). The first cluster pair 
with widespread pain and high pressure sensitivity and the second cluster pair with 
narrow spread pain with low pressure pain sensitivity were further differentiated into 
four sensitivity categories from low to high by the numbers of sensitive tender and 
control points. In addition, cluster 1 was differentiated from all other clusters by the 
very low pressure pain threshold in the quantitative sensory algometer test. Note also 
that not only the number of sensitive ACR tender points but also of sensitive control 
points differentiated the widespread pain clusters 1 and 2 from the clusters 3 and 4 
showing very few pressure-sensitive control points. 
Table 4. Four clusters of clinical characteristics and sensory phenotypes in 
patients with FMS and cUBP 
(A) Prior FMS and cUBP diagnoses  
 Cluster  
Prior Diagnosis 1 2 3 4 Σ 
FMS 
44 a 
(94/64) 
16 
(76/23) 
0 b 
(0/0) 
9 
(16/13) 
69 
cUBP 
3 
(6/3) 
5 
(24/6) 
33 
(100/37) 
49 
(84/54) 
90 
FS    ≥ 12 
40 
(85/49) 
17 
(81/21) 
5 
(15/6) 
19 
(33/23) 
81 
< 12 
7 
(15/9) 
4 
(19/5) 
28 
(85/39) 
39 
(67/50) 
78 
Σ 47 21 33 58 159 
Correlation clusters × prior FMS and cUBP diagnoses: Ccorr, =  0.881, p < 0.001; clusters × 
FS ≥ 12: Ccorr = 0.713, p < 0.001. Notes. Cluster numbering according to rank order of numbers 
of sensitive tender points; LCA maximum likelihood extraction sequence 4-1-3-2. 
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(B) Discriminator profiles 
 Cluster  
Indicator 1 2 3 4 Distance g 
1. Sensitive 
Tender Points c 
16 ± 1.5 
[89 ± 8] 
13 ± 3.0 
[72 ± 17] 
0 + 2 b 
[0 + 14] 
6.5 ± 3 
[36 ± 17] 
0.404  
 
2.Pressure Pain 
intensity d 
6.0 ± 2.0 6.0 ± 1.5 0.0 ± 0.0 b 2.0 ± 2.0 0.330 
 
3.WPI c 
13 ± 3.0 
[68 ± 16] 
11 ± 3.0 
[68 ± 16] 
4 ± 2.0 b 
[21 ± 11] 
5 ± 1.6 
[26 ± 09] 
0.248 
 
4.Sensitive 
Control Points c 
3 ± 2.5 
[21 ± 18] 
6 ± 2.3 
[43 ± 20] 
0 ± 0 b 
0 + 2 
[0 + 14]  
0.242 
 
5.Pressure Pain 
Threshold e 
1.8 ± 0.6 4.0 ± 0.0 4.0 ± 0.5 b 4.0 ± 1.5 0.130 
 
6. Present Pain 
Intensity f 
3.0 ± 0.5 4.0 ± 0.5 3.0 ± 1 b 3.00 ±1 0.060 
Description 
widespread 
pain; highly  
pressure-
sensitive 
mixed 
pain;  
moderately 
pressure-
sensitive 
regional 
pain; 
weakly 
pressure-
sensitive 
mixed 
pain; 
normally 
pressure-
sensitive 
 
a Absolute frequencies; in brackets: column/row %. Cluster 1 & 2: “FMS-like”; cluster 3 & 4: 
“cUBP-like”. 
b No prior FMS diagnoses in cluster 3. 
c Absolute frequencies; in brackets: % of points tested (18 ACR tender points, 14 control points, 
19 WPI body sites); medians ± 0.5 IQD. 
d Pressure pain intensity of the manual test at the right trapezius, VAS rating 0 – 10; medians 
± 0.5 IQD. 
e Pressure pain threshold algometer test; means ± SD. 
f Present pain intensity (MPI-D, item #1), NRS scale 0 – 6; medians ± IQD. 
g Absolute cluster mean differences between all cluster pairs for the indicator (0 – 1 
standardized means; cf. Vermunt & Madison, 2005). Notes. The non-parametric estimator 
does not regard oblique relations between profile vectors; it results in ordinal ranking of the 
LCA discriminators for parameter selection, but not for statistical testing. See also section on 
cross-validation of LCA sensory profiles and Table S26 in Supplemental, Standardized point 
distances per indicator. 
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The best discriminating indicators according to absolute profile distances between the 
four clusters was the number of sensitive tender points followed by the pain intensity 
rating at the trapezius tender point in the manual test and the WPI of clinical pain (Table 
4 A). The first two sensory discriminators differed significantly between all four clusters 
(Kruskal-Wallis & pairwise U-tests: number tender points: p = 0.012; pain intensity 
trapezius: p < 0.001, both corrected familywise; complete sensory statistics in Table 
S29 in Supplemental). The WPI differentiated only between the high and low sensitivity 
cluster pairs but not within them (cluster 1 & 2 vs. cluster 3 & 4: U-test, p < 0.001; 
corrected single contrasts, n. s.). The low pain threshold in the algometer test at the 
trapezius differentiated cluster 1 from the rest (p < 0.001, uncorrected) suggesting a 
unique phenotype within the widespread pain population. 
The clinical and sensory profiles in Figure 4, however, are not accompanied by 
differences in clinical pain intensity despite the obvious differences in spatial spread 
as well as pressure pain sensitivity. Whether this relates to differences between 
subgroups of diagnostic syndromes is clarified by the reclassification of clinicians’ prior 
diagnoses and the diagnoses according to the Fibromyalgia Symptom scale (FS ≥ 12) 
into the four posterior clusters according to LCA-derived sensory-clinical phenotypes 
(Table 4 A). 
Prior FMS and cUBP diagnoses were distributed meaningfully and highly significantly 
different over the four clusters (Table 4 A; p < 0.001; corrected contingency, 
Ccorr = 0.881, df = 3). Clusters 1 and 2 with high WPI and many sensitive tender points 
comprise most FMS patients (87 %) and cluster 1 collected two thirds of them. The 
latter was also differentiated from all other clusters by the lowest pressure pain 
threshold in the quantitative algometer test. In contrast, clusters 3 and 4 with low to 
moderate WPI contain 91 % cUBP patients showing also low pressure sensitivity in 
the manual and the algometer test. Cluster 3 with the least sensitive patients consists 
only of cUBP patients and no FMS patients at all. Cluster 4 with low to medium 
pressure sensitivity contains mainly cUBP patients (84.5 %) and only 9 (15.5 %) FMS 
patients. Table 4 B illustrates the close relations between the clinical profiles of 
widespread vs. regional pain and the phenotypes of high and low pressure sensitivity. 
However, it shows also that the prior diagnosis groups of FMS and cUBP were 
inhomogeneous and may be reclassified by sensory phenotypes into at least four 
subgroups with different clinical and pathogenetic profiles. 
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This becomes particularly clear by cross-tabulating clusters and screening diagnoses 
according to the Fibromyalgia Scale criterion of ≥ 12: The FS criterion misclassified not 
only 20 % of clinicians’ prior diagnoses (FMS: 19 %; cUBP: 21 %) but the cross-
classification with the pain-pressure sensitivity phenotypes of the four clusters was 
more variable and more patients belonging to clusters 1 or 2 vs. 3 or 4 were 
misclassified (FS ≥ 12: 30 %; FS < 12: 14 %). Moreover, it is apparent from the 3-way 
classification of the four pain-pressure sensitivity clusters with prior clinicians’ 
diagnoses and FS screening diagnoses: Clusters largely correspond to clinical 
diagnosis, but the FS criterion led to misclassification especially in the cUBP patients 
in cluster 3 and 4 (FMS: 14%, cUBP: 24 %, Ccorr = 0.310 and 0.331, df = 3, n. s., Table 
4). These results are in line with the mismatch of prior diagnoses (FMS vs. cUBP) and 
the FS screening diagnoses (FS ≥ 12, cf. Table 2, section 3.1) and question the 
discriminative validity of the screening instrument. 
3.3.2 Discriminant analysis of widespread vs. regional pain 
The discriminative power of the selected indicator set characterizing the 4-cluster 
classification was cross-validated with stepwise discriminant function analysis with 
individual indicators entering in the order of their absolute distance scores (cf. Table 
S26 in Supplemental). Three canonical discriminant functions of the four sensory 
indicators alone sufficed to differentiate the four clusters (functions 12: 
Wilks  = 0.093; 23:  = 0.595; function 3:  = 0.881; p < 0.001; overview in Table 
S30 in Supplemental). Pain intensity and WPI added not substantially to cluster 
discrimination although contributing to cluster building by LCA. The first discriminant 
function explained 89.8 % of the variance (canonical R2 = 0.84), the second 7.9 % 
(canonical R2 = 0.32) and the third 2.2 % (canonical R2 = 0.12). Importantly, clusters 
were systematically positioned in the discriminant function space where clusters 1 and 
2 were well separable from 3 and 4 with less good discrimination within these pairs in 
accord with the cluster pair characterization above (Figure 5). 
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Figure 5: Discriminant analysis validation of sensory-clinical phenotypes of widespread and 
regional pain. Result of the linear discriminant function analysis of sensory-clinical phenotypes 
based on the four clusters shown in Figure 4: Location of patients in the 2-dimensional 
projection of the 3D orthogonal discriminant function space. Abscissa: Function 1 (first step 
separation with highest weights for semi-quantitative manual test); ordinate:  function 2 
(second step separation with highest weight for quantitative algometer test); function 3 (least 
discriminating) omitted. Cluster centroids are shown as numbered filled black circles. 
Standardized canonical discriminant function coefficients: Function 1 = 0.868 × Sens TPs          
+ 0.415 × PPI man trap-r – 0.035 × Sens CPs  0.149 × PPT qst trap-r;  
Function 2 = 0.024 × Sens TPs + 0.179 × PPI man trap-r + 0.367 × Sens CPs + 
0.915 × PPT qst trap-r; Function 3 =  0.547 × Sens TPs + 0.244 × PPI man trap-r + 
0.921 × Sens CPs  0.393 × PPT qst trap-r (parameter abbreviations as in Figure 4). 
High-sensitive patients with widespread pain in cluster 1 and 2 (red circles and pentagons) are 
concentrated on the right according to their high positive values in the manual test. The 
singularly low-sensitive cUBP patients of cluster 3 concentrated in the lower left according to 
their negative values on function 1. Note the high concentration of cluster 1 patients in the 
lower right and of cluster 2 above them separated by the second discriminant function 
according to the quantitative algometer test values suggesting two more homogeneous 
subgroups to be identified by improved quantitative sensory testing. While these three clusters 
exhibit more or less homogenous subgroups, the moderately sensitive patients with mixed pain 
in cluster 4 vary considerably and distribute from the middle to the left overlapping partially 
with the other clusters. However, the second discriminant function separates a subgroup of 
this cluster on the upper left which might also be identified with more comprehensive 
quantitative sensory testing. 
Technical note. A stepwise linear (orthogonal) discriminant function analysis was calculated 
with four a priori groups and Wilks' lambda for variable selection using SPSS version 25 (IBM, 
Armonk, NY, USA). 
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Number of sensitive ACR tender points had the highest weight on the first function 
followed by the pain intensity of the manual probe on the trapezius tender point. The 
algometer pressure pain threshold obtained the highest weight on the second 
discriminant function, whereas the number of sensitive control points contributed most 
to the third function. The three functions classified 82.4 % of the original LCA groupings 
correctly (N = 131). The control analysis with listwise inclusion of sensory and clinical 
indicators did not improve the correct classification rate (84.3 %; N =134). 
False classifications of patients with respect to the original four sensory-clinical 
phenotypes occurred only between clusters 1 and 2 and between 3 and 4 by the 
discriminant functions leaving out intensity and spatial spread (WPI) of the clinical pain. 
Patients in cluster 3 having no sensitive tender point and, consequently, reporting no 
pain in the manual test at the trapezius tender point were 100 % correctly classified. 
This relates to the high frequency of cUBP patients in this cluster (33; 37 %) and the 
fewest critical WPI (FS ≥ 12) of all clusters (cf. Table 4). Cluster 2 classification was 
second best with 90.5 % correct. Cluster 1 (the highly pressure sensitive cluster with 
widespread pain) and cluster 4 (the low sensitivity cluster with several pain loci) were 
predicted less well with 80.9 % and 70.7 % correct, respectively. Overall classification 
into one of the two cluster pairs by the sensory profiles was much better and error rates 
dropped to 4.4 % (1 or 2) and 6.6 % (3 or 4). 
3.3.3 Heat pain sensitivity and widespread pain 
Exploring trans-modal associations of pain sensitivity with clinical pain characteristics 
was constrained by the small numbers of patients with complete data remaining in the 
analysis (33 FMS, 20 cUBP). Nevertheless, the robust LCA with the minimal sensory 
and clinical pain indicator set extracted by the pre-analyses (section 3.2.4) generated 
a stable, convergent 2-cluster solution with the WPI and present pain intensity as 
clinical markers, the number of sensitive tender points and algometer thresholds as 
indicators of pressure sensitivity and the tonic heat pain threshold at the thenar control 
point as cutaneous, non-mechanoceptive pain reference. These clusters related well 
to the two pairs of patient clusters found without heat pain: Cluster 1 was characterized 
by high WPIs and heightened pressure as well as heat pain sensitivity reflecting the 
first, high-sensitive cluster pair while cluster 2 contained the patients with low to 
moderate WPIs and lower sensitivity in both modalities related to the second,  more 
insensitive cluster pair. Furthermore, patients with prior FMS and cUBP diagnoses 
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classified differentially also on the two cross-modal clusters (cluster 1: 79 % FMS, 5 % 
cUBP; cluster 2: 21 % FMS, 95 % cUBP; p = 0.001; χ2 = 27.13, df = 1). 
This tentative cluster model was corroborated by direct ex-post comparisons with 
higher power including all patients for whom any heat pain measures data were 
available at all (69 FMS; 90 cUBP). This showed that only heat pain thresholds differed 
significantly between the four clusters (cluster 1 and 2 combined against cluster 3 and 
4 combined: tonic heat pain threshold trapezius and thenar, p < 0.001; phasic heat 
pain thresholds at trapezius and thenar, p = 0.049 and 0.002); neither supra-threshold 
heat pain intensity nor temporal summation differed. 
In summary, while there is evidence of cross-modal lowering of pain thresholds, in 
general, heat pain sensitivity does not add substantially to sensory phenotyping of the 
reclassified patient groups characterized by widespread pain and enhanced pressure 
pain sensitivity. Therefore, the following comparisons of coping with pain and 
secondary factors such as somato-psychic comorbidity and psychosocial factors will 
be based on the sensory and clinical phenotypes identified by the four clusters of 
widespread or regional pain with high or low pressure-pain sensitivity. 
3.4  Comorbidity, coping and psychosocial factors in four clusters of clinical 
pain and pressure sensitivity  
The subgroups of patients with prior diagnoses of FMS or cUBP identified by the four 
clusters of clinical and sensory phenotypes were further explored with respect to 
derived pain aspects not included in clustering, in particular, pain impact and coping, 
chronicity, functional level, comorbidity as well as psychosocial co-factors often 
associated with fibromyalgia and/or chronic unspecific back pain. Table 5 shows the 
results of corresponding group comparisons which differed from the general 
descriptive statistics of the prior diagnosis groups of section 3.1 (cf. Table 2). 
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Table 5. Pain characteristics, coping, comorbidity and psychosocial factors in 
four clusters of sensory-clinical phenotypes 
(A) Pain characteristics of four clusters of sensory-clinical phenotypes 
Cluster 1 2 3 4 
Age [yrs.]  49.9 ± 8.9 48.4 ± 12.9 47.5 ± 13.7 50.2 ± 11.3 
 [22  63] [23  68] [18  67] [23  68] 
Sex [f/m]  45 (95.7) /  19 (90.5) / 20 (60.6) /  39 (67.2) /  
 2 (4.3) 2 (9.5) 13 (39.4) 19 (32.8) 
Pain characteristics    
WPI a  
13.0 ± 3.0 11.0 ± 2.0 4.0 ± 2.0 5.00 ± 1.63 
[3.0 - 19.0 / 47] [5.0 – 19.0 / 21] [0.0 – 14.0 / 33] [2.0 - 15.0 / 58] 
 Kruskal Wallis: p < 0.001***; 1&2 vs. 3&4, U-test: p < 0.001*** 
Pain  
intensity b  
3.3 ± 1.24 3.4 ± 1.25 3.1 ± 1.46 2.9 ± 1.17 
[3.0 ± 0.5 / 47] [4.0 ± 0.5 / 21] [3.0 ± 1.0 / 33] [3.0 ± 1.0 / 58] 
 Kruskal Wallis: p = 0.072, n. s.; 1&2 vs. 3&4, U-test: p = 0.012* 
Pain 
severity b  
3.8 ± 1.1 3.9 ± 1.1 3.6 ± 1.1 3.2 ± 1.1 
[1.3 – 6.0 / 47] [2.0 – 5.3 / 19] [1.0 – 6.0 / 32] [1.0 – 5.7 / 57] 
 Kruskal Wallis: p = 0.011*; 1&2 vs. 3&4, t-test: p = 0.005** 
Pain  
quality c 
    
Sensory 
scale SS10 
22.9 ± 7.2 20.2 ± 6.1 17.4 ± 5.9 17.3 ± 6.1 
[10.0 – 39.0 / 47] [14.0 – 34.0 / 21] [10.0 – 33.0 / 31] [10.0 – 37.0 / 54] 
 Kruskal Wallis: p < 0.001***; 1&2 vs. 3&4, t-test: p < 0.001*** 
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[Table 5 A, continued:] 
Cluster 1 2 3 4 
Affective 
scale AS14 
35.6 ± 10.3 33.5 ± 9.3 30.9 ± 10.1 29.5 ± 8.5 
[18.0 – 56.0 / 47] [20.0 – 52.0 / 21] [17.0 – 54.0 / 31] [14.0 – 48.0 / 55] 
 Kruskal Wallis: p = 0.018*; 1&2 vs. 3&4, t-test: p = 0.001*** 
Chronicity     
Chronic 
Pain Grade d 
3.5 ± 1.0 / 38  3.0 ± 1.0 / 15 1.0 ± 1.5 / 23 2.0 ± 1.0 / 45 
Grade I 7 (14.9) 3 (14.3) 12 (36.4) 20 (34.5) 
Grade II 3 (6.4) 2 (9.5) 2 (6.1) 3 (5.2) 
Grade III 9 (19.1) 5 (23.8) 2 (6.1) 16 (27.6) 
Grade IV 16 (34.0) 5 (23.8) 7 (21.2) 6 (10.3) 
 Kruskal Wallis Test: p = 0.004**; 1&2 vs. 3&4, U-test: p < 0.001*** 
Statistical note. Significance levels familywise corrected (pain characteristics and chronicity: 
Bonferroni-Holm, k = 6). Cell entries mean ± SD or median ± ½ IQD for respective scale 
levels; [Range / N]. 
a Widespread Pain Index (Range 0 – 19) according to the Fibromyalgia Survey Questionnaire 
(FSQ, Häuser et al., 2012), the survey version of the FS scale (Wolfe et al., 2016). 
b MPI-D (Flor et al., 1990). Pain intensity = item #1; pain severity = scale value. 
c Raw sum scores of the affective and sensory subscales (AS: 14 and SS: 10 items, 
respectively) of the German Pain Perception Scale (Schmerzempfindungs-Skala, SES, 
Geissner, 1996). 
d CPG: chronic pain grade according to von Korff (1999). U-tests are of limited value cf. 
bimodality in cluster 4. 
 
 
 
 
 
 
 
 
 
 
 
 
Original contributions 
 
 118 
(B
) 
P
a
in
 i
m
p
a
c
t,
 c
o
p
in
g
, 
c
o
m
o
rb
id
it
y
 a
n
d
 p
s
y
c
h
o
s
o
c
ia
l 
fa
c
to
rs
 o
f 
c
lu
s
te
rs
 o
f 
s
e
n
s
o
ry
-c
li
n
ic
a
l 
p
h
e
n
o
ty
p
e
s
 a
n
d
 p
ri
o
r 
F
M
S
 
a
n
d
 c
U
B
P
 d
ia
g
n
o
s
e
s
 
c
U
B
P
 
 
4
3
.7
 ±
 1
8
.0
 
[7
.2
 –
 7
7
.8
 /
 5
4
] 
t-
te
st
: 
p
 =
 0
.0
0
5
* 
2
.8
 ±
 1
.4
 
[0
.1
2
5
 –
 6
.0
0
 /
 7
3
] 
t-
te
st
: 
p
 =
 0
.0
0
6
* 
7
1
.6
 ±
 1
8
.3
 
[2
0
.8
 –
 1
0
0
.0
 /
 9
7
] 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
F
M
S
 
 
5
3
.8
 ±
 1
6
.9
 
[1
9
.6
 –
 9
0
.0
 /
 4
6
] 
3
.5
 ±
 1
.3
 
[0
.2
5
 –
 5
.5
0
 /
 5
0
] 
5
6
.3
 ±
 1
7
.2
 
[1
3
.6
 –
 1
0
0
.0
 /
 7
2
] 
4
 
  
4
2
.9
 ±
 1
4
.8
 
[7
.2
 –
 6
9
.5
 /
 5
0
] 
K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.0
0
4
**
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
2
.4
 ±
 1
.2
 
[0
.1
 –
 5
.4
 /
 4
3
] 
K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 =
 0
.0
0
8
* 
7
4
.6
 ±
 1
7
.3
 
[2
0
.8
 –
 1
0
0
.0
 /
 5
7
] 
K
ru
sk
a
l W
a
lli
s:
 p
 <
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
3
 
 
3
9
.9
 ±
 1
9
.8
 
[1
4
.8
 –
 7
6
.9
 /
 1
8
] 
3
.4
 ±
 1
.4
 
[1
.0
 –
 6
.0
 /
 2
6
] 
6
8
.3
 ±
 2
0
.0
 
[2
0
.8
 –
 9
5
.8
 /
 3
3
] 
2
 
 
5
3
.7
 ±
 1
4
.3
 
[2
4
.1
 –
 7
1
.7
 /
 1
] 
3
.3
 ±
 1
.4
 
[0
.4
 –
 5
.1
 /
 1
5
] 
5
7
.5
 ±
 1
5
.2
 
[3
3
.3
 –
 8
7
.5
 /
 2
1
] 
1
  
5
6
.6
 ±
 1
8
.6
 
[1
9
.6
 –
 9
0
.0
 /
 2
4
] 
3
.5
 ±
 1
.4
 
[0
.3
 –
 5
.5
 /
 3
3
] 
5
4
.5
 ±
 1
6
.9
 
[1
3
.6
 –
 8
3
.3
 /
 4
6
] 
C
lu
s
te
r 
P
a
in
 i
m
p
a
c
t 
F
M
 i
m
p
a
c
t 
a
  
P
a
in
 
in
te
rf
e
re
n
c
e
 b
  
F
u
n
c
ti
o
n
a
l 
c
a
p
a
c
it
y
 c
  
Original contributions 
 
 119 
[T
a
b
le
 5
 B
, 
co
n
tin
u
e
d
] 
c
U
B
P
 
 
1
.8
 ±
 1
.0
 
[0
.0
 –
 5
.0
 /
 5
2
] 
t-
te
st
: 
p
 =
 0
.0
0
6
**
 
7
.5
 ±
 9
.1
 
[0
.0
 –
 3
0
.0
 /
 3
1
] 
t-
te
st
: 
p
 =
 0
.1
0
7
, 
n
. 
s.
  
2
8
.0
 ±
 1
5
.1
 
[5
.0
 –
 6
9
.0
 /
 9
5
] 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
8
.9
 ±
 6
.1
 
[0
.0
 –
 2
3
.0
 /
 9
6
] 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
F
M
S
 
 
2
.4
 ±
 1
.0
 
[0
.0
 –
 5
.0
 /
 4
5
] 
1
1
.2
 ±
 9
.0
 
[0
.0
 –
 3
0
.0
 /
 3
5
] 
 
4
3
.8
 ±
 1
4
.5
 
[1
5
.0
 –
 8
2
.0
 /
 7
1
] 
1
4
.0
 ±
 5
.2
 
[0
.0
 –
 2
4
.0
 /
 7
1
] 
4
  
1
.8
 ±
 0
.9
 
[0
.0
 –
 4
.0
 /
 3
4
] 
K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.0
0
3
**
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
6
.9
 ±
 9
.1
 
[0
.0
 –
 3
0
.0
 /
 2
3
] 
K
ru
sk
a
l-
W
a
lli
s:
 p
 =
 0
.0
8
7
, 
n
. 
s.
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
 
3
0
.1
 ±
 1
4
 
[1
1
.0
 –
 6
9
.0
 /
 5
5
] 
K
ru
sk
a
l W
a
lli
s:
 p
 <
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
9
.5
 ±
 5
.8
 
[0
.0
 –
 2
3
.0
 /
 5
6
] 
K
ru
sk
a
l W
a
lli
s 
T
e
st
: 
p
 <
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
3
   
1
.7
 ±
 1
.1
 
[0
.0
 –
 5
.0
 /
 1
8
] 
9
.9
 ±
 8
.0
 
[0
.0
 –
 1
9
.0
 /
 8
] 
  
2
4
.6
 ±
 1
5
.5
 
[5
.0
 –
 6
1
.0
 /
 3
3
] 
7
.8
 ±
 6
.6
 
[0
.0
 –
 2
3
.0
 /
 3
3
] 
2
   
2
.3
 ±
 0
.6
 
[1
.0
 –
 3
.0
 /
 1
3
] 
9
.6
 ±
 8
.8
 
[0
.0
 –
 2
5
.0
 /
 7
] 
  
3
8
.0
 ±
 1
0
.3
 
[1
4
.0
 –
 5
4
.0
 /
 2
1
] 
1
2
.2
 ±
 4
.6
 
[4
.0
 –
 2
0
.0
 /
 2
1
] 
1
   
2
.6
 ±
 1
.1
 
[0
.0
 –
 5
.0
 /
 2
7
] 
1
2
.9
 ±
 9
.8
 
[0
.0
 –
 3
0
.0
 /
 2
3
] 
 
4
6
.9
 ±
 1
6
.8
 
[9
.0
 –
 8
2
.0
 /
 4
5
] 
1
4
.6
 ±
 5
.8
 
[0
.0
 –
 2
4
.0
 /
 4
5
] 
C
lu
s
te
r 
P
a
in
 c
o
g
n
it
io
n
s
  
C
a
ta
s
tr
o
p
h
iz
in
g
 d
  
B
e
li
e
f 
re
tu
rn
 w
o
rk
 e
  
S
o
m
a
ti
c
 c
o
m
o
rb
id
it
y
  
G
B
B
 s
u
m
 f
  
G
B
B
 –
 e
x
h
a
u
s
ti
o
n
 f
 
  
Original contributions 
 
 120 
[T
a
b
le
 5
 B
, 
co
n
tin
u
e
d
] 
c
U
B
P
 
3
.9
 ±
 3
.9
 
[0
.0
 –
 1
7
.0
 /
 9
6
] 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
3
.4
 ±
 3
.6
 
[0
.0
 –
 1
6
.0
 /
 9
5
] 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
1
1
.9
 ±
 4
.4
 
[5
.0
 –
 2
3
.0
 /
 9
5
] 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
9
 (
8
.4
) 
C
co
rr
 =
 0
.6
5
2
, 
p
 <
 0
.0
0
1
**
* 
3
7
.7
 ±
 9
.3
 
[1
9
.0
 –
 6
0
.0
 /
 9
0
] 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
F
M
S
 
6
.5
 ±
 4
.9
 
[0
.0
 –
 2
4
.0
 /
 7
2
] 
6
.3
 ±
 4
.0
 
[0
.0
 –
 1
7
.0
 /
 7
2
] 
1
6
.8
 ±
 4
.0
 
[8
.0
 –
 2
4
.0
 /
 7
2
] 
3
2
 (
4
1
.0
) 
3
1
.2
 ±
 7
.8
 
[1
8
.0
 –
 5
4
.0
 /
 6
6
] 
4
 
4
.1
 ±
 3
.4
 
[0
.0
 –
 1
4
.0
 /
 5
6
] 
 K
ru
sk
a
l W
a
lli
s:
 p
 <
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
3
.9
 ±
 3
.6
 
[0
.0
 –
 1
3
.0
 /
 5
5
] 
K
ru
sk
a
l W
a
lli
s:
 p
 <
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
1
2
.6
 ±
 4
.4
 
[6
.0
 –
 2
3
.0
 /
 5
5
] 
 K
ru
sk
a
l W
a
lli
s:
 p
 <
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
1
2
 (
2
0
.7
) 
C
co
rr
 =
 0
.5
8
3
, 
p
 =
 0
.0
0
1
**
* 
3
8
.4
 ±
 9
.0
 
[2
2
.2
 –
 6
0
.2
 /
 5
1
] 
 K
ru
sk
a
l W
a
lli
s:
 p
 <
 0
.0
0
1
**
*;
 1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 <
 0
.0
0
1
**
* 
3
 
3
.3
 ±
 4
.0
 
[0
.0
 –
 1
7
.0
 /
 3
3
] 
2
.7
 ±
 3
.6
 
[0
.0
 –
 1
6
.0
 /
 3
3
] 
1
0
.8
 ±
 4
.2
 
[5
.0
 –
 2
0
.0
 /
 3
3
] 
1
 (
3
.0
) 
3
5
.6
 ±
 9
.2
 
[1
9
.4
 –
 5
4
.3
 /
 3
1
] 
2
 
5
.0
 ±
 3
.0
 
[1
.0
 –
 1
0
.0
 /
 2
1
] 
5
.4
 ±
 3
.5
 
[0
.0
 –
 1
3
.0
 /
 2
1
] 
1
5
.2
 ±
 4
.1
 
[6
.0
 –
 2
4
.0
 /
 2
1
] 
9
 (
4
2
.9
) 
3
5
.2
 ±
 9
.9
 
[2
0
.9
 –
 5
4
.4
 /
 1
9
] 
1
 
7
.6
 ±
 5
.6
 
[0
.0
 –
 2
4
.0
 /
 4
6
] 
7
.0
 ±
 4
.3
 
[0
.0
 –
 1
7
.0
 /
 4
6
] 
1
7
.3
 ±
 4
.5
 
[5
.0
 –
 2
4
.0
 /
 4
6
] 
1
8
 (
3
8
.3
) 
2
9
.6
 ±
 7
.2
 
[1
8
.4
 –
 4
8
.9
 /
 4
4
] 
C
lu
s
te
r 
G
B
B
 g
a
s
tr
o
in
te
s
ti
n
.f
   
G
B
B
 c
a
rd
io
v
a
s
c
u
l.
 f
   
G
B
B
 m
u
s
c
u
lo
s
k
e
l.
 f
   
F
G
ID
 g
 N
 (
%
) 
 
S
F
-1
2
 p
h
y
s
ic
a
l 
c
o
m
p
o
n
e
n
t 
h
 
 
Original contributions 
 
 121 
[T
a
b
le
 5
 B
, 
co
n
tin
u
e
d
] 
c
U
B
P
 
8
.8
 ±
 4
.4
 
[2
.0
 –
 1
9
.0
 /
 5
1
] 
t-
te
st
: 
p
 =
 0
.0
1
2
* 
 
4
3
.2
 ±
 1
0
.2
 
[2
4
.0
 –
 6
7
.0
 /
 5
3
] 
t-
te
st
: 
p
 =
 0
.0
1
5
* 
 
2
8
.5
 ±
 1
2
.1
 
[1
1
.0
 –
 5
4
.0
 /
 4
8
] 
t-
te
st
: 
p
 =
 0
.0
3
1
* 
3
.0
 ±
 1
.7
 
[0
.0
 –
 6
.0
 /
 8
6
] 
t-
te
st
: 
p
 =
 0
.2
1
3
, 
n
. 
s.
 
F
M
S
 
1
1
.0
 ±
 4
.4
 
[3
.0
 –
 2
0
.0
 /
 4
6
] 
 
4
8
.6
 ±
 1
1
.8
 
[2
8
.0
 –
 7
7
.0
 /
 5
1
] 
 
3
5
.0
 ±
 1
5
.8
 
[2
.0
 –
 7
0
.0
 /
 4
1
] 
3
.3
 ±
 1
.7
 
[0
.0
 –
 6
.0
 /
 6
5
] 
4
 
9
.0
 ±
 4
.4
 
[2
.0
 –
 1
8
.0
 /
 3
4
] 
 K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.0
7
5
, 
n
. 
s.
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 =
 0
.0
2
8
* 
 
 
4
3
.7
 ±
 9
.5
 
[2
8
.0
 –
 6
0
.0
 /
 3
5
] 
 K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.1
1
0
, 
n
. 
s.
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 =
 0
.0
1
2
*  
3
0
.8
 ±
 1
2
.9
 
[1
1
.0
 –
 5
7
.0
 /
 3
2
] 
K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.1
5
2
, 
n
. 
s.
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 =
 0
.0
6
7
, 
n
. 
s.
 
2
.8
 ±
 1
.7
 
[0
.0
 –
 5
.7
 /
 5
1
] 
K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.2
0
6
, 
n
. 
s.
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 =
 0
.0
7
6
, 
n
. 
s.
 
3
 
7
.9
 ±
 4
.8
 
[2
.0
 –
 1
9
.0
 /
 1
5
] 
 
4
2
.2
 ±
 1
1
.2
 
[2
4
.0
 –
 6
5
.0
 /
 1
7
] 
 
2
5
.7
 ±
 1
0
.7
 
[1
3
.0
 –
 4
7
.0
 /
 1
4
] 
3
.2
 ±
 1
.7
 
[0
.0
 –
 6
.0
 /
 2
8
] 
2
 
1
1
.7
 ±
 3
.8
 
[4
.0
 –
 1
8
.0
 /
 1
2
] 
 
5
0
.7
 ±
 1
0
.8
 
[3
4
.0
 –
 6
7
.0
 /
 1
2
] 
 
3
6
.7
 ±
 1
3
.5
 
[2
2
.0
 –
 6
0
.0
 /
 1
0
] 
3
.3
 ±
 1
.8
 
[0
.0
 –
 6
.0
 /
 2
0
] 
1
 
1
0
.3
 ±
 4
.3
 
[3
.0
 –
 2
0
.0
 /
 2
9
] 
 
4
8
.3
 ±
 1
2
.5
 
[2
8
.0
 –
 7
7
.0
 /
 3
3
] 
 
3
4
.2
 ±
 1
5
.8
 
[2
.0
 –
 6
0
.0
 /
 2
6
] 
3
.6
 ±
 1
.7
 
[0
.0
 –
 6
.0
 /
 4
0
] 
C
lu
s
te
r 
P
S
Q
I 
s
le
e
p
 s
u
m
 i    
P
s
y
c
h
ic
 c
o
m
o
rb
id
it
y
  
G
e
n
e
ra
l 
a
n
x
ie
ty
 j    
P
s
y
c
h
o
s
o
c
. 
fa
c
to
rs
  
S
e
lf
-r
e
p
o
rt
e
d
  
s
tr
e
s
s
 k
   
S
o
c
ia
l 
s
u
p
p
o
rt
 b
 
  
Original contributions 
 
 122 
[T
a
b
le
 5
 B
, 
co
n
tin
u
e
d
] 
c
U
B
P
 
2
.5
 ±
 1
.5
 
[0
.0
 –
 6
.0
 /
 8
4
] 
t-
te
st
: 
p
 =
 0
.0
2
4
* 
S
ta
tis
tic
a
l n
o
te
s.
 S
ig
n
ifi
ca
n
ce
 le
ve
ls
 f
a
m
ily
w
is
e
 B
o
n
fe
rr
o
n
i-
H
o
lm
 c
o
rr
e
ct
e
d
; 
k 
=
 4
 (
p
a
in
 im
p
a
ct
),
 7
 (
p
a
in
 c
o
g
n
iti
o
n
s,
 c
o
p
in
g
),
 1
2
 (
co
m
o
rb
id
ity
) 
a
n
d
 1
3
 (
p
sy
ch
o
so
ci
a
l f
a
ct
o
rs
, 
st
re
ss
).
 *
 p
 <
 0
.0
5
; 
**
 p
 <
 0
.0
1
; 
**
* 
p
 <
 0
.0
0
1
 a
ft
e
r 
co
rr
e
ct
io
n
. 
V
a
ri
a
b
le
s 
w
ith
 d
iff
e
re
n
ce
s 
p
 >
 0
.1
0
 n
o
t 
sh
o
w
n
 b
u
t 
in
cl
u
d
e
d
 in
 f
a
m
ily
w
is
e
 c
o
rr
e
ct
io
n
. 
a
 F
ib
ro
m
ya
lg
ia
 I
m
p
a
ct
 Q
u
e
st
io
n
n
a
ir
e
 (
G
e
rm
a
n
 v
e
rs
io
n
: 
O
ff
e
n
b
ä
ch
e
r 
e
t 
a
l.,
 2
0
0
0
; 
o
ri
g
in
a
l v
e
rs
io
n
: 
B
u
rc
kh
a
rd
t 
e
t 
a
l.,
1
9
9
1
).
 
b
 M
P
I-
D
 (
F
lo
r 
e
t 
a
l.,
 1
9
9
0
).
 
c 
H
a
n
o
ve
r 
F
u
n
ct
io
n
a
l A
b
ili
ty
 Q
u
e
st
io
n
n
a
ir
e
 (
F
F
b
H
-R
; 
K
o
h
lm
a
n
n
 &
 R
a
sp
e
, 
1
9
9
6
).
 
d
 G
e
rm
a
n
 v
e
rs
io
n
 o
f 
th
e
 P
a
in
-R
e
la
te
d
 S
e
lf 
S
ta
te
m
e
n
ts
 S
ca
le
 (
F
S
S
; 
F
lo
r 
e
t 
a
l.,
 1
9
9
3
).
 
e
 F
e
a
r-
a
vo
id
a
n
ce
-b
e
lie
fs
 q
u
e
st
io
n
n
a
ir
e
 (
F
A
B
Q
; 
P
fin
g
st
e
n
, 
e
t 
a
l.,
 1
9
9
7
).
 
f 
G
ie
ss
e
n
 S
u
b
je
ct
iv
e
 C
o
m
p
la
in
ts
 L
is
t 
(G
B
B
-2
4
; 
B
rä
h
le
r 
e
t 
a
l.,
 2
0
0
8
).
 
g
 D
ia
g
n
o
se
s 
a
cc
o
rd
in
g
 t
o
 s
e
lf-
re
p
o
rt
 q
u
e
st
io
n
n
a
ir
e
 f
o
r 
fu
n
ct
io
n
a
l g
a
st
ro
in
te
st
in
a
l d
is
o
rd
e
rs
 (
H
e
rs
ch
b
a
ch
, 
1
9
9
6
).
 
h
 H
e
a
lth
-R
e
la
te
d
 Q
u
a
lit
y 
o
f 
L
ife
 Q
u
e
st
io
n
n
a
ir
e
 –
 S
h
o
rt
 V
e
rs
io
n
 (
S
F
-1
2
; 
B
u
lli
n
g
e
r 
&
 K
ir
ch
b
e
rg
e
r,
 1
9
9
8
).
 
i  P
itt
sb
u
rg
 S
le
e
p
in
g
 Q
u
a
lit
y 
In
d
e
x 
(P
S
Q
I;
 B
u
ys
se
 e
t 
a
l.,
 1
9
8
9
).
 
j  S
ta
te
-T
ra
it 
A
n
xi
e
ty
 I
n
ve
n
to
ry
 (
S
T
A
I-
T
; 
L
a
u
x 
e
t 
a
l.,
 1
9
8
1
).
  
k 
S
h
o
rt
 Q
u
e
st
io
n
n
a
ir
e
 f
o
r 
R
e
co
g
n
iti
o
n
 o
f 
S
tr
e
ss
-F
a
ct
o
rs
 (
G
e
rm
a
n
 “
K
u
rz
e
r 
F
ra
g
e
b
o
g
e
n
 z
u
r 
E
rf
a
ss
u
n
g
 v
o
n
 B
e
la
st
u
n
g
e
n
, 
K
F
B
; 
F
lo
r,
 1
9
9
1
).
 
O
ve
ra
ll 
st
ra
in
 r
e
p
o
rt
e
d
. 
F
M
S
 
3
.1
 ±
 1
.6
 
[0
.2
 –
 6
.0
 /
 6
8
] 
4
 
2
.5
 ±
 1
.4
 
[0
.0
 –
 5
.0
 /
 5
0
] 
K
ru
sk
a
l W
a
lli
s:
 p
 =
 0
.1
7
5
, 
n
. 
s.
; 
1
&
2
 v
s.
 3
&
4
, 
t-
te
st
: 
p
 =
 0
.0
3
0
* 
3
 
2
.7
 ±
 1
.5
 
[0
.4
 –
 6
.0
 /
 2
8
] 
2
 
3
.0
 ±
 1
.6
 
[0
.0
 –
 5
.4
 /
 1
9
] 
1
 
3
.2
 ±
 1
.6
 
[0
.2
 –
 6
.0
 /
 4
3
] 
C
lu
s
te
r 
S
o
li
c
it
o
u
s
  
re
s
p
o
n
s
e
 b
 
  
Original contributions 
 
 123 
The differences found could not have been due to age because its distributions were 
alike in all four clusters (Table 5). However, female patients were more prevalent in the 
widespread pain-like clusters 1 and 2 (95.7 % and 90.5 %) compared to the regional 
pain-like clusters 3 and 4 (60.6 % and 67.2 %) as in the groups with prior FMS and 
cUBP diagnoses (93.6 and 64.5 %). Clusters 1 and 2 also had significantly higher 
Chronic Pain Grades (CPG medians, cluster 1: 3.5; cluster 2: 3.0; cluster 3: 1.0; cluster 
4: 2; Kruskal-Wallis, p = 0.004). Physical load at the work place or in the household (N 
= 92 valid cases) did not differ between clusters except minor differences on the 
subscale of musculoskeletal load on the shoulder (cf. Table S31 in Supplemental). 
Comparing the complete array of sensory and clinical pain measures including those 
not used in the LCA profiles in relation to specific secondary chronicity and comorbidity 
factors qualifies the current evidence on their relative diagnostic significance in 
important ways (Table 5 B): 
Closely pain-related indicators, in particular, pain severity (MPI-D, part I, subscale 1), 
sensory and affective pain quality (SES), interference (MPI-D, part I, subscale 2) and 
impact (Fibromyalgia Impact Questionnaire, FIQ) differed most between sensory 
phenotypes. Pain severity as well as present pain intensity was higher in patients of 
cluster 1 and 2 than in cluster 3 and 4 (t-test: p = 0.005; U-test: p = 0.012). Sensory 
and affective pain aspects (SES scales) scored higher in cluster 1 and 2 compared to 
cluster 3 and 4, while pain-related affective distress (MPI-D, part I, subscale 3) did not 
differ. In general, the differences reflected those between the prior diagnosis groups of 
FMS vs. cUBP. 
Coping with pain showed a similar pattern at the cognitive level, with higher 
catastrophizing thoughts (FSS) in cluster 1 and 2 than in clusters 3 and 4 whereas 
active coping and the response to the question on having control over one’s life (MPI-
D, part I, subscales 5) did not differ. The subscales of the fear avoidance beliefs 
(FABQ) did also not differ between sensory-clinical clusters except “return to work 
prognosis” which was higher in clusters 1 and 2 compared to 3 and 4. There were no 
differences in FABQ scales between prior FMS and cUBP diagnosis groups. 
Functional capacity (FFBH) of patients in clusters 1 and 2, however, was significantly 
lower than in clusters 3 and 4 (p < 0.001). The systematic increase from cluster 1 to 
cluster 4 related to pain severity and impact reflected an analogue difference between 
prior diagnosis groups.  
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Psychosocial factors, in particular, social support (MPI-D, part I, subscale 4) and 
responses by significant others (punishing, solicitous, distracting; MPI-D, part II, 
subscale 1-3) were not significantly different between the four clusters of clinical and 
sensory phenotypes. Perceived stress load (overall, work, psychosocial strain, KFB) 
did also not differ except for everyday strain which was higher in cluster 1 and 2 than 
in cluster 3 and 4. Cluster differences were also not found in the general activity level; 
only “outdoor activities” was somewhat lower in cluster 1 and 2 than in cluster 3 and 4. 
Most importantly and contrary to previous work on clinical FMS criteria, psychic 
comorbidity, i.e., depression and self-reported mental health (ADS, SF-12-mental) did 
not differ, neither between the four clusters of pain phenotypes nor prior diagnoses. 
Only trait anxiety (STAI-T) was somewhat higher in clusters 1 and 2 compared to 
clusters 3 and 4 (p = 0.012) as well as in FMS vs. cUBP (p = 0.015). Major depression 
diagnoses were below 5 % in all clusters as in the prior diagnosis groups. Subjective 
sleep quality (PSQI), a marker item for depression, was also not different between 
clusters despite a trend for worse sleep in cluster 1 and 2 (p = 0.075). This fits the fact 
that the decreased sleep quality reported previously could not be replicated in our 
patients with prior FMS diagnoses although the PSQI sum scores was slightly lower in 
FMS than in cUBP patients (p = 0.012; n. s., corrected). 
In contrast, somatic comorbidity in terms of self-reported body complaints (GBB, total 
symptom burden) and somatic health (SF-12 physical component) differed strongly 
between the four clusters increasing progressively from cluster 3 and 4 to 2 and 1 
(Kruskal-Wallis; p < 0.001). Clusters 1 and 2 were well separated from clusters 3 and 
4 with respect to their somatic symptom burden (multiple t-tests; p < 0.001 corrected) 
similar to prior diagnostic groups. Patients in cluster 1 with widespread pain and high 
pressure pain sensitivity had the highest somatic symptom scores and the lowest 
physical well-being. Cluster 2 lay between cluster 1 and the low-symptomatic groups 
of cluster 3 and 4. This pattern was preserved when the pain-related GBB subscale 
“musculoskeletal complaints” was taken out. The GBB subscales of cardiovascular 
complaints, exhaustion, gastrointestinal complaints were also higher in cluster 1 and 2 
than in cluster 3 and 4 indicating a higher somatic symptom burden in the first. The 
cluster differences in subjective somatic symptoms were not directly associated with 
prior medical diagnoses of gastrointestinal, endocrinological or urogenital disease 
according to anamnestic data (cf. Table S1 in Supplemental). 
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The higher gastrointestinal score in clusters 1 and 2 is underlined by the distribution of 
functional gastrointestinal disorders (irritable bowel syndrome, IBS, and/or non-ulcer 
dyspepsia, NUD) according to the FGID questionnaire across the four clusters and 
prior FMS and cUBP diagnoses (prevalence of subcategories in Table S32 in 
Supplemental). Again, functional gastrointestinal disorders were most frequent in 
cluster 1 and 2 (27 of 68; 39.7 %) and lowest in cluster 3 and 4 (13 of 91; 14.3 %); 
cluster 4 showed intermediate gastrointestinal disorders prevalence (12 of 58; 20.7 %). 
The frequencies were comparable to those in the prior diagnosis groups (FMS: 29 of 
73; 39.7 %, cUBP: 8 of 69; 11.6 %). This general pattern of FGID distribution across 
clusters (1 ≈ 2 > 4 > 3) did not change when the FGID frequency was compared in 
females only.  
4 Discussion  
In this study, patients with prior diagnoses of Fibromyalgia Syndrome (FMS) and 
chronic unspecific back pain (cUBP) suffering from widespread and regional 
musculoskeletal pain of comparable severity were reclassified according to their 
sensory-clinical phenotypes of pressure and heat pain sensitivity combined with spatial 
spread and severity of the clinical pain. Sensory phenotypes were derived by stepwise 
data-reduction through descriptive statistical, correlational and structural analysis 
techniques identifying economic and coherent clusters of pathophysiologically and 
clinically meaningful indicators of pressure and heat pain sensitivity. The final 
optimized indicator set of four sensory and two clinical essential markers was apt to 
identify subgroups of patients with distinguishable sensory-clinical pain phenotypes 
independent of their prior diagnoses. 
We hypothesized that the identified pain phenotypes would differentiate several 
subgroups of widespread and regional pain which differed in pain mechanisms, 
secondary responses to the pain and other, not directly pain-related aspects such as 
somato-psychic comorbidity and psychosocial co-factors. The general hypothesis 1 
was clearly supported by the finding of four coherent clusters with distinct differences 
in pain sensitivity and degree of spatial spread of clinical pain across the body. The 
general hypothesis was qualified, however, with regard to the diagnostic significance 
of the classical ACR “tender points” and comorbid psychopathology and functional 
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Our hypothesis 2, that the total number of sensitive body sites indicates a more or less 
generalized pressure hypersensitivity and that a continuity from patients with more or 
less regionally confined pain (cUBP) to highly pressure sensitive patients with 
widespread pain (FMS) would exist, was also supported. This was reflected in the 
orderly sequence of numbers of pressure-sensitive body sites and pressure pain 
thresholds from cluster 4 to the most sensitive cluster 1 with informative exceptions of 
cluster 3 (see below). 
However, the corollary assumption that classical ACR “tender points” did not 
qualitatively differ in this respect from control points at other muscle or soft tissue sites 
was rejected: FMS patients reported higher pain intensity when probed at tender points 
than at control points and provoked pain intensity increased linearly with numbers of 
sensitive ACR tender points but unsystematically with numbers of sensitive control 
points. Most, but not all cUBP patients reported less than 11 sensitive ACR tender 
points at re-examination and here pain intensity did not linearly increase with the 
number of sensitive tender or control points. These results support the older studies 
on enhanced pressure sensitivity of FMS patients in tender points which is less 
pronounced in control points (Granges & Littlejohn, 1993; Wolfe et al., 1990). 
Unspecific reduced pressure pain sensitivity at tender as well as control points has 
been interpreted as indication of a diffuse change in central pain modulation in FMS. 
Our results on the functional difference of tender points, however, emphasize the 
modality specificity and the clinical significance of ACR tender points which has been 
disputed previously (Wolfe et al., 2016). 
Our hypothesis 3 suggested that two or more circumscribed subgroups could be 
differentiated within the continuum from localized, regional to widespread pain by the 
pattern of sensory data and clinical pain characteristics without recourse to secondary 
pain responses, not directly pain-related comorbidities and psychosocial co-factors. 
This was confirmed by the isolation of two intermediary subgroups of patients between 
those in cluster 1 with pronounced widespread pain, a high number of pressure-
sensitive body sites and very low pressure pain thresholds and the patients in cluster 
4 with regionally confined pain, low numbers of pressure-sensitive body sites and 
normal pressure pain thresholds. The intermediary clusters 2 and 3 resembled the 
respective neighboring (clusters 1 and 4) in certain aspects (large vs. small pain extent; 
high vs. low numbers of sensitive body sites) but differed characteristically in others 
representing two phenotypically discernible subgroups of different pathogenetic status: 
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Most patients in cluster 2 had prior FMS diagnosis and all but one patient had ≥ 11 
“tender points” similar to the high-sensitive cluster 1 but showed less enhanced 
pressure sensitivity and still normal pressure pain thresholds at quantitative sensory 
testing. This sensory parameter was the only one differentiating the group from the 
high-sensitive cluster 1 arguing for an intermediary pain status with still developing 
pain enhancement. The few patients in the intermediary cluster 2 not meeting classical 
FMS criteria may be considered as having “widespread or FMS-like pain” and 
increased muscle and/or soft-tissue pain sensitivity, possibly on their way to 
aggravation. Cluster 4 predominated by cUBP patients with regional pain stands at the 
lower end of these three subgroups with progressively more widespread pain. It 
contained most of the cUBP patients characterized by several pain loci and a 
clandestine spread of muscle and soft-tissue hypersensitivity to manual probing but 
quantitative thresholds still normal. In contrast, patients in cluster 3 appear to be 
qualitatively different and not to fit into the continuum from regional to widespread pain. 
They showed regionally confined pain with a median WPI of 4 – 5 and low to normal 
pressure sensitivity similar to patients with regional pain in cluster 4. Cluster 3, 
however, consists exclusively of patients with prior cUBP diagnosis and the highest 
ratio of patients with an FS < 12 (85%). Their sensory characteristics deserve a closer 
look in a larger homogeneous group to improve differential diagnostic assessment of 
this group of “pure” back pain patients compared to those in cluster 4. 
This demonstrates again the general problem of homogeneity and stability of the 
categorical diagnostic distinction of fibromyalgia based exclusively on standard clinical 
criteria as applied routinely in pain clinics and should be further pursued. Albeit prior 
diagnoses of FMS and cUBP had been applied by trained physicians in the 
collaborating pain clinics the differentiated sensory-clinical clusters contained varying 
mixtures of FMS and cUBP patients of whom 10% in the intermediary clusters no 
longer met extant tender point criteria at retesting (3 FMS < 11 TP; 12 cUBP ≥ 11). 
This fits with other studies in favor of a continuity of pressure-sensitive body sites 
arguing that more than 6 tender points qualified patients for a clinical FMS diagnosis 
by experienced physicians (e.g., Katz, Wolfe, & Michaud, 2006). Increasing numbers 
of hypersensitive body sites above that point could simply reflect a progressive spread 
with increasing pain severity rendering cut-off criteria more or less artificial. This is also 
shown in our results on the increasing pain intensity with increasing numbers of 
pressure-sensitive body sites specific to FMS. We expect that thorough qualitative and 
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quantitative sensory characterization of “tender” body regions would clarify the issue 
and allow better differentiation of subgroups at different stages and spread of pressure 
hypersensitivity which might follow also different history trajectories requiring specific 
treatments. 
The number of body regions in pain recently put forward to differentiate widespread 
from regional syndromes of musculoskeletal pain (Wolfe et al., 2016) was corroborated 
as a distinct discriminator in this study, whereas present pain intensity and overall 
severity did not differentiate. This was independent of the pain type asked for (recent, 
current or major) and whether regions were defined according to the IASP Taxonomy 
or the 19 mostly non-articular pain sites specified by the WPI based on the Regional 
Pain Scale (Wolfe, 2003) as implemented in current FMS criteria (Wolfe et al., 2010; 
Wolfe et al., 2011; Wolfe et al., 2016). Number of pain regions, however, was not 
sufficient to identify the intermediary sensitivity clusters and sensory data were 
necessary in addition. 
The corollary hypotheses 5 and 6, that quantitative sensory testing of heat pain 
sensitivity as non-mechanoceptive control modality would differentiate a separate 
phenotype of generalized hyperalgesia not limited to pressure stimulation could not be 
supported. We were not able to isolate a discernible phenotype of enhanced temporal 
summation related to impaired descending inhibitory control as found previously in 
FMS (Horn-Hofmann et al., 2018; Julien et al., 2005). Thus, the identified sensory 
phenotypes appear to be fairly specific to pressure pain and argue for its diagnostic 
significance in syndromes with widespread pain, in particular, for fibromyalgia. 
However, this interpretation of the heat pain part of the study is preliminary because of 
the reduced thermo-nociceptive assessments and the marked sample attrition after 
combining pressure and heat pain sensitivity indicators. The issue remains important, 
nevertheless, for deriving mechanism-based diagnostic categories and requires further 
transdiagnostic studies using thorough quantitative sensory testing beyond pressure 
sensitivity in conjunction with clinical assessment as already established for 
neuropathic pain conditions (Baron, Forster, & Binder, 2012). More sufficient 
comparative data on enhanced temporal summation, in particular, associated with the 
sensory-clinical phenotypes identified in our study are needed to elucidate the 
interaction of peripheral sensory and central pain mechanisms in widespread and 
regional pain syndromes. For instance, recent work has shown descending modulatory 
control of nociceptive signaling to be modality-specific especially for heat pain (Brietzke 
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et al., 2019; Horn-Hofmann et al., 2018) but the evidence on similar effects in pressure 
pain is still scarce and controversial (e.g., La Coba, Bruehl, Galvez-Sanchez, & Reyes 
Del Paso, 2018). Including sensory indicators of heat pain sensitivity and temporal 
summation as proxies for generalized hyperalgesia and impaired descending control 
in the sensory-clinical phenotyping of larger samples with musculoskeletal pain might 
reveal further subgroups with alterations in the central nervous system in the otherwise 
heterogeneous FMS construct (Sluka & Clauw, 2016). 
The present study set out to differentiate sensory-clinical pain phenotypes within global 
chronic widespread and regional pain syndromes which could be related to different 
types of pain processing elucidating in this way the roles of secondary responses to 
pain, psychic and somatic comorbidities and psychosocial co-factors in the process of 
spreading pain becoming chronic (cf. hypothesis 4). This aim could only partially be 
achieved in so far as the directly pain-related indicators of severity, sensory and 
affective pain quality of patients’ pain did not differ dramatically between phenotypes 
and to variable extent. Similarly, coping, interference by and impact of the pain 
symptoms including global chronicity (CPG) were not characteristic and cluster 
differences in single variables appeared to be population-dependent and related to 
prior diagnosis ratios. This suggests evermore that the phenotypic domains of primary 
sensory pain processing and the clinical picture should be distinguished carefully from 
the individual dealing with and the life consequences of the pain in construing 
nosological entities. This conclusion is emphasized by the fact that psychic comorbidity 
(in particular depression) and psychosocial co-factors (burden of stress) did not differ 
between the phenotypically defined subgroups. This argues clearly against including 
comorbid depression or depression-equivalents (e.g., sleep disturbance) into cardinal 
criteria of FMS (Häuser et al., 2009) and is in line with the current controversy about 
further FMS revisions (Arnold et al., 2019; Wolfe, 2019). Entering depression and 
anxiety markers together with the sensory characteristics in sufficiently powered 
studies would be needed to decide whether psychopathological subsyndromes could 
be isolated within the sensory-clinical chronic pain clusters identified in our analysis.  
In contrast to the fairly even distribution of comorbid psychopathology, the burden of 
functional somatic symptoms other than pain differed clearly between phenotypical 
clusters. Self-reported body complaints and perceived somatic health assessed by 
established questionnaires scored highest in the highly sensitive clusters with 
widespread pain containing many patients with prior FMS diagnoses. Cardiovascular 
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complaints, exhaustion and gastrointestinal complaints measured by the respective 
GBB subscales were most prominent in these subgroups. The differences in the 
subjective symptom burden were not directly associated with prior medical diagnoses 
of gastrointestinal, endocrinological or urogenital disease according to anamnestic 
data. The enhanced medically unexplained somatic symptoms may reflect 
psychosomatic correlates of somatoform pain (Häuser & Henningsen, 2014) or 
indicate a general hypervigilance to somatic input with enhanced symptom perception 
not necessarily limited to FMS (Boeckle, Schrimpf, Liegl, & Pieh, 2016; Craig, 2011; 
Mier et al., 2017). Earlier work had already suggested that the high incidence of other 
somatic symptoms of patients with widespread pain and conventional FMS diagnoses 
was due to an underlying common functional somatic syndrome of which the extant 
diagnostic categories represented only different severities (Wessely, Nimnuan, & 
Sharpe, 1999). The systematic trend of increasing functional somatic symptoms from 
the low to the high sensitive clusters with increasing spatial spread of pain in our study 
would indeed argue for such a dimensional diagnostic view on other somatic symptoms 
comorbid to the primary chronic pain disorder instead of further subcategories (cf. Rief 
et al., 2019). Moreover, in our pain patients, somatic symptoms were not evenly 
distributed across organismic systems. In particular, the relative high incidence of 
gastrointestinal symptoms as well as circumscribed functional gastrointestinal 
disorders such as the irritable bowel syndrome concurs with the accumulating 
evidence of a discriminable subsyndrome of fibromyalgia with associated IBS and/or 
NUD (Becker et al., 2011; Costantini et al., 2017; Thieme et al., 2015). This and the 
reported comorbidity with pelvic pain (Johnson & Makai, 2018) would argue for gender-
specific syndromes of enhanced sensitivity to noxious stimuli including visceral pain 
possibly explaining the dominance of females in both IBS and fibromyalgia (Sperber & 
Dekel, 2010; Tremolaterra et al., 2014). Similar arguments could be raised for 
comorbid chronic fatigue syndrome, sleep disorders and other somatic syndromes of 
the depressive spectrum (Iacob et al., 2016; Thieme, Turk, & Flor, 2004). The issue 
has to be clarified, however, by appropriate structural analyses including sensory 
phenotyping and quantitative somatic symptom assessment not relying on clinical 
categories alone. 
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Limitations 
This retrospective, cross-sectional study is limited in two respects, first, by the non-
random samples from which the sensory and clinical data at entrance were obtained, 
and, second, by the multiple structure-finding methods by which the indicator sets for 
the final sensory and clinical phenotyping were optimized to retain maximal case 
numbers for sufficient power. The statistical probabilities of this explorative definition 
phase are inflated but the final profile clustering is not nor are the comparisons between 
clusters with respect to a priori and external criteria not used in clustering (prior 
diagnoses, comorbidity, co-factors). The combined explorative-inferential strategy may 
also have lost relevant phenotypes marked by indicators abandoned because of 
sample attrition, gender differences in prevalence or unreliability of sensory 
assessments. The phenotypes as positively identified, however, should be valid and 
so is the core result on the phenotypical heterogeneity of fibromyalgia and regional 
pain categories and the necessity to re-install minimal sensory assessment into 
diagnostic evaluation of chronic musculoskeletal pain. 
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3 GENERAL DISCUSSION 
3.1 General characterization of the dissertation project 
The dissertation explored the discriminability of subsyndromes of chronic 
musculoskeletal pain (MSP) on the basis of mechanism-related somatosensory and 
clinical phenotypes within the continuum from regionally confined to widespread pain. 
Two empirical studies were conducted: 
The first study questioned the one-dimensionality and generality of the construct of 
chronicity given the multidimensionality of pain and the multifactorial causation of 
different syndromes. Two exemplary samples from model populations of chronic MSP 
patients and a nationwide sample of active workers at risk for chronic MSP were 
compared. The marker sets of the IASP Pain Taxonomy Axis IV (IASP Taxonomy 
Working Group, 2017), the Chronic Pain Grade (Korff et al., 1992) and the Mainz Pain 
Staging System (Pfingsten et al., 2000) were reanalyzed by correlations and frequency 
distributions of successive duration classes. Factor and latent class analyses were 
applied to assess the dimensional structure of pain and chronicity.  
The second study based on a dimensional analysis of sensory and clinical 
characteristics within a circumscribed dataset of chronic MSP patients with prior clinical 
diagnoses of fibromyalgia syndrome (FMS) and chronic unspecific back pain (cUBP). 
The role of sensory and clinical characteristics and their discriminative power to 
differentiate widespread from regional pain was questioned against the background of 
the recent scientific debate on revisions of FMS classification (Arnold et al., 2019; 
Wolfe et al., 2016; Wolfe, 2019). Necessary and sufficient markers of sensory and 
clinical characteristics were to be identified. All markers of sensory and clinical 
characteristics were derived from a comprehensive set of semiquantitative and 
quantitative indicators of pressure and heat pain sensitivity combined with established 
indices of spatial spread and severity of the clinical pain. Finally, differences between 
the empirically derived sensory-clinical phenotypes in psychopathology such as 
depressive symptoms, other somatic complaints and psychosocial characteristics were 
evaluated.   
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3.2 Study 1: The chronicity construct 
Results of the first study yielded a multidimensional structure of the chronicity 
construct, that differed between the diagnostic groups (patients vs. active workers). 
Duration and pain intensity related differently to each other and differed between the 
diagnostic groups. Patients reported lower pain intensities after longer durations 
(negative correlation), while employees recorded the lowest intensities at durations 
below six months moderately increasing in consecutive duration classes (positive 
correlation). The correlations of both intensities and durations with the CPG were also 
group-dependent: Pain duration correlated negatively with the CPG in patients (lower 
CPG the longer the pain duration) and the intensity distributions developed non-
monotonically with increasing CPG from Grade II to IV. In employees, in contrast, 
duration did not correlate with the CPG, but intensity and CPG were positively 
correlated. By comparison, the MPSS did not correlate with duration in patients, while 
MPSS was positively correlated in employees. Pain intensity correlated positively with 
MPSS in both groups. The major finding derived by factor and hierarchical latent class 
analyses (LCA) revealed that chronicity refers to a composite construct. This construct 
is reflected differently in global indices depending on whether they emphasize either 
severity and duration or interference and disability facets. 
Factor analyses did not reveal a general, common ‘chronicity’ factor. Instead, three 
factors were identified in the patient sample, while only two factors were found in the 
employee sample. The two factors in the employee sample comprised disability and 
pain characteristics loading on the first factor. Characteristics of the chronic 
development such as duration and health care utilization were loading on the second 
factor. The three factors in the patient sample were differently composed: The first 
factor comprised primarily disability, the second factor contained pain characteristics 
and the third resembled the chronic development. The LCA yielded two super-clusters 
in both samples, the first comprising the chronic development, while the second 
entailed disability and pain characteristics. Whereas the first cluster appeared relatively 
similar in both samples, the second differed in composition revealing sub-clusters 
composed of disability one the hand and pain characteristics on the other hand. In 
summary, the study revealed the construct of ‘chronicity’ of MSP is inherently 
multifactorial and different for the diagnostic group considered. 
The study highlights the multifactorial composition of chronicity, which was not in focus 
in scientific research before. Previous studies used, in particular, duration as classifier 
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for a state of chronicity (> 12 weeks; Furlan et al., 2015) or simply base the chronic 
pain state on the diagnosis of the physician at study entry (Geneen et al., 2017). Those 
studies applying the CPG appreciate the consideration of severity and disability in only 
one compound code in order to practically assess both aspects at the same time 
together (Dunn, Jordan, & Croft, 2011; Rushton et al., 2018). Thereby neglecting the 
multidimensionality within this instrument and ignoring the fact that the highest CPG 
Grades III and IV solely base on disability scores. An assessment of different 
dimensions of chronicity with scores for each dimension is not available in the scientific 
literature. If the search for multidimensional assessment of chronicity was expanded 
and other dimensions apart from the state of chronicity, such as operant aspects and 
activities, were allowed, the West Haven-Yale Multidimensional Pain Inventory was the 
only instrument available that considered the multifactorial composition and did not 
derive any compound score (Flor et al., 1990; Kerns et al., 1985; Turk & Rudy, 1987b, 
1988). 
To conclude, the implementation of the results in form of a differential assessment of 
the multidimensional structure of chronicity adapted for the diagnostic group 
considered is highly desirable, but not yet realized. In future studies, comprehensive 
questionnaires for chronicity would comprise items assessing the primary clinical 
characteristics of the pain, the direct consequences of its current interference with 
activities and the related aspects of the patient history. A possibility for a translation of 
the results into practice would be a three-dimensional index of these components in 
the assessment of chronicity instead of the conventional one-dimensional approach by 
a global index such as the CPG. Applying a three-dimensional index would help to 
better stratify pain patients in scientific practice, but also help to derive a differential 
indication of specific treatment modules in pain therapy. The appropriate statistical 
model that manages a three-dimensional criterion of chronicity prediction is provided 
by the nonlinear canonical regression analysis of extant databases. This differential 
regression model is supposed to better identify psycho-social factors and somatic 
agents that lead to higher scores in one of the dimensions inherent in the 
multidimensional chronicity construct (pain characteristics, disability or duration).  
In order to design an economic instrument assessing the multiple dimensions, it will be 
further necessary to identify items loading highest on one of these three dimensions. 
Moreover, subsequent analyses of the chronicity indices applied in the study (CPG, 
MPSS and intensity and duration) with other chronicity indices such as the Örebro 
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Musculoskeletal Pain Questionnaire (Linton & Halldén, 1998) or the Heidelberg Short 
Questionnaire (Neubauer, Junge, Pirron, Seemann, & Schiltenwolf, 2006) would be 
also recommended in order to validate the results. It is expected that the three 
dimensions derived in our study will be repeated, but maybe further expanded by 
dimensions comprising cognitive-evaluative or affective characteristics as implied by 
the content of the items of the latter two indices. Finally, it is obligatory that the results 
are further validated in comparable datasets of participants with MSP but also repeated 
in other exemplary groups from different pain populations for example neuropathic 
pain. 
3.3 Study 2: Sensory and clinical pain phenotypes 
The second study showed that patients with prior diagnoses of Fibromyalgia Syndrome 
(FMS) and chronic unspecific back pain (cUBP) could be reclassified into several 
sensory and clinical phenotypes by thorough sensory testing and comprehensive 
clinical pain characterization. Four clusters of differential sensory-clinical phenotypes 
were discovered that covered a spectrum from regional to widespread MSP. The final 
optimized indicator set of the clusters included four sensory markers (number of 
sensitive ACR tender and control points, test pain intensity and pressure pain threshold 
both at the trapezius tender point) and two clinical pain markers (WPI pain regions, 
present pain intensity). A consecutive discriminant analysis revealed that sensory 
markers sufficed to distinguish between the four clusters with a high correct rate. The 
sensory-clinical phenotypes differed substantially in somatic symptom burden, 
impairment and functionality. There were no differences in depression or psychosocial 
factors such as stress load.   
The results are in contrast to the recent revisions of FMS diagnostics (Arnold et al., 
2019; Wolfe et al., 2016) that rely only on a minimum number of clinical pain regions 
and symptoms of somatic and psychic comorbidity. The study showed that primary 
somatosensory characteristics suffice to differentiate within MSP groups. The most 
distinctive indicator was the tender point count.  
This strongly supports to retain the ACR tender points as markers for chronic 
widespread pain in research and clinical assessment of FMS (Wolfe et al., 1990). 
Although the pathophysiology behind the pressure pain sensitivity at these specific 
points remains unknown (Eich et al., 2017), the tender point count is supposed to be a 
differential diagnostic marker. Previous research was not able to identify a specific 
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muscle pathology behind the sensitivity at these points (Simms, 1996). More recent 
research focused on the extraction of common etiological factors of sensitive 
myofascial trigger points and the sensitivity at tender points because of their frequently 
found association (Ge et al., 2009; Ge et al., 2010). The overlap with myofascial trigger 
points proposes a peripheral etiology primarily related to muscle overuse or direct 
trauma (Bron & Dommerholt, 2012), however, there are characteristic differences 
between tender and trigger points in terms of stimulation and origin (Mense, 2011). It 
is supposed that the sensory and clinical pain phenotypes derived in the present study 
could help to identify pathophysiologic mechanisms not limited to the ACR tender 
points. Neurobiological research suppose a peripheral etiology of FMS with the pain 
maintained by a combination of tonic impulses from deep tissues together with central 
sensitization (Price & Staud, 2005). The profiling of sensitive ACR tender points 
together with other sensory characteristics such as pain thresholds at selected sites in 
various modalities could be a mean to differentiate pathophysiologic mechanisms as 
successfully shown for peripheral neuropathic pain (Baron et al., 2017). Research in 
molecular neurobiology has revealed a diversity of nociceptive neurons (Dubin & 
Patapoutian, 2010) and it is likely that patterns of differential activation of neurons are 
associated with these sensory-clinical phenotypes.  
Moreover, the sensory characteristics found in the present study are in line with other 
critical research searching for best discriminators that differentiate between patients 
with prior clinical FMS diagnosis and patients with chronic non-inflammatory rheumatic 
pain (Ghavidel-Parsa et al., 2019). These authors showed also sensory parameters as 
best discriminating, i.e., the algometer pressure pain threshold at the lateral epicondyle 
tender point. However, the results of the discriminative power of sensory 
characteristics is not limited to FMS patients, sensory nociceptive characteristics in 
three modalities (pressure, heat and cold) were also discovered to differentiate 
subgroups within chronic low back pain patients (Rabey, Slater, O'Sullivan, Beales, & 
Smith, 2015). This line of empirical evidence renders the exclusion of sensory 
characteristics in the differentiation of FMS from other regional unspecific MSP 
syndromes obsolete.  
This empirical study is in contrast to previous studies as it focused on both sensory 
and clinical pain indicators combined to derive clusters within a spectrum from 
widespread to regional pain. Other studies were either limited to correlational analyses 
and a subsequent comparison of correct classification rates of those patients 
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diagnosed by the ACR 1990 criteria vs. the ACR 2010/11 criteria (e.g., Kim, Lee, & 
Kim, 2012; Wolfe, 2003; Wolfe et al., 2010) or based on consensus by experts (Arnold 
et al., 2019). This circularity of discrimination studies using the clinical diagnoses 
based on their own criteria as external reference for hit and miss may fail to identify 
the underlying indicator dimensions and/or domains causing the apparent correlations. 
There is only one study available that extracted dimensions from the combined item 
pool of the ACR 1990 and 2010/11 criteria in conjunction with the Fibromyalgia Impact 
Questionnaire, but no sensory markers. The latter two instruments comprise clinical 
pain characteristics, in particular the number of clinical pain regions and pain intensity, 
together with not directly pain-related symptoms of psychic comorbidity, fatigue and 
impairment (Ghavidel-Parsa et al., 2019). There is no study available that 
systematically starts extracting the primary dimensions of sensory and clinical 
characteristics (cf. Figure 1 in chapter 1.1.2: process model of core eliciting and 
sustaining mechanisms in MSP becoming chronic). As a potential consequence, the 
necessary evidence why a certain correspondence of FMS classification emerged is 
lacking and might, at the worst, be the result of certain confounding variables such as 
depressive mood. These confounding variables obscure the actual causal relationship 
and hamper research on underlying mechanisms.  
The revised classification systems not only abandoned the tender point testing as 
cardinal criteria but also include characteristics of secondary comorbid somatic and 
psychiatric disorders: The ACTTION-American Pain Society Pain Taxonomy (AAPT) 
diagnostic criteria for FMS includes sleeping problems as cardinal criteria for FMS 
(Arnold et al., 2019). Apart from symptoms of fatigue and somatic complaints such as 
“pain or cramps in lower abdomen” the ACR 2010/2011 fibromyalgia diagnostic criteria 
incorporates non-somatosensory criteria such as depression (page 326; Wolfe et al., 
2016). This inclusion of non-primary pain related characteristics adds to the high 
comorbidity of FMS with functional gastrointestinal disorders but also with depression 
as repeatedly reported (e.g., Buskila & Cohen, 2007; Whitehead, Palsson, & Jones, 
2002). The high coincidence of functional gastrointestinal disorders and psychic 
comorbidity has face validity for the inclusion of such criteria. However, without 
systematic evidence showing clinical or non-somatosensory criteria corresponding to 
ACR tender points it is premature to exclude primary sensory indictors as cardinal 
criteria for FMS diagnosis.  
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Further empirical studies are strongly needed that include both sensory and clinical 
pain characteristics, isolate dimensions and derive a parsimonious set of indicators 
that differentiate within other MSP disorders with several to many pain locations.  
Replication studies, in addition, are necessary that support the sensory-clinical 
phenotypes derived in the present study. Such studies are recommended to apply at 
least the number of sensitive ACR tender points, the number of some control points, 
the WPI, a specific near-threshold intensity rating and a corresponding algometer pain 
threshold, the latter both measured at the trapezius ACR tender point. Depending on 
the sample size, it would be highly appreciable to include other sensory-clinical pain 
characteristics, such as supra-threshold sensitivity or sensitization to heat pain 
together with the temporal pattern of clinical pain. If other secondary indicators are 
subsequently integrated, e.g., indicators of fatigue or depression, resulting model fits 
could be compared.   
3.4 Conclusions: Relevance for basic science and clinical settings 
The dissertation project showed a systematic phenotypic approach to derive 
distinguishable dimensions within chronic MSP syndromes from primary sensory-
clinical pain characteristics to distal psychosocial factors. The studies discovered a 
multidimensional structure of chronicity and identified necessary and sufficient sensory 
and clinical indicator domains able to differentiate between different MSP syndromes. 
The following paragraph discusses the implications for research and clinical practice. 
3.4.1 Multidimensional assessment of the chronicity construct 
Chronicity in MSP was discovered as inherently multidimensional construct. There was 
evidence for at least three core domains of chronicity in MSP, i.e., the primary clinical 
pain characteristics, the direct consequences of current interference with activities and 
aspects of the patient history (duration and health care utilization), which are only 
weakly coupled and varied across syndromes. The results underline that there is no 
single ‘chronicity’ entity, for all syndromes and all pain populations, over the whole 
range of severity and durations of the pain disorder. At present, evaluation of chronicity 
should be specific to the syndrome considered as well as the population and diagnostic 
context of the person investigated. Sticking to global indices leads to inherently 
inhomogeneous patient groups that obscure the relationships of predictive factors and, 
hence, hampers the necessary search for core mechanisms in chronic MSP. 
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As a desideratum it is recommended to use a 3- to 4-dimensional (multivariate) instead 
of global (scalar) indices in assessing chronicity, in particular, of musculoskeletal pain. 
The items should assess as a minimum requirement the primary clinical 
characteristics, the direct consequences of current interference with activities and 
aspects of the patient history. The study reminds researchers and medical practitioners 
to consider the inherently multidimensional structure behind the chronicity construct. 
The appropriate consideration of this multivariate clinical endpoint criterion establishes 
the basis for mechanism-oriented research on differential pathophysiology in chronic 
MSP syndromes.  
3.4.2 Main indicator domains for chronic musculoskeletal pain 
The second study showed that subsyndromes within the continuum from regionally 
confined to widespread chronic MSP were primarily discriminable by sensory pain 
characteristics (i.e., number of sensitive ACR tender and control points, test pain 
intensity and pressure pain threshold both at the trapezius tender point) which 
differentiated four meaningful phenotypes relating to different pain processing and 
symptom generation. The cluster of regionally confined pain comprising patients only 
weakly pressure sensitive was separated from the cluster of widespread pain, entailing 
patients with high pressure sensitivity. It is assumed that the former cluster of regional 
pain relates to peripheral sensitization whereas the latter cluster of widespread pain is 
more likely to be associated with central sensitization (Graven-Nielsen & Arendt-
Nielsen, 2010; Roussel et al., 2013; Staud, 2002). The two intermediate clusters are 
supposed to be in a transition stage from regional to widespread pain and, hence, the 
relative importance of peripheral and central processes is supposed to be shifted 
accordingly. One of the intermediate clusters did not fit as well as the other cluster into 
the continuum from regional to widespread pain. It comprised exclusively cUBP 
patients and, hence, is suggestive for a distinctive pathogenetic determination related 
to back pain but deserves further research in order to substantiate a differential 
assessment of this group of patients in comparison to patients with multilocular or 
widespread pain.  
Furthermore, there was evidence for a lowering of heat pain thresholds in the pressure 
sensitive, FMS-like, clusters 1 and 2. In particular, the tonic heat pain thresholds at the 
trapezius and thenar differed significantly between cluster 1 and 2 vs. cluster 3 and 4 
underlining the assumed involvement of central sensitization in these first two clusters. 
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However, this result bases on ex-post comparisons and low power due to the reduced 
sample size in the dataset with pressure and heat pain indicators combined. 
The best clinical indicator was the number of pain sites as measured with the WPI, but 
could be also replaced with other regional indices such as the number of pain regions 
according to the IASP Taxonomy of chronic pain. By comparison, the pain intensity did 
not proof as distinctive indicator. Moreover, secondary indicators for psychic 
comorbidity or psychosocial aspects did also not differ between the sensory-clinical 
phenotypes and, thus, were considered as not necessary to differentiate 
subsyndromes within MSP. 
In summary, the results suggest that necessary and sufficient indicator sets to identify 
meaningful pain phenotypes within the spectrum from regional to widespread MSP 
required at least three sensory indicator domains: (1) the spatial distribution of 
hypersensitivity to percutaneous pressure, (2) pressure pain sensitivity as measured 
with quantitative sensory test measures and, although only weakly supported with the 
available data, (3) quantitative sensory test measures of non-mechanoceptive 
modalities such as cutaneous heat pain sensitivity.  
As a desideratum it is recommended to apply a representative measure of each of the 
three sensory domains in diagnostic assessment of chronic MSP syndromes. For 
practical reasons the assessment could be in form of bedside testing and might include 
a reduced number of sensitive control points. The results remind researchers and 
physicians of the importance of sensory testing yielding different and even more 
differential diagnostic information than the clinical pain assessment. 
3.4.3 Categorical vs. dimensional diagnostics 
The dissertation aimed at setting the necessary prerequisites for a dimensional 
assessment of MSP with the identification of phenotypes that base on core domains 
related to pathophysiologic mechanisms in chronic MSP. Given the heterogeneity and 
the diversity of initializing and sustaining mechanisms of chronic MSP, the common 
diagnostic classification systems started by revising the coding of chronic unspecific 
MSP syndromes in order to eliminate the dichotomy of chronic pain with either somatic 
or psychosomatic origin (cf. 1.2.1 Diagnostic of medically unexplained pain in general 
introduction). However, aspects of depression or mental distress are still included as 
cardinal criteria for these unspecific MSP disorders (cf. DSM IV; American Psychiatric 
Association, 2013). The results of the PhD thesis contradict the inclusion of such 
secondary characteristics since the systematic phenotypic approach showed sensory 
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and clinical pain indicators as sufficient to discriminate within chronic unspecific MSP 
syndromes. Moreover, depressive symptomatology did not differ between the resulting 
phenotypes. A translation of these results into application within these classification 
systems would be highly appreciable and is supposed to result in the end of an 
inclusion of symptoms of spurious comorbidity diagnoses in the diagnostic of MSP pain 
syndromes. 
The dissertation study applied a dimensional approach, which enabled data analyses 
of distinguishable core domains with high statistical power. This in contrast to the 
available diagnostic manuals which apply a categorical classification despite the 
inherent dimensional nature of continuous clinical phenomena (Chmura Kraemer, 
Noda, & O'Hara, 2004; Goldberg, 2000). Diagnostic categories are assigned for a 
certain number of symptoms, leaving the decision to what extent the symptom has to 
be present to fulfill a criterion to the clinician. Those patients that exhibit several 
symptoms qualifying for more than one diagnosis receive a comorbid diagnosis. This 
common practice contributes to potential variation within different patient diagnoses, 
as the actual contributing dimensions causing the symptomatology are obscured. 
By comparison, dimensional diagnostic approaches quantify within a spectrum of 
multiple continuously or ordinally scaled dimensions across different diagnoses - as 
shown for mental disorders in the Research Domain Criteria project (RDoC) (Cuthbert, 
2014). The dissertation project postulates that chronic MSP syndromes can be 
specified within the same spectrum of multiaxial dimensions that are related to proximal 
(close to the pain physiology) over intermediate (pain sustaining) to distal (secondary 
pain modulating) mechanisms. Further studies using a systematic phenotypic 
approach with more extended sensory and clinical indicator sets promise to detect 
additional dimensions at the next level of approximation to the multi-staged cascade 
of pain becoming chronic. 
3.4.4 Empirically guided intervention assignment 
A dimensional phenotypic classification could also improve the selection of necessary 
modules within multimodal pain therapy (Mathews, 2014). There is a high need to 
standardize the selection of modules specific to the pain symptomatology in order to 
avoid polypragmasia (Kaiser, Treede, & Sabatowski, 2017). Recent revisions of 
diagnostic classification systems (cf. DSM-V: somatic symptom and related disorders, 
American Psychiatric Association, 2013; ICD-11: chronic primary pain, Treede et al., 
2015) do not provide individual treatment recommendations, leaving the decision to 
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physicians and therapists. Although the results of this dissertation do not cover such 
individual treatment decisions, they might serve as basis for group level decisions as 
exemplarily attempted in Figure 2 (Flowchart of empirically guided treatment 
components of multimodal pain therapy as derived from the dissertation results).  
Patients suffering from chronic MSP with a prior diagnosis of FMS or cUPB would now 
be further distinguished by sensory and clinical characteristics (as derived from the 
pain and pressure sensitivity profiles in the second study; cf. Figure 4 and Table 4 B). 
Chronicity was identified as multidimensional construct composed of at least three 
dimensions (severity, impairment and duration) as one of the essential results of the 
first study. Empirical research would now be necessary that combines the different 
dimensions inherent in the chronicity construct with the sensory-clinical pain 
phenotypes. However, for this exemplary treatment derivation it is assumed that both 
patient groups present, on average, medium severity and impairment with relatively 
long duration >60 months (cf. Table 1B and Table 2 in second study). Treatments are 
selected corresponding to the indicator domains at the proximal level as previously 
derived from the process chart of mechanisms in pain becoming chronic (cf. Figure 1 
in chapter 1.1.2); i.e., each sensory-clinical phenotype is associated with a specific 
sensory or perceptual pain therapy at the same level closely related to the pain 
pathophysiology. 
Those patients qualifying for the cluster of widespread pain with high pressure 
sensitivity (cluster 1; cf. Figure 2, left) are supposed to benefit from a desensitization 
training that increases the pain tolerance at selected ACR tender point sites which had 
been shown to have limited success in complex regional pain syndrome (Harden et al., 
2013). The pathophysiology behind the pressure pain sensitivity at ACR tender points 
is still unknown (Eich et al., 2017), however, as the sensitivity at the ACR tender points 
was shown as most distinctive indicator in the second study, it is supposed that the 
pain therapy should also directly target this sensory phenomenon. As the pressure 
pain sensitivity at the right trapezius quantitatively assessed by the algometer was only 
reduced in this cluster 1 and corresponding pain intensity of the manual probe high, 
the pain tolerance training is recommended to start at this specific ACR tender point 
(cf. for more details on sequence of loci to be trained in caption of Figure 2). The 
pressure at each specific site shall be increased gradually starting below the individual 
pain threshold in the initial examination. 
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The desensitization training is effective if the patient reports a decreased number of 
sensitive ACR tender points. This sensory generalization may also lead to a reduction 
of clinical pain sites and, thus, a reduced WPI. Under the condition that sensory 
generalization was successful the supposed general hypervigilance to somatic or 
visceral afferent signaling underlying gastrointestinal or heart complaints could be 
checked by assessing elevated scores in somatic comorbidity (cf. caption of Figure 2 
and discussion section in the second study). If the scores of somatic symptom 
complaints are very high, it is supposed that patients might benefit from a direct 
perceptual training that aims to shift the attention away from the clinical pain 
symptomology and overall somatic input (Kleinstäuber, Thomas, Witthöft, & Hiller, 
2018). The differential selection of treatment modules could be supplemented by a 
training to increase physical functioning by physiotherapy (Kaiser et al., 2017), since 
the overall functional capacity was evaluated as relatively low in cluster 1 and 2. 
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WPI ≥ 8 and 
sens TPs ≥ 10 and 
PPT qst trap-r < 2.5
Desensitization 
training 
(TP at trapezius –> 
pain site with 
highest pain)
Somatic 
comorbidity
yes
attention training 
to reduce general 
hypervigilance to somatic or 
visceral afferent signaling 
yesCluster 1
Generalization 
successfull
no
next module
 (e.g., physical reconditioning 
with physiotherapist)
no Cluster 3
Attention training
 adapted for back 
pain
Vary 
application site  
or change 
application 
mode 
WPI ↓
sens TPs 
> 2 and <10
yes
‘Light’  
desensitization 
training 
specific for painfull 
tender points
yes
yes
no
Intermediate 
Clusters
mixed
yes
Cluster 2
no
Cluster 4
WPI ≥ 8 and 
sens TPs ≥ 10 and 
PPT qst trap-r ≥  2.5
Adapted 
desensitization 
training 
(sites with 
highest pain 
ratings first)
Attention 
training
adapted for 
multilocular 
pain
no
Functional 
capacity 
yes
Body-oriented therapy
time- or aim-contigent 
increase in activity
next module
 (e.g., reduce pain medicine)
Chronicity
Severity & impairment: 
Medium
Duration: High       
yes
no Conduct further empirical research on subgroups
Chronic
unspecific MSP 
(FMS/cUBP)
 
Figure 2: Flowchart of empirically guided treatment components of multimodal pain therapy 
as derived from the dissertation results. Exemplary treatment indication schema for the four 
clusters identified in the second study for the application of selective modules (abbreviations 
as in Figure 4 in the second study). It is assumed that both patient groups with a priori diagnosis 
of FMS or cUBP report pain since a long duration and, on average, medium values in severity 
and impairment (empirical research would be necessary for patients with other values on these 
dimensions inherent in the chronicity construct). A Widespread Pain Index (WPI) of ≥ 8, 
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sensitive ACR tender points (sens TPs) ≥ 10 and a reduced pressure pain threshold at the 
right trapezius (PPT qst trap-r) of <2.5 kp in the algometer testing differentiated best between 
cluster 1 vs. cluster 3 (cf. Table 4 B and Figure 5 in the second study). 
Those patients qualifying for cluster 1 (left) are recommended to receive a desensitization 
training with an algometer. The study’s results suggest to start generalizing the pain tolerance 
at the right ACR trapezius tender point, since the pain intensity at this particular tender point 
differentiated the sensory-clinical profile clusters best after the overall ACR tender point count. 
If the pain threshold and the corresponding pain intensity rating can be increased, the left 
trapezius followed by the tender point with the next highest pain intensity in manual probe is 
recommended to be trained bilaterally. It is supposed that a generalization of the training to 
other loci has started If the pain thresholds have increased at all four sites selected. Under the 
condition that there is no generalization, it is suggested to expand the training to other more 
distal sites, e.g., the tender point at the knee, or to vary the application mode, e.g., with pinprick. 
The sensory generalization is also supposed to result in a decreased number of clinical pain 
sites (WPI). The therapy could be continued with the treatment of the general hypervigilance 
to input of somatic or visceral afferent signaling assessed by somatic symptom complaints (cf. 
Table 5: Giessen Symptom Questionnaire, GBB-24; Brähler, Hinz, & Scheer, 1995). If the 
GBB-24 scores are high, it is supposed that patients might benefit from an expanded attention 
training to reduce the possible hypervigilance to overall somatic input such as gastrointestinal 
or heart complaints. The differential allocation of modules could be continued with physical 
reconditioning (cf. Table 5: functional capacity decreased in cluster 1, assessed by Hanover 
Functional Ability Questionnaire FFbH-R; Kohlmann & Raspe, 1996). 
For those patients qualifying for cluster 3 (right) with regional pain an attention training adapted 
for chronic back pain is recommended. If this attention training is ineffective and patients have 
also a limited number of sensitive tender points, a reduced version of the desensitization 
training could be applied. This ‘light’ version would target the particular sensitive tender points, 
starting with the respective point with the highest pain intensity and continue with the second 
highest pain intensity rating and so forth. Both trainings, the desensitization and the attention 
training, could be supplemented with a body-oriented therapy. This body-oriented therapy is 
recommended to implement a time- or aim contingent increase in activity, since the functional 
capacity in cluster 3 remained high. The next module could focus on a decrease of pain 
medication. 
The intermediate cluster 2 (middle left) might also benefit from an adapted desensitization 
training. This training is recommended to start at the specific tender point with the highest pain 
rating in manual probe and would then be continued with the second highest and so forth. In 
contrast to cluster 1, the application will not necessarily start at the trapezius ACR tender point, 
since patients in this cluster do not report a reduced pressure pain threshold in the algometer 
test. A generalization occurs if pain thresholds have increased at the four sites with the 
respective highest pain rating. If no generalization occurs, the decision tree corresponds to 
cluster 1 which suggests to vary the application site or to vary the application mode.  
The intermediate cluster 4 (middle right) is considered to benefit from an attention training 
adapted for multilocular pain followed by the ‘light’ version of the desensitization training. 
 
 
By comparison, for those patients qualifying for the cluster of regional pain (cluster 3; 
cf. Figure 2, right) an attention training adapted for chronic back pain is recommended 
that aims to shift attention away from the back pain (cf. Kleinstäuber et al., 2018). The 
patients in this cluster were shown to be weakly pressure sensitive but reported clinical 
pain at the back, hence, the training was supposed to target the clinical pain 
perception. Therapy effectiveness should be assessed by the clinical endpoint of a 
decreased WPI with special emphasis on back or spine locations. Another option, 
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under the condition of missing therapy success, might be the application of a body-
oriented therapy that indirectly aims to shift the attention away from the pain utilizing 
the remaining functional capacity of those patients in cluster 3 and cluster 4. This body-
oriented therapy is recommended to apply the time- or aim-contingent increase of 
activity irrespective of the pain symptomatology (Flor & Turk, 2011b; Geneen et al., 
2017; Marley et al., 2017). The next following module could comprise the medical 
assistance to decrease the use of pain medication as a modulating variable (for a 
possible implementation: cf.  Flor & Turk, 2011b). 
For the intermediate clusters (cluster 2 and 4; cf. Figure 2, middle) not meeting all of 
the specific criteria (i.e., high scores in WPI and tender point count, but reduced 
pressure sensitivity) the previous treatment suggestions have to be adapted. It is 
suggested that those patients in cluster 2 (cf. Figure 2, middle left) with high WPI and 
high tender point count also receive a desensitization training, since the number of 
sensitive tender points remains still high in this group. However, as the algometer 
pressure pain threshold at the trapezius is not reduced in this group, the desensitization 
training would start at the specific tender point with the highest pain intensity in manual 
probe and follow a generalization plan that continues with the next highest pain 
reported (cf. caption of Figure 2 for details). Those patients in cluster 4 (cf. Figure 2, 
middle right) reporting multilocular pain in the WPI and some sensitive ACR tender 
points (cf. Figure 2, right: sens TP > 2 and <10) are recommended to receive an 
adapted attention training for multilocular pain not specifically related to back pain (cf. 
Kleinstäuber et al., 2018). Patients in this cluster might be in a transition stage from 
localized to widespread pain, hence, this attention training is supposed to highlight the 
perceptual processes that are involved in the generalization of pain to other body parts. 
The training effectiveness is again measured by a reduced WPI. Under the condition 
that this adapted attention training for multilocular pain is not effective, a ‘light’ 
desensitization training is suggested that only treats the limited number of sensitive 
ACR tender points (cf. caption of Figure 2 for details). 
This example for an empirical deduction of treatment modules is reduced to primary 
sensory and perceptual treatment options, but would be expanded accordingly if other 
domains were considered in empirical phenotyping of chronic MSP.  
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3.5 Open questions and outlook 
Both studies contributed to the understanding of the multifactorial structure of 
chronicity and the particular relevance of sensory characteristics in the assessment of 
MSP syndromes, but also raised further questions. 
The two studies provide a way to empirically assess necessary and sufficient 
characteristics referring to marker domains in chronic MSP syndromes and highlight 
the advantages to consequently follow a phenotypic approach in order to derive a 
dimensional diagnostic. Future studies could continue this work and combine the 
necessary components of chronicity (duration, severity and impairment) and the 
sensory and clinical pain phenotypes in sample selection. A possible realization might 
be starting with selected samples that share the same sensory and clinical pain 
characteristics of one out of the four empirically derived clusters in the second study. 
These samples would be subsequently assessed for the inherent chronicity 
components preferably analyzed by linear and probabilistic structure finding 
procedures (e.g., with principal components and latent class analyses). It is expected 
that the sensory-clinical phenotypes will be split up in further subsamples depending 
on their relative loading on the chronicity components. Patients with a longer pain 
history might, for example, reveal moderate values in pain intensity. The selection of 
further possible indicator variables supposed to better inform the existing phenotypes 
would then also start at proximal domains closely related to the pain pathophysiology 
and end at distal marker domains comprising comorbidity and psychosocial aspects 
(cf. Figure 1 in chapter 1.1.2 and Table 1 in chapter 1.1.3). In the example of patients 
reporting a relatively long pain duration with moderate values of pain intensity, the 
proximal to distal selection strategy for the next indicators would include markers of 
affective pain perception. Marker variables would, thus, be selected out of the affective-
motivational domain. The next following level would be a selection of marker variables 
out of the cognitive-evaluative domain and so forth. In this regard, it could be also likely 
that there emerge certain dimensions involving aspects of more than one domain, e.g., 
suffering comprising the affective but also cognitive load caused by the pain 
symptomatology (Bustan et al., 2015). The clusters would, finally, be checked for 
possible differences in psychosocial factors. Of course, this systematic phenotypic 
approach needs to be assessed in large samples comprising diverse musculoskeletal 
patient clients with heterogeneous characteristics.  
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Another interesting field of research is the identification of neuronal and neurochemical 
differences in the emerging sub-clusters. It is likely, that the phenotypes identified by 
this thorough mechanism-oriented deduction also share the same structural and 
endocrinological characteristics.  
The phenotypic characterization presented here serves as an example for a 
dimensional assessment of musculoskeletal pain syndromes. The results help to 
identify necessary and sufficient marker variables necessary to identify subgroups 
within musculoskeletal pain syndromes differing in pain processing and maintaining 
factors. A dimensional assessment closely related to involved pathogenetic 
mechanisms contributes to the adequate and economic selection of modules within 
multimodal pain therapy. This opens another interesting field of research that evaluates 
therapy success by comparing a focused sequential pain therapy by one of the 
conventionally applied multimodal pain therapy in selected pain centers. 
 
Summary 
 
 157 
4 SUMMARY 
The dissertation investigated the differentiation of subsyndromes in a spectrum from 
regional to widespread chronic musculoskeletal pain on the basis of mechanism-
related somatosensory and clinical phenotypes within the framework of the 
multidimensional model of chronic pain. The first study analyzed the dimensional 
structure of the chronicity construct and its necessary and sufficient components. The 
second study identified discriminable pain-related phenotypes in two exemplary 
syndromes of chronic musculoskeletal pain by a stepwise cluster-analytic approach 
and related these to secondary comorbidity and psychosocial factors. 
In the first study, diagnostic entrance data of 185 patients with chronic regional vs. 
widespread musculoskeletal pain (unspecific back pain, fibromyalgia syndrome) from 
regional pain clinics and of 170 active employees in a nationwide prevention program 
were included in a retrospective cross-sectional analysis to reanalyze the construct of 
chronicity. The marker sets of three established chronicity indices (IASP Pain 
Taxonomy Axis IV, Chronic Pain Grade, Mainz Pain Staging System) were reanalyzed 
by correlations and frequency distributions of successive duration classes. Factor and 
latent class analyses were applied to assess the dimensional structure of pain and 
chronicity. Pain intensity distributions showed inhomogeneous courses from short to 
long durations differing between groups. Both dimensions, pain intensity and duration, 
related unsystematically to CPG and MPSS. Different dimensions and clusters of 
chronicity markers were discovered, that differed between the groups (three 
dimensions and clusters in patients, two dimensions and clusters in employees). In 
fact, there was evidence for at least three weakly coupled core domains of chronicity, 
i.e., the primary clinical pain characteristics, the direct consequences of current 
interference with activities and aspects of the patient history (duration and health care 
utilization). 
In the second study, the sensory and clinical characteristics of the patient sample were 
reanalyzed to identify necessary and sufficient markers differentiating subsyndromes 
with different sensory-clinical phenotypes along the continuum from regionally confined 
to extensively widespread pain. For this purpose, 107 chronic unspecific back pain 
patients and 78 patients with fibromyalgia syndrome were taken as exemplary 
instantiations with circumscribed diagnoses. Four clusters of differential sensory-
clinical phenotypes covering a spectrum from regional to widespread pain were 
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discovered on the basis of four pressure pain sensitivity markers (number of sensitive 
ACR tender and control points, test pain intensity and pressure pain threshold) and 
two clinical pain markers (number of pain regions, present pain intensity). A 
consecutive discriminant analysis showed that the pressure sensitivity markers alone 
sufficed already to discriminate between the clusters with a high correct rate. The 
sensory-clinical phenotypes differed also in other somatic symptoms and impairment 
but not in psychopathology nor in psychosocial co-factors. 
The project showed that differential diagnostics of chronic musculoskeletal pain 
requires at least a multifactorial determination of its chronicity with respect to the 
necessary components of duration, severity and impairment and the identification of 
the individual pain phenotype by comprehensive sensory and clinical assessment. This 
is considered as the prerequisite of differential indication of specific modules in 
multimodal pain therapy to avoid unselective polypragmasia. 
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